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Summary 
 
Dry powder inhaler (DPI) formulations are usually comprised of a mixture of 
micronised active pharmaceutical ingredient (API) with aerodynamic diameter 1-5 m 
to allow deposition in the lower airways, and a coarse (~70 micron) excipient, 
typically -lactose monohydrate, used to aid the handling, metering and dosing of the 
formulation. These components are usually combined in a secondary manufacturing 
process such as high shear blending (HSB), which is used primarily to distribute the 
cohesive drug particles throughout the bulk excipient to create a chemically 
homogeneous formulation.  
This thesis explores the use of HSB to produce mimic DPI formulations and assesses 
the effect of different blending and storage regimes on various physicochemical 
properties of such powders. A novel fluidised bed elutriation (FBE) technique was 
developed to test the ability of fine mimic drug particles to separate from coarse 
particles in such formulations, along with conventional air jet sieve (AJS) and Next 
Generation Impactor (NGI) studies.  
Results showed that, generally, blending regimes were seen to have little effect on the 
in vitro performance of these mimic formulations, with extended storage at high 
humidity having a more profound effect on the separation of fine particles. Tests on the 
performance of formulations using the FBE technique showed that fluidisation 
performance alone is insufficient to identify blending-induced changes; however, 
analysis of the fine elutriated fraction has shown subtle changes in the populations of 
particles due to HSB. Notable differences were observed between the mimic cohesive 
and adhesive drugs, indicating the ability of these tests to identify formulations with 
different adhesive properties. In addition, a study to determine the specific energy 
input (SEI) required to achieve chemical homogeneity suggested that extended high 
shear blending beyond a given energy input may only alter the size distribution of the 
formulation, and not improve homogeneity, thus having implications for the 
manufacture of such products.  
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1.0. Introduction 
ABSTRACT 
Dry powder inhalers (DPIs) are commonly used devices employed to facilitate the 
delivery of drug formulations designed to treat a range of lung disorders including 
asthma and chronic obstructive pulmonary disease (COPD). The powders used in such 
treatments often consist of a near-homogeneous, interactive mixture of micronised 
(1-5 m) active pharmaceutical ingredient (API) and coarse (~70 m), inert excipients 
(usually -lactose monohydrate) added to aid the dispensing, filling and metering of 
the formulation. These formulation components are usually combined in a secondary 
manufacturing process; with high shear blending (HSB) being the focus of this thesis. 
During an inhalation event, drug particles separate from excipient and deposit in the 
lower airways – the site of action. This chapter reviews the many factors influencing 
the efficiency of drug-carrier detachment, along with methods to test the adhesive 
strength between drug and excipient. 
A key area of focus for DPI formulation production is the establishment of techniques 
to monitor the properties of the formulation throughout the manufacturing process, in 
an attempt to identify and correct problems as soon as possible in order to reduce 
batch wastage. 
This chapter introduces the possibility of employing a novel fluidised bed elutriation 
(FBE) method to assess the bulk-scale properties and characteristics of DPI 
formulations – work which forms the basis of chapters 5 and 7 of this thesis. 
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1.1. History of Inhalation Therapy and Devices 
The use of dry powder inhalers (DPIs) in the medical treatment of a range of lung-
related and systemic conditions requires the careful design and manufacture of an 
array of products and formulations in order to deliver the desired therapeutic effect. 
Considerations need to be made regarding the patient’s lung physiology, and design of 
both the inhaler and the formulations containing the active pharmaceutical ingredient 
(API). Key factors involved in the delivery of powders include the physiology and 
deposition mechanisms associated with the various regions within the lungs and the 
physicochemical properties of the formulations, including particle size, shape, 
morphology, and chemistry (Hickey et al., 1994). In addition, the processing stages 
involved in formulation manufacture play a vital role in the product’s efficacy, along 
with the mechanisms responsible for transferring powder from a static bed within the 
device to an aerosol for delivery to the lungs. Each of these factors is described in this 
chapter; however, the key focus of this thesis involves the effect of high shear blending 
(HSB) – a secondary manufacturing process for combining drug and excipient - on the 
in vitro performance of DPI formulations. 
Delivery via the respiratory tract is one the oldest and most common methods for 
administering drugs into the human body. Aerosols, smoke, vapour, and gases have 
been inhaled for many centuries in an attempt to cure or treat a wide range of 
ailments. Pulmonary administration is desirable for several reasons, not only for local 
therapy in the lungs but also for systemic treatments throughout the body (Grossman, 
1954; Gonda, 1990, 2006; Siekmeier and Scheuch, 2008; Allen, 2008).  
Inhalation therapy has a long history, with leaves of the Atropa Belladonna plant and 
the leaves and flowers of the Datura Stramonium smoked as cough suppressants, up 
until the 1950s (Grossman, 1954). Modern inhalation therapy began in the nineteenth 
century when nebulisers were introduced, although more compact treatments began 
with the first pressurised metered dose inhaler (MDI) developed in the 1950s 
(Medihaler®, Riker). However, MDIs were reliant on ozone-depleting 
chlorofluorocarbons (CFCs) as propellants, consequently, the Montreal Protocol 
(1987) required the substitution of CFCs with hydrofluoralkanes (HFAs) and 
subsequent reformulation of MDI formulations (Ashurst et al., 2000). 
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In 1970, the first breath-actuated DPI was introduced onto the market (Fisons 
Spinhaler®). Since then, many different varieties of DPIs have been developed, both 
multi- and single-dose devices, using technologies drawn from a range of disciplines. 
These developments were stimulated by the dramatic increase in patients suffering 
from asthma and chronic obstructive pulmonary diseases (COPDs) in the twentieth 
century, along with the desire to develop a non-invasive method of drug delivery for 
formulations that cannot be delivered orally to the gastrointestinal (GI) tract, or have a 
low bioavailability via the oral route, such as therapeutic peptides and proteins for 
systemic action (Zijlstra et al., 2004; van Drooge et al., 2005).  
The differences between MDIs, DPIs, and nebulisers are based on the physical states of 
the dispersed phase and continuous medium; within each category, there are different 
types of system based on the method of metering and dispersion. 
The clinical performance of the various types of inhalation devices has been 
extensively reviewed (Barry and O’Callaghan, 2003; Dolovich et al., 2005), with 
conclusions made that no class of device is superior, and that choice should be based 
on convenience, cost, patient preference, and treatment required. With a global market 
share of about 80%, the MDI remains the most widely used device (O’Connor, 2004). 
Since a MDI is pressurised, the dose is emitted at high velocity, hence premature 
deposition in the oropharynx is likely (Newman and Clarke, 1993; Ganderton, 1997). It 
has also been found that due to incorrect use of MDIs - in particular, the poor 
coordination of actuation and inhalation - decreased asthma control has been found in 
a substantial proportion of patients treated with corticosteroid MDIs (Giraud and 
Roche, 2002). 
1.2. Dry Powder Inhalers 
Since the introduction of the first DPI in 1970 (Ashurst et al., 2000), many variations of 
the DPI have been developed, although they are generally classified as being either 
unit-dose or multi-dose inhalers. The sharp rise in the number of cases of lung-related 
illnesses in the 20th century stimulated the development of DPIs, although possibly the 
most crucial event leading to the advance in technology was the prohibition of 
chlorofluorocarbons (CFCs) as propellants in MDIs. Since CFCs are known ozone 
depleters, the introduction of hydrofluorocarbons (HFCs) as a replacement propellant 
required the formulations used in MDIs to be redesigned. 
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One of the advantages of DPIs over MDIs is removal of the need for patient 
coordination in administration of the drug. DPIs in common use today are often 
breath-actuated and the energy for powder dispersion and generation of the aerosol is 
derived from the patient’s inhalation. This method alleviates the problem of 
coordination of actuation and inhalation that many patients (particularly children and 
the elderly) have with MDIs. DPIs are thus far easier to use, and offer more stable and 
efficient systems.  
DPIs comprise various types (multi-unit dose, multi-dose reservoir, single-unit dose, 
single-use disposable – shown in Fig. 1.1). A more detailed description of each type of 
DPI is given by Daniher and Zhu, (2008).  
Reservoir systems that have simple designs where the formulation is stored in a bulk 
chamber within the device are far cheaper to produce than the factory metered 
designs; however, they have the disadvantages of having lower dose reproducibility 
due to inconsistent powder dispensing and having less moisture protection. Factory-
metered blister strips allow greater reproducibility of dose due to the consistency in 
controls for metering, however due to the large number of components required, the 
costs of pre-metered DPIs is a drawback. 
The active ingredients within these systems typically comprise particles with 
aerodynamic particle size that allows deposition in the tracheobronchial regions of the 
lungs (1-5 m – Newman and Clarke, 1983). However, powders of this size are 
notoriously cohesive and in order to improve handling, dispersion and metering, the 
active ingredient is often mixed with an excipient carrier of larger (~70 m) mean 
geometric particle size (Bridson et al., 2007).  
The major factor in the design of DPIs is the need to overcome the strong interparticle 
forces between API and excipient to produce an aerosol consisting primarily of de-
agglomerated particles with an aerodynamic diameter suitable for lung deposition at 
the target area (Hickey et al., 1994; Timsina et al., 1994). Often, forces generated in 
passive DPIs are insufficient to overcome these interparticle forces, thus only a small 
fraction of dose is available for efficient inhalation. Engineers specialising in fluidised 
bed technology have suggested numerous mechanisms to reduce interparticle forces in 
DPI formulations, in order to improve aerosolisation. Such methods include: passing 
aerosol through Venturi tubes to increase velocity; impaction against baffles, plates, or 
Investigation into the Effects of High Shear Blending and Storage on Powders for Inhalation 24 
Introduction 
other surfaces; circulation and cyclone chambers, or by using pressurised air and 
vacuum chambers (Finlay, 2001). In addition, external energy may be applied to 
enhance deagglomeration within the device – these are known as active DPIs. Active 
DPIs have integrated energy and dispersion sources (compressed air, battery, or spring 
mechanisms to store energy – Crowder and Hickey, 2006) and enhance the dose 
reproducibility and reduce dependence of the patient’s inspiratory flow rate, 
coordination and ability to generate sufficient pressure (Tobyn, et al., 2004). In 
addition, several power-assisted devices have been developed that utilise vibration 
(Crowder, 2004); pneumatics, or impaction forces (Crowder et al., 2001). Naturally, 
these are preferred for children and patients who cannot generate sufficient pressure 
or flow rate on their own.  
Despite these advantages, active DPIs are complex and expensive to both develop and 
manufacture and their intricate nature leads to regulatory approval issues; however 
since they require little or no coordination, active DPIs frequently achieve better lung 
delivery than analogous MDIs (Dunbar et al., 1998; Labiris and Dolovich, 2003).  
Different available DPI designs result in varying resistances to airflow during 
inhalation; the fine particle output of the device depends on the generated inspiratory 
flow profile, the inhaler design, and the powder formulation. Therefore, for a particular 
device-formulation combination, there exists an optimal flow profile at which 
maximum fine particle generation occurs (de Koning et al., 2002). 
 
 
Fig. 1.1. Illustration of four dose design options available for DPIs (adapted from Daniher and Zhu, 2008). 
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Since DPI formulations are typically one-phase, solid particle blends, they are 
preferential to MDIs from a stability and processing standpoint (Borgstrom et al., 
1996; Ashurst et al., 2000). Dry powders are at a lower energy state, which reduces the 
rate of chemical degradation and the likelihood of reaction with contact surfaces. In 
addition, MDI formulations, which include propellant and cosolvents, may extract 
organic compounds from the device components, thus subjecting the patient to 
unnecessary chemical exposure (Norwood et al., 1995). However, since administration 
is controlled by inspiration alone, patients with COPDs and subsequently low 
inhalation flow rates, certain DPIs may be unsuitable (deBoer et al., 1997).  
Generation of a DPI aerosol begins when movement initiated by a patient’s inspiratory 
airflow disperses a static bed. When the patient inhales, airflow through the device 
creates shear and turbulence; air is introduced into the powder bed, the static bed 
becomes aerosolised and enters the patient’s airways (Fig. 1.2). The drug particles then 
separate from the carrier particles and are carried deep into the lungs, while the 
carrier particles impact into the oropharynx and are removed into the GI tract (Cegla, 
2004). Therefore, the degree of deposition into the lungs is determined by the patient’s 
variable inspiratory airflow (Newman et al., 1994; Dunbar et al., 2000). Ineffective 
separation between drug and carrier is one of the main reasons (along with dose 
uniformity) behind low deposition efficiency associated with DPIs (Zeng et al., 2000a). 
 
Formulation Dispersion Deposition Pulmonary delivery
 
Fig. 1.2. Principle of DPI design. The formulation comprises micronized drug (red particles) blended with larger 
carrier particles (white blocks). The formulation is dispensed by a metering system, before being dispersed by 
an active or passive system that entrains the particles into the patient’s airways, where drug particles 
separated from the carrier particle and are carried into the lung (adapted from Telko and Hickey, 2005).  
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The degree to which drug detachment from carrier particles occurs during inhalation 
is related to the strength and efficiency of de-agglomeration forces generated within 
the inhaler, relative to the adhesive forces in the mixture (Clarke et al., 2002). The 
detachment force and adhesive force need to balance in order to achieve the required 
powder homogeneity and stability, and sufficient detachment of drug particles to 
deliver the required dose (Brown et al., 2003). 
Obtaining this balance requires the ability to control the parameters that affect the 
drug-carrier interaction in adhesive mixtures, an effective inhaler device, and an 
understanding of the detachment forces generated within the inhaler. Unfortunately, 
not all aspects of the drug, carrier, or inhaler can be controlled; both the drug and 
carrier will have natural variations in their size and shape, and their level, and nature 
of surface impurities. Variations in the manufacturing and storage conditions and in 
patient physiology make optimising performance difficult. Fig. 1.3 summarises the 
factors that affect the adhesive and de-agglomeration forces in a DPI formulation and 
their impact on the fine particle fraction (FPF) generated by the inhaler device. The 
FPF is a commonly used measure of the amount of fine drug particles in a formulation 
that can be deposited in the lower airways at the site of action; this is usually defined 
as the fraction of particles with aerodynamic diameter between 1-5 m (Newman and 
Clarke, 1983; Zanen et al., 1994). 
 
Drug:
•Type of drug
•Size distribution
•Conditioning
•Payload on carrier
Carrier:
•Surface properties
•Bulk properties
•Conditioning
•Stability
Mixture:
•Type of mixture
•Homogeneity
•Conditioning
Inhalation test
•Type of inhaler
•Inhalation manoeuvre
•Test system
FINE PARTICLE FRACTION
Mixing process:
•Type of mixer
•Mixing time
•Batch size
 
Fig. 1.3. Summary of factors that affect aerosol generation in a DPI (adapted from de Boer et al., 2003b). 
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1.3. Respiratory Tract Physiology and Deposition 
The human respiratory system is divided into three main sections, the upper 
respiratory tract consisting of the nasal passages, sinuses and throat (pharynx); the 
respiratory airways consisting of the larynx (voice box), trachea, bronchi, and 
bronchioles; and finally the lungs consisting of the alveolar ducts, sacs, and alveoli. 
Moving down the system, the airways decrease in size (Table 1.1) and numerous 
bifurcations occur, with between 20 and 23 divisions common from trachea to alveoli 
(Weibel, 1963).  
There are major advantages in administering drugs for local therapy by inhalation; 
firstly, the drug is delivered direct to the target area, hence a rapid and controllable 
effect is achieved (Niven et al., 1994). Secondly, its dose can be dramatically reduced in 
relation to oral or parenteral administration, hence systemic side effects can be 
reduced (Patton, 2000). Advantages of the systemic action of inhalation therapy 
include the non-invasive nature of the treatment, removal of first-pass metabolism of 
drug by the liver and degradation by high pH and enzyme levels (Crooks and Damani, 
1990) in the GI system (Byron and Patton, 1994; Patton, 2000; Zijlstra et al., 2004; van 
Drooge et al., 2005). In addition, the large surface area of the alveoli (80-100 m2), and 
the thin absorption barrier allow for swift uptake into the blood stream (Frijlink and 
de Boer, 2004). 
Target areas in the lungs vary with the type of disease to be treated, and subsequently, 
the type of drug to be administered. For example, asthma is usually associated with the 
lymphocytes and eosinophil cells (Krishna et al., 1997; Carroll et al., 1997). As there 
have been discrepancies about whether central or peripheral inflammation of the 
airways is more important in asthma treatment, it is recommended that inhaled 
steroids are deposited throughout the airways (Leach, 1998), and can therefore reach 
the optimal site of the small airways (Jackson and Lipworth, 1995). 
Pulmonary drug delivery is also the most efficient method to treat obstructive airway 
diseases such as asthma and COPDs. These drugs are typically 2 adrenergic agonists 
such as salbutamol and formoterol, corticosteroids or anticholinergics. Such locally 
acting drugs do not need to be absorbed into the bloodstream to exert their 
pharmacologic effect, instead, they target specific regions of the respiratory tract for 
which their effect is desired (de Jongh, 1995). For example, both corticosteroids, which 
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target inflammatory cells, and anticholinergics, which target muscarinic receptors, are 
both deposited throughout the lower airways and alveoli (Labiris and Dolovich, 2003). 
1.3.1. Deposition In The Respiratory Tract 
The deposition of particles in the lungs is reliant upon the same mechanisms that 
control collection of particles in filters. However, filtration normally occurs within a 
system at a fixed (constant) flow rate; whereas deposition in the respiratory tract 
occurs at varying flow rates due to the various geometries experienced (Table 1.1). 
Table 1.1. Characteristics of the respiratory tract with respect to drug deposition in different pulmonary 
regions, assuming a steady inspiratory flow rate of 60 l min
-1
. Dsed is the distance that a 1 m particle will 
sediment during transport to the region, Stk is the Stokes’ number for a 1 m particle in that region, whilst Re
 
is the Reynolds’ number for that region (adapted from Davies, 1961). 
Region Number 
Diameter 
(cm) 
Length 
(cm) 
Residence 
time (s) 
Dsed 
(  10
-4 
cm) 
Stk 
(  10
-3
) 
Re 
Mouth 1 2 7 0.022 0.7 0.48  
Pharynx 1 3 3 0.021 0.7 0.14  
Trachea 1 1.7 12 0.027 0.9 0.78 5010 
Main bronchi 2 1.3 3.7 0.010 0.3 0.88 3300 
Lobar bronchi 5 0.8 2.8 0.007 0.2 1.5 2220 
Segmental bronchi 18 0.5 6 0.021 0.7 1.71 942 
Intrasegmental bronchi 252 0.3 2.5 0.045 1.5 0.57 225 
Bronchioles 504 0.2 2.0 0.032 1.1 0.95 84 
Secondary bronchioles 3024 0.1 1.5 0.036 1.2 1.27 28 
Terminal bronchioles 12,100 0.07 0.5 0.023 0.7 0.93 10 
Respiratory bronchioles 1.7  10
5
 0.05 0.2 0.067 2.2 0.18 1 
Alveolar ducts 8.5  10
5
 0.08 0.1 0.44 14.5 0.01 0 
Atria 4.2  10
6
 0.06 0.06 0.71 23.4 0.01 0 
Alveolar sacs 2.1  10
7
 0.03 0.05 0.75 24.8 0.01 0 
Alveoli 5.3  10
8
 0.015 0.015 4 132   
 
The amount and site of particle deposition depends on several factors relating to the 
physical properties of the particles (size, shape, and density) and lung physiology 
(geometry, respiratory flow rate, tidal volume). The three major deposition 
mechanisms in the lung (Fig. 1.4) are impaction due to the inertia of particles, 
sedimentation due to gravitational forces, and diffusion, which is linked to the 
Brownian motion of surrounding gas molecules (Agnew, 1984; Schulz, 1998).  
Impaction 
The probability of particle deposition by impaction is governed by the momentum 
(mass and velocity) of the particle; it becomes significant during shallow breathing for 
particles >2 m and is most likely to occur in the extra-thoracic and large conducting 
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airways where flow velocities are high, and rapid directional changes in airflow occur 
(Hahn et al., 1993; Swift et al., 1988).  
Sedimentation  
The probability of sedimentation is proportional to the settling distance of a particle 
within the airways, which in turn, is dependent on the residence time and settling 
velocity (Schulz et al., 1998). As with impaction, the particle mass influences the 
settling velocity such that sedimentation becomes negligible for particles <0.5 m. 
Therefore, deposition by sedimentation occurs most frequently in larger particles with 
relatively long residence times, this primarily occurs in the small conducting airways 
and alveolar regions of the lung (Schulz et al., 1998). 
Diffusion 
The random displacement of a particle due to diffusion increases with time and 
decreasing particle diameter. The highest probability of particle deposition due to 
diffusion occurs for very small particles (<0.5 m) inhaled into the peripheral regions 
of the lung with their small airway dimensions. 
 
Impaction Diffusion
Gravity
Sedimentation
 
Fig. 1.4. Deposition mechanisms in the lung. 
 
A crucial parameter in inhalation therapy is the mass of active ingredient delivered by 
the deposited particles to the oro-laryngeal, tracheobronchial or alveolar regions. 
Hence, the particle mass deposited is crucial to the dose delivered; for example, a 2 m 
particle delivers approximately the same dose as 60 × 0.5 m particles. The mass 
deposited in the oro-larynegeal regions is highest for forced breathing, with particles 
larger than 4-6 m, thus coarse particles with high velocity usually deposit here. 
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However, quiet breathing of particles 2-4 m is sufficient to deliver the API to the 
alveolar region, and deposition in the upper respiratory tract is minimised (Gebhart 
et al., 1981; Ferron et al., 1988). Kim et al., (1994) showed that deposition of 5 m 
particles at a flow rate of 30 l min-1 was greatest in the upper airways, whereas 
sedimentation was greater in the lower airways. Maximum sedimentation was found 
to occur in the lower airways for particles between 3 and 5 m and decreased with 
particle diameter due to the reduced settling velocity. Clark and Egan (1994) 
supported these findings, and found that 5 m particles could not penetrate the 
respiratory zone (alveoli) effectively at flow rates higher than 40 l min-1. Further work 
conducted by Martonen and Katz (1993) showed that particle residence time in the 
lungs was more influential than inspiratory flow rate on particle deposition. 
1.4. Formulation Properties 
The properties of DPI formulations are vital in controlling performance (Pell and 
Dunson, 1999). A range of particle and bulk powder properties influence the amount of 
fine particles that reach the target areas of treatment; this is often defined as the fine 
particle fraction (FPF) – the amount of fine drug particles reaching the lower airways 
(Hickey et al., 1994). 
1.4.1. Forces Experienced by Formulation 
Typical DPI formulations consist of adhesive mixtures where drug particles are 
distributed homogeneously over the total surface area of larger carrier crystals 
(Boerefjin et al., 1998). The work on the adhesive strengths of DPI formulations 
follows from that by Jones and Pilpel (1965), who were the first to observe the 
adhesion of particles smaller than 5 m onto the surface of larger particles in an 
interactive powder mixture. Research on adhesive mixtures for inhalation requires the 
optimisation of homogeneity, stability, and drug-particle detachment during 
inhalation. This requires the balance of the adhesive forces in the mixture and the 
detachment forces experienced during inhalation; a “Force Distribution Concept” has 
explained the importance of this (de Boer et al., 2003a; Frijlink and de Boer, 2004). 
Drug and carrier properties, carrier payload, mixing conditions and inhaler design all 
need consideration in this necessary balance. 
The major forces which are relevant to the adhesion and separation of such particles 
include: van der Waals forces, which act between solid surfaces over distances 
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between 0.2 and 1 nm (Atkins, 1998); Coulombic (electrostatic) forces due to the 
insulating nature of the powder; capillary forces due to liquid bridges; mechanical 
forces caused by interlocking or irregularly shaped particles and surface asperities; 
and solid bridges (individual particles joined at point of contact by sintering, chemical 
reaction or re-crystallisation) - Visser, (1989); Hickey et al., (1994) also affect 
adhesion. 
Bulk-scale physical interactions due to surface roughness, shape, and size are major 
obstacles to overcome in particle dispersion. Temperature and humidity variations can 
lead to the formation of solid bridges through crystallisation/recrystallisation events 
at the particle surface (Crowder, 2003). Moisture can also induce the formation of 
capillary forces (Israelachvili, 1991). The strength of these forces is determined by the 
diameter of pores in which the moisture resides, and the tension experienced between 
surfaces due to hydrogen bonding between the water molecules. Changing the 
humidity of the environment that surrounds the formulation affects both capillary 
forces and the surface charge of the particles by different means: reducing humidity 
increases the electrostatic force but decreases capillary interactions whereas 
increasing humidity increases capillary forces but reduces the electrostatic force. 
Therefore, a careful control of humidity is vital in order to balance the capillary and 
electrostatic forces experienced by the formulation. Electrostatic charging can 
originate from atmospheric ionisation, chemical composition, contact with charged 
objects or tribocharging through motion. Since most pharmaceutical powders are good 
insulators, electrostatic charge plays an important role in their dispersion. One method 
of reducing the van der Waals forces is by using high-porosity, low-density particles 
(Edwards et al., 1997). The forces of interaction between pharmaceutical powders are 
difficult to characterise and control due to the heterogeneous nature of the bulk 
powder, both in terms of composition and physicochemical properties.  
Advances in characterisation and measurement techniques used to determine the 
adhesive and cohesive forces within DPI formulations increases knowledge of 
properties and behaviour of such products. Recent advances which have supplemented 
the traditional techniques include electrical low-pressure impaction for measuring 
electrostatic effects (Telko et al., 2007) and nano-indentation for characterisation of 
the effect of mechanical properties for individual properties (Taylor et al., 2004). In 
addition, focused-ion beam milling has been used in conjunction with SEM to observe 
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the interior of spray-dried particles for inhalation by removing outer layers of particles 
and imaging the cross-section (Heng et al., 2007). 
1.4.2. Powder and Aerosol Physics 
An important process in the generation of a therapeutic aerosol by a DPI is the 
fluidisation and entrainment of the bulk powder (Telko and Hickey, 2005). The 
generation of an aerosol from a static powder bed defines the dispersion step shown in 
Fig. 1.2. Separate phases can be defined, including dilation, flow, and aerosol 
production (Dunbar et al., 1998), however the influence and understanding of these 
mechanisms have often been overlooked, partly due to their transient nature and the 
fact that they typically occur simultaneously thus making them difficult to define and 
quantify (Daniher and Zhu, 2008). Recent work has studied the effects of fine particles 
on the “fluidisation and entrainment” behaviour of bulk DPI excipient (Shur et al., 
2008). However, the definition of fluidisation in their work is arguably more general 
than the traditional descriptions of fluidisation with respect to fluidised bed 
technology in chemical engineering applications. Regarding DPI formulations, 
fluidisation is defined as “the process by which a powder mass is disturbed by a stream 
of airflow resulting in the powder bed exhibiting ‘fluid-like’ properties” (Shur et al., 
2008). Following fluidisation, the powder removed from the device chamber is said to 
be entrained into the airflow (Castellanos, 2005) by the patient’s inhalation (Telko and 
Hickey, 2005), where air is passed through the static bed creating a pressure 
differential causing powder to be pneumatically conveyed through the device. This 
differs to traditional fluidised bed applications in chemical engineering where gas is 
passed upwards through a bed of particles and the state of fluidisation is said to occur 
when the buoyant weight of the bed is supported by the upwards flow of gas (Seville 
et al., 1997). 
Following entrainment into an airstream, de-agglomeration or detachment of drug and 
carrier particles occurs via the forces generated by the pressure differential, or via 
particle-particle and particle-wall collisions within the device (Castellanos et al., 1999; 
Zeng et al., 2001). Detachment forces include: aerodynamic, centrifugal, inertial, shear 
and frictional forces, all of which attempt to overcome the adhesive forces described in 
section 1.4.1 (Timsina et al., 1999; de Boer et al., 2003a). 
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More recently, powder-packing properties have been linked to the aerosolisation 
ability of DPI formulations. Many previous studies have attempted to link the packing 
properties of such powders to their in vitro performance (Zeng et al., 2001; Concessio 
et al., 1999; Crowder and Hickey, 2006); however, Shur et al., (2008) take this concept 
further by attempting to relate the in vitro performance to the packing and tensile 
strength of formulations, but also consider the fluidisation ability of such powders. 
Other work relating to the aerosolisation of DPI formulations includes that by Versteeg 
et al., (2005) who again investigate the aerosolisation of powders by a vertical jet of 
air, concluding that the initial mechanism of powder bed break-up is by shear 
fluidisation, where particles are entrained layer-by-layer producing a slow 
entrainment rate. Following this, the jet-flow penetrates the powder bed and aerates 
the entire bed from the centre – thus producing a fast entrainment rate. Although these 
qualitative results are conclusive, little quantitative data is produced. 
1.4.3. Effect of Particle Size  
Particle size is one of the most important design considerations to make regarding DPI 
formulations (Daniher and Zhu, 2008). Methods for determining the particle size 
distribution (PSD) of a formulation explore a range of geometric features and 
physicochemical properties (Snow et al., 1999). Of these properties, aerodynamic 
diameter is the most important regarding drug delivery to the lung and hence, 
therapeutic effect. The aerodynamic diameter is defined as the diameter of an 
equivalent volume sphere of the same density with the same terminal velocity as the 
actual particle. Pharmaceutical powders are rarely spherical; however, various shape 
factors can define the deviation from sphericity. The dynamic shape factor is described 
as the ratio of the resistance force experienced by the non-spherical falling particle to 
the resistance force of a spherical particle of the same volume (Hinds, 1999). Thus, the 
aerodynamic diameter can be increased by increasing the particle size, increasing the 
particle density, or decreasing the dynamic shape factor. 
As described in section 1.3.1, it is important to control particle size since it describes 
the crucial mechanisms of particle deposition in the lung via inertial impaction, 
sedimentation, and diffusion. To reach the lower airways, particles need to be in the 1-
5 m aerodynamic diameter range (Newman and Clarke, 1983; Zanen et al., 1994), 
particles greater than this typically deposit in the oral cavity or pharynx; whilst 
Investigation into the Effects of High Shear Blending and Storage on Powders for Inhalation 34 
Introduction 
particles smaller than this are prone to not deposit at all. In addition, smaller particles 
are not as efficient at delivering dose to the lungs; a 0.5 m particle will only deliver 
0.1% of the mass a 5 m particle is able to carry (Bates et al., 1966).  
There have been many techniques employed to produce particles in the preferred 
aerodynamic size range, such as fluid energy milling by Lai et al., (1981). Shekunov et 
al. (2003), and Schiavone et al. (2004), employed supercritical fluid crystallisation 
(SFC) to create drug particles not only of the desired size, but also with the desired 
surface characteristics, as opposed to the conventional jet milling process, which does 
not allow the control of such features. Their work claimed that drug particles 
manufactured by the SFC method yield increased FPF compared to standard 
micronised drug particles. Other particle techniques have been considered to produce 
drug particles for use in pulmonary treatments; these include spray-drying, 
supercritical drying and spray freeze-drying. These procedures can also be used to 
increase the ratio between geometric and aerodynamic particle size in order to reduce 
phagocytic clearance (Edwards et al., 1997) or to increase the dispersibility compared 
to micronized particles (Vanbever et al., 1999; Duddu et al., 2002). In addition, 
nanospheres of hydroxyl-propyl-methylcellulose phathalate (Kawashima et al., 1998b) 
have been considered, along with agglomerated drug crystals (Ikegami et al., 2003) 
and salts of the same drug compound (Jashnani and Byron, 1996) to modify the 
physicochemical properties of the drug. The addition of salt compounds to the mixture 
affects the affinity of the drug to water, hence affecting its aerosolisation ability within 
the inhaler. 
1.4.4. Crystallinity and Polymorphism 
Most APIs and excipients are crystalline materials (Britain, 1995; 1999); however, non-
crystalline materials are also common in DPI formulations, often as a result of the 
manufacturing process (Moulton et al., 2001). In addition, the polymorphs of 
crystalline material can exhibit different physicochemical properties (density, 
solubility, melting point and hygroscopicity - Hancock et al., 1995); whilst the 
mechanical properties and vapour sorption ability of amorphous material may be 
significantly different from the crystalline material (Hancock and Zografi, 1997), and 
the chemical reactivity of amorphous substances may be significantly greater (Pikal et 
al., 1977). In addition, crystallisation can also affect particle shape, since crystal growth 
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rates can vary independently of the crystal lattice and thus the morphology of the 
particles can be affected (Larhrib et al., 2003a). This in turn can affect the aerodynamic 
behaviour and consequentially, the lung deposition, due to changes caused by 
impurities during crystallisation, and processing variables such as temperature, pH, 
and viscosity (Wood, 2001; Rodriguez-Hornedo and Sinclair, 2002). 
1.4.5. Moisture Content and Hygroscopicity 
Hygroscopicity is the inclination of a material to uptake moisture from its 
surroundings, and is directly affected by both the crystallinity and morphology of the 
particles. Hygroscopic compounds are much more prone to chemical and physical 
instability, notably dissolution and recrystallisation. This can cause irreversible 
aggregation through solid bridge formation (Dunbar et al., 1998) which adversely 
affects aerosol generation and subsequently lung deposition (Braun et al., 1996; Chew 
and Chan, 2002). Hygroscopicity can also affect the adhesive and cohesive properties 
of formulations, along with significantly affecting PSDs (Hickey and Martonen, 1993; 
Maggi et al., 1999). As aerosols enter the lungs, they approach a very high humidity 
environment (99.5% RH at 37°C); here susceptible particles may be subjected to 
hygroscopic growth that affects lung deposition (Martonen and Katz, 1993). Therefore, 
equilibrium moisture content of both drugs and excipients must be determined over a 
range of relative humidities in order to obtain suitable process and storage conditions. 
An example of such a study is shown by Zhu et al., (2008), who recognise the 
importance of relative humidity on the performance of salbutamol sulphate containing 
formulations in an airstream. 
1.4.6. Effect of Shape and Surface Impurities 
The surfaces of DPI formulation particles play important roles in the interactions, 
stability, and dispersion of such powders. Due to their low mass: surface area ratio, API 
particles have a greater potential for electrostatic charging and moisture uptake, in 
addition, their small size makes them more susceptible to the effects of van der Waals 
forces (Fults et al., 1997; Young et al., 2002). 
Both drug and carrier particles can be modified to obtain desired surface 
characteristics in order to control lung deposition; ideally, the forces are balanced such 
that adhesion is strong enough to provide a stable formulation, but weak enough to 
allow separation during an inhalation event. The surface morphology of carrier and 
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drug particles has been shown to influence the FPF in several studies; Zeng et al., 
(2000a) suggests that smooth surface lactose particles enhance FPF, whilst Zeng et al., 
(2001) and Young et al., (2002), contradict this claim, suggesting that rough carrier 
particles increased the FPF. 
The majority of attempts to increase the amount of drug released from carrier particles 
during inhalation have involved the altering of the surface properties of the carrier 
particles (Podczeck, 1998a; Karhu et al., 2000; Harjunen et al., 2002) since surface 
features such as discontinuities (pores, clefts and cavities) - otherwise known as 
rugosity - and impurities are one of the dominant factors affecting interaction between 
drug and carrier particles. These carrier sites with high rugosity and number of 
impurities produce multiple contact points and allow an increase in the contact area. 
These are known as ‘active sites’ which have enhanced binding energies between 
carrier and drug; therefore, it is recommended to use smooth, clean particles which 
increase the ability for carrier and drug to detach during inhalation (Kassem and 
Ganderton, 1990; Kawashima et al., 1998a; Podczeck, 1998a; Zeng et al., 2000a; Zeng et 
al., 2000b). However, different studies have found that there may be optimal carrier 
rugosities (Ganderton and Kassem, 1992, Vanderbist and Maes, 1998; Zeng et al., 
2000a; Young et al., 2002), such that smooth carrier surfaces may exhibit lower (Zeng 
et al., 2001a) and higher drug depositions (Kawashima et al., 1998a). 
Surface morphology measurements are often based on the amount of gas adsorbed to 
the powder surface at a given pressure. Inverse gas chromatography (IGC) is able to 
determine surface area (Grimsey et al., 2002) and surface energy changes (Cline and 
Dalby, 2002), along with changes in surface characteristics due to processing (Ohta 
and Buckton, 2004). Scanning Electron Microscopy (SEM) and Atomic Force 
Microscopy (AFM) (Danesh et al., 2000; Trojak et al., 2001) are also used to describe 
the surface morphology of formulation particles. 
In addition, the shape of the carrier particles is known to influence the drug particle 
detachment in inhalers due to turbulent shear forces (Zeng et al., 2000a; Larhrib et al., 
2003b). However, these studies involved carrier particles specially prepared using 
crystallisation techniques that produced much smoother surfaces than the carrier 
particles in everyday use. 
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1.4.7. Excipients 
Since excipients can typically make up in excess of 99% of the product by weight, they 
are crucial factors in the performance of a DPI formulation. Excipients improve the 
non-pharmacologic properties of a drug primarily through enhancement of the 
physicochemical stability of the API, its mechanical properties, or its pharmaceutical 
properties such as dissolution and permeation (Smyth and Hickey, 2005). In DPI 
formulations, their primary role is to act as a carrier particle. Typically, the drug dose 
required is only a few g, therefore excipients provide bulk to improve the handling, 
dispensing and metering of the drug (Ashurst et al., 2000). Unlike the GI tract, lungs 
have a low buffering capability, hence only a narrow range of mid-pH substances can 
be administered in order to prevent irritation. Therefore, potential excipients are 
limited to compounds that can be easily metabolised or cleared by aspiration. 
Lactose is by far the most commonly used excipient in DPI formulations. It had long 
been used in oral dosage forms before being chosen for use in DPI formulations due to 
its established safety and stability profile, its rigid manufacturing process with strict 
controls on purity and physical properties, availability, and low cost. Lactose has the 
smooth surfaces and adequate flow properties desired in DPI carrier particles (Smyth 
and Hickey, 2005). It is less hygroscopic than other sugars and is relatively versatile, 
with various size distributions (Saint-Lorant et al., 2007), grades, and morphologies 
readily available. Its main drawbacks arrive from the fact it is a reducing sugar, thus 
making it incompatible with molecules with amine functional groups (Handbook of 
Pharmaceutical Excipients, American Pharmaceutical Association); and its problems 
associated with the lactose-intolerant population. Lactose is commonly found in four 
crystalline forms with -lactose monohydrate used in DPI formulations, whilst the 
stable anhydrous form is used in MDIs and -lactose used in tablets due to its 
preferential compaction properties (Hein et al., 2008). 
Other sugars such as mannitol (Tee et al., 2000), glucose (Braun et al., 1996; Steckel 
and Müller, 1997a), trehalose (Bosquillon et al., 2001a), sorbitol (Tee et al., 2000), 
sucrose (Naini et al., 1998) and phospholipids such as phosphatidyl choline and 
cholesterol have been shown to be viable alternatives to lactose, (Kawashima et al., 
1998b), however this study focuses on the use of -lactose monohydrate. 
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The physicochemical properties, especially the size and morphology of the excipient 
particle will have significant effects on the performance of the DPI. Adhesive forces 
must be carefully considered, as inadequate separation of drug from carrier will cause 
major deposition problems. Excipients for DPIs are commonly in the mean geometric 
size range of 63-90 m (Zeng et al., 1998), in order to facilitate accurate dosing from 
the device and improve flow properties into the lung (Crowder et al., 2001; Giry et al., 
2006). 
The size distribution of carrier particles affects drug-carrier detachment (Chew and 
Chan, 2002; Podczeck, 1999; Karhu et al., 2000). Many studies have shown that the 
respirable (in vitro) fractions dramatically increase when finer carrier particles are 
used (Ganderton and Kassem, 1992; French et al., 1996; Steckel and Müller, 1997b) 
due to the number and size of surface discontinuities and impurities increasing with 
mean diameter of crystals (de Boer et al., 2002c; de Boer et al., 2003b). On the other 
hand, the attachment forces between the carrier and drug produced during mixing 
increase (Podczeck, 1996b); coarser carrier particles produce much more friction and 
collision forces than fine particles. 
An advantage of coarse carrier particles is their superior flow properties which 
increases the reproducibility of doses into capsules, blisters or metering devices, due 
to the ease at which they can be dispensed; however, there is a limit to the size of 
particles that can be entrained or pass through certain gaps in the device or capsule 
(Steckel et al., 2004). 
More recent studies have shown the importance of experimental design on the control 
of particle size during the manufacturing process (Guenette et al., 2009) in the 
development of DPI formulations. 
1.4.8. Effect of Carrier Payload 
The concentration of drug in the powder mixture is a vital parameter regarding drug-
carrier interactions. As with carrier surface properties and size distribution, the role of 
the carrier payload may depend upon many other parameters. The drug concentration 
on the carrier surface can affect the bonding capacity of active sites on the carrier – and 
can be compounded if the active sites correspond to surface discontinuities as the drug 
particles may be sheltered from press-on forces experienced during mixing (Srichana 
et al., 1998). Therefore, the drug concentration needs to consider the sheltering 
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capacity of the surface discontinuities. A range of payloads has been studied in 
previous DPI literature; a list of examples is given in Table 1.2. 
Table 1.2. Examples of carrier payloads used in other DPI studies. 
Author Payload (% drug by weight) 
Schlimmer, 2002 
Dubois et al., 2003 
0.05 
Podczeck, 1998a, 1999 0.2 
Harjunen et al., 2003 0.6 
Young et al., 2005 0.8 
Steckel and Müller, 
1997a 
1.0 
Kassem and Ganderton, 
1990 
Timsina et al., 1994 
Srichana et al., 1998 
Zeng et al., 1998 
Larhrib et al., 1999 
Zeng et al., 2000a 
Zeng et al., 2001 
Flament et al., 2004 
Flament et al., 2006 
Thi et al., 2008 
1.46 
Heng et al., 2000 2.0 
Iida et al., 2001 
Iida et al., 2003 
2.5 
Harjunen et al., 2003 3.2 
Steckel and Müller 1997b 5.0 
Harjunen et al., 2003 6.6 
Steckel and Müller 1997b 9.0 
Ikegami et al., 2000 
Ikegami et al., 2003 
10.0 
Kawashima et al., 1998a 11.1 
 
1.4.9. Introduction of Ternary Components to Adhesive Mixtures 
Typically, DPI formulations comprise micronised API and coarse lactose carrier 
(typically 63-70 m size range). However, research has been conducted into the effect 
of adding ternary components to the mixture in order to enhance the performance of 
the formulation. 
1.4.9.1. Lactose fines 
Lactose fines generally less than 10 m have been added to adhesive mixtures to 
influence the forces between API and excipient. Lactose fines are likely to be found in 
mixtures as a result of wear due to mixing and transport, from the selection of lactose 
blends with wide size distributions (Karhu et al., 2000), or from the deliberate addition 
of lactose fines to coarse lactose fractions (Podczeck, 1998b; Zeng et al., 1998). Zeng et 
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al., (2001) suggests that the addition of lactose fines to adhesive mixtures has a more 
dominant effect on drug dispersion than effects of carrier size and surface rugosity. It 
is also known that the amount of lactose fines added to the formulation influences the 
amount of drug that reaches the lower airways. A range of hypotheses has been 
proposed to describe this effect. These include: the possibility that lactose fines 
compete with API particles for “high energy” active sites on the carrier (Hersey, 1975; 
Staniforth, 1996); lactose fines form readily-dispersible “multiplets” with drug 
particles (Lucas et al., 1998); lactose fines create mono- or multi- layers between the 
drug and carrier particles, thus minimising the van der Waals forces between them 
(Zeng et al., 1998); or the fines act as a lubricant, preventing the build-up of 
electrostatic forces that affect adhesion between drug and carrier (Zeng et al., 1998).  
1.4.9.2. Force control agents 
Force control agents (FCAs) such as isoleucine and magnesium stearate have been 
added to the mixtures (Ganderton and Kassem, 1992; Colombo et al., 2000; Young et 
al., 2002; Begat et al., 2009) in order to decrease the interaction forces between the 
drug and carrier particle. The effect of van der Waals forces is reduced by forming a 
film around the excipient and/or drug particles; being hydrophilic, the capillary forces 
are also reduced. They also preferentially fill active sites on the carrier surface, thus 
reducing the ability of drug particles to occupy these strong attachment areas (Faqih et 
al., 2007). Louey et al., (2003) also suggest that these ternary compounds may 
agglomerate with drug particles, which results in an increase in the detachment forces 
experienced during inhalation. 
1.4.10. Formulation Processing (Blending and Storage) 
Once drug and excipient have been manufactured into their desired physical form, they 
need to be combined to produce the working formulation. Understanding and control 
of this process has often been overlooked, despite the importance of obtaining optimal 
performance from a formulation (Sudah et al., 2002a). When mixing powders with 
different properties, particle sizes and ratios, inadequate mixing can cause poor dose 
uniformity, something that may not be cured with increasing mixing time. Choice of 
mixer, rotation speed, capacity, and fill level all require optimisation, as they are likely 
to affect the blend homogeneity (Alexander et al., 2004). In addition, blending 
conditions can also influence the interparticulate forces, which in turn determine the 
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FPF (Iida et al., 2001). Different mixtures of drug and excipient along with different 
component ratios will affect the mixing conditions required (Staniforth et al., 1981). 
Increasing the mixing time of adhesive mixtures may increase the stability and 
homogeneity of the formulation. This is due to the prolonged period of time for which 
the adhesive forces are allowed to form which, in turn, increases the drug-carrier 
interaction. In addition, the extended mixing time allows for enhance distribution of 
drug over the carrier surface, thus allowing for an increase in occupation of active 
bonding sites (de Boer et al., 2002c). However, as the drug-carrier interaction 
increases, it is likely that the drug detachment during inhalation will decrease – an 
undesirable effect from extending the mixing time. The strength of the adhesive and 
detachment forces needs to be controlled by modifying the drug concentration in the 
mixture in relation to the surface rugosity – hence the binding capacity of active sites. 
There have been relatively few studies determining the effect of mixing time on the 
drug-carrier interaction in adhesive mixtures for the use in DPIs (de Boer et al., 2002c). 
This study focuses on high shear blending (HSB), a technique used primarily to 
overcome the cohesive forces found in micronised API, thus aiding dispersion of drug 
throughout the formulation in order to create a chemically homogenous mixture – a 
more detailed description of the uses of HSB is given by Wellm, (1997) and Knight et 
al., (2001). In this thesis, details of the HSB process and equipment can be found in 
section 4.2.3. This study differs from other work studying blending effects on DPI 
formulations in that low-shear tumbling methods are employed by Podczeck (1999), 
Zeng et al., (2000) and Dickhoff (2006). More recent work by Shur et al., (2008) 
focuses on two low shear blenders – the Turbula and Whirlimixer alongside a small-
scale imitation high shear blender which was initially intended for use as a coffee 
grinder (Braun KSM2, Kronberg, Germany) which operated via a mechanism 
comparable to milling devices. 
Following blending, the formulation is filled into capsules, blisters, or reservoirs ready 
for use with the inhaler device. Then, in order for the formulation to maintain its 
physicochemical integrity and dispersive properties, the product must be suitably 
stored. Storage conditions, primarily temperature and humidity profoundly affect DPI 
formulation stability (Podczeck 1996a; Podczeck et al., 1997; Young et al., 2004). The 
drug-carrier interaction in adhesive mixtures is susceptible to change over time and is 
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directly linked to the storage conditions, payload and carrier size fraction (Broadhead 
et al., 1995; Harjunen et al., 2003). Braun et al., (1996) showed that the FPF of two 
strengths of disodium cromoglycate was increased when the formulation was stored 
for 27 days at 33% relative humidity rather than 55% relative humidity. In addition, it 
has been discovered that the relative humidity of the air during inhalation may 
influence the fraction of drug detached from the carrier particles (Vidgren et al., 1987; 
Hindle et al., 1995; Jashnani et al., 1996) since the energy required to separate particles 
is directly influenced by humidity (Price et al., 2002). 
1.5. Measuring Drug-Carrier Adhesion 
A good estimation of the force of drug-carrier adhesion can be made from the particle 
detachment force (Zimon, 1982), assuming that the two forces are equal in magnitude 
but act in opposite directions. There are two types of methods for interparticulate 
force analysis - bulk detachment, or single particle detachment. Bulk detachment 
methods include centrifugation (Podczeck and Newton, 1995; Podczeck, 1997), 
mechanical/air jet sieving (Staniforth et al., 1981; Iida et al., 2003, Flament et al., 
2004), or impact separation (Concessio et al., 1999), whilst measurement of single 
particle adhesion force is usually performed via AFM. The varying performance of 
formulations containing different carriers can be attributed to the differences in the 
relative drug-carrier adhesive forces; this is the basis behind choice of drug. These 
have been quantified by colloidal AFM and utilised in an approach that measures the 
ratios of drug adhesion to cohesion – known as the cohesive-adhesive balance (CAB) 
(Begat et al., 2004) between both hydrophilic and hydrophobic drugs and excipient in 
DPI formulations.  
This allows differences to be found in the relative affinities for the mimic drugs to each 
other compared to their affinity to lactose carriers – as described in the CAB work by 
Begat et al., (2004) and Jones et al., (2008). In addition, the use of shear test methods 
can allow differences to be found in flow properties that can be related to cohesivity of 
powder; this has been applied to salmeterol (hydrophilic drug) and salbutamol 
(hydrophobic drug) by Zhou et al., (2010).  
 A CAB <1 describes an adhesive formulation that forms a stable, ordered mixture on 
blending, whereas a CAB >1 describes a cohesive formulation where a less uniform 
mixture is produced, which is likely to contain agglomerates of active ingredient (de 
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Boer et al., 2002b). The work by Jones et al. (2008) used this approach to quantify the 
CAB for four carriers (lactose, glucose, mannitol, sorbitol) with four drugs possessing 
various physicochemical properties (fluticasone propionate, salmeterol xinafoate, 
budesonide and formoterol fumarate dihydrate) in an attempt to investigate the 
dispersion mechanisms of formulations containing fine excipient particles and relating 
them to the CAB properties of the formulation constituents. Results showed no 
relationship between the CAB ratio and homogeneity achieved during blending, and 
found that a formulation with greater CAB ratio resulted in enhanced in vitro fine 
particle delivery performance. 
Images of drugs can be achieved using tapping mode AFM and numerous studies have 
been performed on the adhesive strength between drug and carrier (Louey et al., 2001, 
Louey and Stewart, 2002; Eve et al., 2002; Hooton et al., 2003; Begat et al., 2004). In 
addition, AFM can also be used to study the crystallisation of lactose (Price and Young, 
2004) and the effect of mechanical processing on the powder surface (Begat et al., 
2003; Young et al., 2007b). Despite the advantages of AFM, it still has drawbacks, 
primarily in that statistically significant numbers of particle pairs cannot be easily 
analysed, along with the fact that results generated can vary strongly – up to 100x 
difference in some cases – thus rendering the relevance of such measurements 
questionable (Price et al., 2002; Tsukada et al., 2004; Schiewe and Zierenberg, 2004). 
Other findings concluded that the relative humidity in which the experiment was 
conducted affected the adhesive force between the drug and carrier particles 
(Podczeck et al., 1996: Price et al., 2002; Tsukada et al., 2004); however, the extent to 
which the force increased was dependent upon the hygroscopicity of the drug.  
1.5.1. In-vitro Methods to Assess Adhesion on a Bulk Scale 
1.5.1.1. Air Jet Sieve 
An air jet sieve (AJS) is a device in which a portion of powder in a sieve is fluidised by 
air passing upwards through it from a rotating slit. At the same time, a negative 
pressure is applied to the bottom of the sieve that removes the fine particles to a 
collecting device (vacuum with fine particle filter). A more detailed description of the 
working principles of an AJS is given in section 6.1. 
AJS analyses have often been used to determine the rate of drug detachment from 
carrier crystals in an air stream. Dickhoff et al., (2006) assess the rate of terbutaline 
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sulphate detachment from crystalline carriers exposed to differing surface treatments; 
Flament et al., (2006) assess the adhesion between the APIs terbutaline sulphate and 
formoterol fumarate and four types of carrier, whilst Iida et al., (2003) link surface 
properties of carriers to their adhesion with salbutamol sulphate. Each of the studies 
use comparable procedures for assessing detachment of API such that formulations are 
exposed to the air stream for varying lengths of time against a fixed pressure drop. The 
amount of drug not removed (still attached to the coarse carriers) is then assayed to 
determine the extent of fine drug particle removal through the sieve. 
1.5.1.2. Cascade Impactors 
Primarily a tool for determining the aerodynamic PSD, cascade impactors can also be 
used to determine the degree to which APIs separate from excipient, and are often 
used to asses the efficacy of DPI formulations by evaluating the in vitro FPF. The 
aerodynamic PSD of an aerosol cloud defines where the particles in that cloud are 
likely to deposit following inhalation (Hinds, 1999; de Boer et al., 2002a). As stated in 
section 1.4.3, it is generally accepted that to be therapeutically effective, particles need 
an aerodynamic particle diameter between 1-5 m to settle in the lung (Newman and 
Clarke, 1983), with the particle mass below 5 m defined as the FPF (Marple et al., 
2004). 
The European Pharmacopoeia (Ph.Eur) Method, Chapter 2.9.18 specifies four 
impactors (one twin, and three multi-stage) for the aerodynamic assessment of inhaled 
particles from both MDIs and DPIs: Ph.Eur apparatus A – Glass Twin Impinger; 
apparatus C – Multi-stage liquid impinger; apparatus D – Andersen cascade impactor 
(ACI); apparatus E – Next generation impactor (NGI). However, only two impactors, the 
ACI and NGI, are recommended for use with MDIs and DPIs by both the European and 
United States Pharmacopoeias. 
 All inertial impactors operate using the same principle: the aerosol is passed through a 
nozzle and the output jet is directed against a flat (impaction) plate that directs the 
particles to form an abrupt 90° bend in the gas streamlines. The particles with inertia 
greater than a given value are unable to follow the streamlines and collide on the flat 
plate. Smaller particles follow the streamlines and avoid collision with the impact 
plate; they remain airborne and flow out of the impactor. 
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Therefore, each stage of the impactor separates aerosol 
particles into two size ranges: those that are greater than 
the aerodynamic size are removed from the airstream, and 
those with lower aerodynamic size, which pass through the 
impactor. Their main advantage over other methods is that 
they directly measure aerodynamic diameter of particles, 
rather than equivalent-volume diameter (from cross-
sectional area data) (Marple et al., 2001). The use of several 
impactors in series is used such that the impactors are 
arranged in order of decreasing cut-off size, with the largest 
cut-off first. This is known a cascade impactor, and the cut-
off size reduction at each stage is achieved by decreasing the nozzle size (Fig. 1.5). This 
increases the flow velocity and reduces the average size of particles passing through. 
Since the same volume of gas flows through each stage, the flow rate at just one nozzle 
needs to be controlled. Each stage is fitted with a removable impaction plate that needs 
to be removed with each experiment for gravimetric or chemical determination of the 
particles that are accumulated. The final action of the impactor is usually a filter that 
captures all particles less than the cut-off for the final stage (Mitchell and Nagel, 2003). 
1.5.1.3. Centrifugal Techniques 
Centrifugal techniques are based on the notion that force of adhesion is equal in 
magnitude, but opposite in direction to the centrifugal force required to dislodge fine 
particles from larger surfaces. This technique has been used extensively for both the 
separation of particles from flat surfaces (Podczeck et al., 1995) and drug particles 
from excipients (Podczeck, 1996a; Iida et al., 2003). A concise explanation of 
centrifugal adhesion measurements is given by Böhme et al., (1964). 
1.6. Fluidised Beds 
In this study, it was hypothesised that elutriation from fluidised beds could be used as 
a method to assess changes in physicochemical properties of DPI formulations that 
have been exposed to varying HSB regimes (chapters 5 and 7). 
A fluidised bed forms by passing a fluid upwards through a bed of particles, as the 
velocity of the fluid is increased, the pressure drop across the bed increases until it 
equals the weight of the bed per unit area. At this point, the bed is said to be fluidised 
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Fig. 1.5. Schematic of a 
typical cascade impactor 
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(the corresponding gas velocity is known as the minimum fluidisation velocity, Umf). At 
increasing fluid velocities, particles begin to entrain from the bed, and at sufficient 
velocity (greater than the terminal velocity of the particle), particles will elutriate out 
of the system. 
Fluidised beds are commonly used in industry, primarily due to their ability to 
promote high levels of contact between solids and fluids (gases or liquids), and provide 
solids with a set of basic properties, including: extremely high surface area between 
solid and fluid per unit bed volume, high relative velocities between the dispersed solid 
and fluid phases, and high levels of intermixing and frequent particle-particle and 
particle-wall collisions. 
Although more common in traditional chemical engineering industries, fluidised beds 
have been used in the pharmaceutical industry, notably for drying of pharmaceutical 
granules (including lactose) – Chaplin et al., (2005); and for the coating of 
pharmaceutical products – Fukumori et al., (1987). 
Most fluidised bed applications in industry do not require separation of particles 
according to size – in fact, many applications consider the loss of fines (elutriation) to 
be a problem (Colakyan and Levenspiel, 1984), and as a result, utilise circulating beds 
that collect the fine particles and return them to the bed. However, due to elutriation, 
fluidised beds have the ability to act as air classifiers and separate particles according 
to their aerodynamic size by adjusting the flow rate of the incident fluid (Wu and 
Baeyens, 1998). 
At gas velocities greater than Umf, some of the fluidising gas passes through the bed in 
the form of bubbles, resembling a viscous fluid. Fig. 1.6 shows a typical pressure drop 
vs. superficial gas velocity (SGV) curve for readily fluidised material. The experimental 
Umf can be approximately determined by the method described by Richardson 
(Richardson, 1971; Turki and Fatah, 2008), where the horizontal line representing 
fluidised bed operation, and the curve that exhibits packed bed operation intersect. 
The horizontal line and the curve are estimated with a regression analysis to 
approximately fit the SGV value. It is at the turning point of pressure drop that the 
maximum aerodynamic drag force is experienced by the powder bed (Valverde et al., 
1998). 
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Fig. 1.6. Typical pressure drop ( P) vs. velocity (U) plot for fluidised beds. Initially if the bed is densely 
packed the pressure drop overshoots the fluidisation pressure until the particles separate and fluidise 
(Ganguly, 1993). 
 
Material is held in a fluidised state by the action of gas flow through the distributor at 
the base of the column. In order to have sufficient carryover of material from the bed, 
the fluidising velocity needs to be several times greater than the Umf (Gugnoni and 
Zenz, 1980). At high velocities, most of the fluidising gas forms bubbles which rise 
through the suspended solids phase and burst at the bed surface. The bursting action 
of the bubbles ejects large amounts of particulate solids of varying size into the 
freeboard above the bed surface (Ganguly, 1982). 
Following fluidisation, particles are entrained (removed) from the system into the 
airstream (Castellanos, 2005), and subsequently elutriated from the device. 
Fluidisation is governed mainly by the bulk properties of the powder, primarily its 
packing, which in turn, is governed by the physicochemical properties of the particles 
and their interactions with each other and the bed apparatus (Valverde et al., 1998). 
This freeboard height is commonly referred to as the transport disengagement height 
(TDH) (Geldart, 1986). However, only the finest particles can be fully elutriated by the 
freeboard gas flow, the coarser particles fall back into the bed since their terminal 
velocity is greater than the upwards force produced by the gas (Geldart, 1986). This 
results in a decrease in solids density in the freeboard with height. If the freeboard 
height is sufficiently large, only fine particles that have a terminal velocity less than the 
freeboard gas velocity will be removed from the bed. 
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1.6.1. Geldart Classification of Powder 
A key factor in considering the fluidisation ability of powders is the cohesivity of the 
material. Several attempts have been made to devise both theoretical and empirical 
classifications of powder behaviour; the most comprehensive attempt was made by 
Geldart, (1973) to describe the fluidising behaviour of powders according to their 
mean particle size and density difference between solid and fluidising gas (Fig. 1.7). 
 
 
Fig. 1.7. Geldart Classification of Powder for Fluidisation Chart (Geldart, 1973). * is the density difference 
between fluidising gas and solid, whilst dp is the average particle diameter.  
 
Inhalation-grade lactose has previously been shown to be cohesive and notoriously 
difficult to fluidise (Zeng et al., 2001). As a natural product, it has inherent variability in 
its size, shape, and morphology; although its average particle size suggests it is a 
Geldart group A powder, its wide PSD includes a significant proportion of group C 
powder. Table 1.3 shows the characteristic features and examples of each of Geldart’s 
powder groups. 
Group C powders form stable channels from the distributor to the surface, and may lift 
as a cohesive plug, particularly if the apparatus is small, and there is a high surface-to-
volume ratio. The pressure drop across the bed usually remains below the bed weight 
per unit area, and mixing and heat transfer are poor. Fluidisation can be improved by 
increasing the gas velocity to break up the cohesive structure, by mechanical stirring, 
or vibration. Electrostatic forces can be reduced by making the apparatus conducting, 
and by moderate humidification of the gas stream. Once group C powders become 
aerated, they generally take a long time to de-aerate. 
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When fluidising group A particles, bed expansion occurs above the Umf but before 
bubbling occurs. Experimental evidence (Seville, 1987) suggests that group A particles 
are intermediate in cohesiveness between group C and B particles, and have the 
interparticle forces being the same order of magnitude as the particle weight. 
 
Table 1.3. Characteristics of fluidisation behaviour (Geldart, 1973); adapted from Seville et al., 1997. 
 Group 
 C A B D 
Typical 
characteristics 
Cohesive, difficult 
to fluidise 
Bubble-free range 
of fluidisation 
Starts bubbling at 
Umf 
Coarse solids 
Examples Cement, flour Cracking catalysts Sand, salt 
Crushed limestone, 
coffee beans 
Property     
1. Bed expansion 
Low when bed 
channels; high 
when fluidisation 
occurs 
High Moderate Low 
2. Deaeration rate Can be very slow Slow Fast Fast 
3. Bubble 
properties 
Channels readily 
Spitting and 
coalescence; 
limited bubble 
size; large wake 
fraction 
Stable large size 
Size limited by fluidising 
vessel; small wake 
fraction 
4. Solids mixing Very low High Moderate Low 
5. Gas back-mixing Very low High Moderate Low 
 
Fluidisation engineers have attempted to reduce interparticle forces by various means, 
namely: mechanical vibration (Dutta and Dullea, 1991; Jaraiz et al., 1992; Mori et al., 
1990), acoustic waves (Chirone and Massimilla, 1994; Chirone, et al., 1993; Montz et 
al., 1988; Morse, 1955; Nowak, et al., 1993; Russo, et al., 1995), mechanical stirring 
(Godard and Richardson, 1969; Nezzal et al., 1998; Reed and Fenske, 1955), and 
magnetic or electrical field disturbance (Hristov, 2000; Liu et al., 1991). 
1.6.2. Air Classification Using Fluidised Beds 
Particle size classification enables products to be removed from the fluidised bed 
(Gugnoni and Zenz, 1980). Classification can be achieved by various process 
equipment depending on the physical properties of the material, the required cut size, 
and the process economics (Perry and Green, 1997; Heath and Aconsky, 1963). 
Air classifiers exploit the principles of drag, gravity, and particle inertia, which are all 
determined by particle size – and described by Stokes’ equation (section 5.4). Small, 
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lighter particles are carried upwards in a gas stream with sufficient velocity, enough to 
overcome the terminal velocity of the particle (Seville et al., 1997; Perry and Green, 
1997) whilst the bulk material remains in the bed in a loose, free-flowing state (Kunii 
and Levenspiel, 1991). 
A recent study (Deng et al., 2010) has used the principles of fluidised bed elutriation 
(FBE) to mimic the air-induced segregation effects observed in direct compression 
pharmaceutical formulations as they are discharged from container to tablet press 
through a vertical chute. The segregation of API and excipient during the discharge 
event was studied and used a vertical column separated into seven vertical sections, 
which were sealed against airflow as the powder was loaded into the hopper above the 
column. A low SGV was applied to the system to initiate a bubbling regime before the 
powder was allowed to settle each stage was then assayed to determine API/excipient 
composition. 
Elutriation from fluidised beds in the traditional sense has been extensively studied 
(Wen and Chen, 1982; Pemberton and Davidson, 1986; Chang et al., 2005) and in 
particular the effect of fine particles on the elutriation performance of systems with 
multi-modal size distributions (akin to the inhalation-grade lactose used in this thesis). 
Both Choi et al., (2001) and Li et al., (2004) explore the effects of fine cohesive 
powders on the elutriation of particles in fluidised beds, whilst Smolders and Baeyens, 
(1997) define the critical particle size at which interparticle adhesion forces become 
significant in fluidised beds. Baeyens et al., (1991) and Saleh et al., (2008) study the 
effect of adding fine, cohesive Group C powder (see section 1.6.1) to a readily fluidised 
Group A powder. Both Santana et al., (1999) and Mahmoud et al., (2004) employ this 
property and use fluidisation to deliberately separate fine particles (group C) from 
coarse (group A) bulk powder bed. Santana et al., show that fines in such systems exist 
as either free particles, small agglomerates with each other, or agglomerates with 
larger particles. Mahmoud et al., (2004) again showed that fines exist as different 
entities in such systems and also found that elutriation from these fluidised beds was 
strongly affected by interparticle adhesion forces. However, none of the above studies 
attempts to relate the HSB and storage conditions of DPI formulations to fluidisation 
and elutriation behaviour – the primary focus of this thesis. 
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PSD measurements of unprocessed lactose used in this study reveal a clear bimodal 
distribution (Fig. 1.8). Group C particles are extremely cohesive (section 1.6.1) and lift 
as a plug or channel badly. Thus, conventional fluidisation is difficult to achieve. 
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Fig. 1.8. PSD of unprocessed lactose (dry dispersion), clearly showing a bimodal population of fine, cohesive 
Group C powder and free flowing, aeratable Group A powder. 
1.7. Motivation and Aims of Project 
In 2002, the Food and Drug Administration (FDA) introduced a new initiative 
“Pharmaceutical cGMPs for the 21st Century” which proposed a risk-based approach to 
pharmaceutical manufacturing. This led to the creation of PATs (Process Analytical 
Technologies) – a framework for understanding and improving the processes involved 
in pharmaceutical development, manufacturing, and quality control. PAT operates on 
the premise that quality cannot be tested into products; instead, it should be built-in or 
should arise from design – QbD (Quality by Design). Therefore final product quality is 
achieved by understanding and controlling the processes involved in the 
manufacturing procedure. 
One of the key areas for development in DPI formulation production is the 
understanding of the effect of blending on lactose-drug interactions. Previous work 
(Bridson et al., 2007) focused on the effect of blend parameters on formulations 
containing solely -lactose monohydrate. In that study, a linear relationship between 
specific energy input (SEI) and number of “free” lactose fines was found; as the 
performance of DPI formulations is known to be affected by “free” lactose fines (see 
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section 1.4.9.1), it was proposed that this relationship could affect the FPF of drug 
particles. Other findings suggested that changes in the water sorption characteristics of 
lactose observed post-blending were indicative of changes in the lactose surface 
chemistry, potentially affecting lactose-drug adhesion. Storage conditions of -lactose 
monohydrate prior to blending were also found to affect the blend behaviour. 
At present, there is very little information relating blending regimes to DPI 
performance, and in particular, the critical fluidisation-like stage involved in 
generating an aerosol from a static powder bed. Recent work by Shur et al., (2008), and 
Tuley et al., (2008) began to investigate this, however this thesis will differ by using 
larger scale blenders with a distinct high shear mixing process and will investigate the 
classical fluidisation and elutriation ability of such formulations, rather than mimicking 
an inhalation event by employing large flow rates, much greater than the Umf of 
inhalation-grade lactose. 
The key aim of this work is to develop understanding of the relationships between 
blend (primarily SEI) and storage conditions to the in vitro formulation performance.  
More specifically, the main aims of this work were to: 
 Investigate the effects of SEI on the properties of model DPI excipient ( -lactose 
monohydrate) and compare results with previous literature. 
 Investigate the effects of scale of HSB regimes on the properties of mimic DPI 
formulations, including PSD, SSA, and chemical homogeneity; this is to be used 
as a comparison against previous literature which investigated the effects of 
blending on the -lactose monohydrate excipient used in DPI formulations.  
 Explore the use of a classical FB to test DPI formulations and employ the 
principles of elutriation from a FB to separate fine particles from the bulk 
powder within the bed.  
 Investigate the effects of HSB and storage regimes on the in vitro performance 
of mimic DPI formulations using the novel FBE technique, and compare to 
conventional AJS, NGI, and AFM separation techniques.  
 Relate the in vitro performance of the mimic DPI formulation to the properties 
of the constituent mimic API. 
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2.0. Analytical Method Development 
ABSTRACT 
Particle characterisation is a vital part of understanding the behaviour of dry powder 
inhaler (DPI) formulations. Even slight changes in the physicochemical properties of 
the materials used in these products can have profound implications for the behaviour 
of the formulations that in turn, can significantly affect in vivo performance. 
This chapter describes the development of methods frequently used throughout this 
thesis. Techniques such as laser diffraction (with various dispersion mechanisms) for 
exploring size distributions, scanning electron microscopy for surface morphology and 
size verification, and dynamic vapour sorption (DVS) methods for specific surface area 
and surface characterisation are explained, along with the rationale behind their use. 
In addition, bulk powder characterisation measurements were performed via a ring 
shear test method to determine the flow properties of excipients and mimic active 
pharmaceutical ingredients (APIs) – a property of powders known to affect the fine 
particle fraction (FPF) of DPI formulations. 
 
Investigation into the Effects of High Shear Blending and Storage on Powders for Inhalation 54 
Analytical Method Development 
2.1. Introduction  
2.1.1. Particle Size Analysis by Laser Diffraction 
The particle size distribution (PSD) of powders used in DPI formulations are known to 
have significant effects on the performance of the final product (Newman and Clarke, 
1983; Zanen et al., 1994; Ashurst et al., 2000; Crowder et al., 2001; Giry et al., 2006; 
Daniher and Zhu, 2008;). Generally in the pharmaceutical industry, the particle size 
affects a range of attributes such as appearance, solubility, bioavailability, stability, 
processability, and content uniformity. In addition, particle size of APIs is a major 
parameter that can affect blending, flowability, compressibility, and segregation 
propensity. Therefore, the PSD of the powders should be measured using appropriate 
validated analytical methods, of which, laser diffraction is one of the most commonly 
used techniques. The method is popular since it is relatively quick and easy to use, is 
flexible, and can be adapted to measure samples in various physical forms; it is 
potentially seen as an alternative to impactor analyses for the study of fine particle 
fractions (FPFs) of DPI formulations (Marriott et al., 2006).  
Fine powders such as those used throughout this study are notoriously difficult to 
handle due to their cohesive nature; in addition, such powders often contain 
agglomerates of “primary” particles held together by interactive forces (see section 
1.4.1). Due to this cohesivity, effective de-agglomeration and particle detachment from 
surfaces is required to obtain size measurements of primary particles. Therefore, a 
well-defined degree of dispersion is required in order to both obtain these primary 
particles, and to prevent samples from re-agglomerating. In this particular study, 
determining the size of both primary particles and agglomerates was important, thus 
two separate dispersion techniques were employed. 
Dry dispersion methods use pressurised air stream (Xu and Guida, 2003), whilst a wet 
method using solvents to disperse particles has been developed (Adi et al., 2007) for 
inhalation-grade lactose. Xu et al., (2009) emphasise the need for rigorous method 
development of particle size measurements since their work on spray-dried infant 
formula found that dispersion by large air pressures caused particle fracture, thus 
producing a smaller average particle size than wet dispersion in hexane.  
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The choice of method should primarily be made on the degree of dispersion required. 
In all cases, whether liquid or gas is used as the dispersion medium, irreversible 
changes to the particle size through dissolution, milling or aggregation should not 
occur (Merkus, 2009). In addition, the sample should be correctly mixed before a 
measurement is made. Dry powders will separate out when stored for a long time or 
vibrated - larger particles rise to the surface and smaller particles collect at the bottom 
of the container. A comparison between the dispersion methods used in this study is 
given in Table 2.1. 
 
Table 2.1. Features of wet and dry dispersion systems for laser diffraction used in this study. 
Wet dispersion Dry Dispersion 
Analysis time: minutes Analysis time: seconds 
Sample size: several mg Sample size: several g 
Interaction with dispersant No chemical interactions 
Liquid disposal No liquid disposal required 
 
However, it must also be considered that the different scattering theories applied to 
the data may also affect the results. The Fraunhofer theory (used by Sympatec) does 
not require optical information regarding the particles or dispersing medium, on the 
other hand, the Mie theory (used by Malvern) requires the refractive indices of both 
the dispersing medium and the particles to be measured. Incorrect prediction of the 
scattering efficiency has been shown to overestimate the fine particle fraction of 
pharmaceutical powders using the Fraunhofer theory (Malvern Application Notes), 
thus the particle size values quoted in this thesis are best used as a comparison 
between samples (Xu et al., 2000). 
2.1.1.1. Wet Analysis 
Wet analysis requires samples to be correctly dispersed in a liquid. The correct choice 
of dispersant prevents particles from agglomerating, floating on the surface, or even 
dissolving (Merkus, 2009). These events influence the particle size data due to their 
effect on the laser intensity reaching the detector. For example, dissolution of samples 
causes the obscuration to decrease over the course of the measurement. The 
dispersant should be free from impurities and should be degassed before use – 
especially if it has been stored at low temperatures or under high pressure. Bubbles 
can interfere with results as they can be mistaken for particles in the cell window 
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(typically appearing as a secondary peak around 100 m). In addition, the dispersant 
and instrument should be at similar temperatures whilst performing the measurement 
to prevent condensation from forming on the cell window, which again could adversely 
affect results (Merkus, 2009). 
In order to achieve suitable dispersion, the solids typically require wetting, the 
deagglomeration and stabilisation of the suspension (de Villiers, 1995). Mechanical 
methods used to enhance the stability of suspensions include stirring, shaking, and 
application of ultrasound. Various methods have been trialled to optimise the 
dispersion of inhalation-grade lactose for laser diffraction particle size analysis. 
Examples include: dispersion in chloroform with added sorbitan trioleate (Span 85) 
surfactant and 1 min sonication (Tee et al., 2000); dispersion in ethanol and sonication 
for 1 min (Louey and Stewart, 2002); dispersion in butan-1-ol with 3 min sonication 
(Islam et al., 2004). With cohesive powders, wetting of particles may not be sufficient 
to overcome the interparticle forces, therefore, further de-agglomeration may be 
required in order to obtain primary particles. Surfactants may be added to aid 
dispersion by reducing surface charge effects that can cause both agglomeration, and 
cause the sample to float on the surface of the liquid. Ultrasound may be applied to aid 
the dispersion if large particles or agglomerates are seen to sink to the bottom of the 
sample; however, fragile particles are susceptible to breakage with extended 
ultrasound application so care needs to be taken (Merkus, 2009).  
Whilst performing PSD measurements, it is important to ensure that recordings are 
made when the laser obscuration is stable (Tinke et al., 2009). If the obscuration 
decreases over the course of the measurement, the particle size may be increasing 
because of agglomeration, or even swelling due to the dispersant. Other causes can be 
attributed to particles settling due to insufficient stirring or particles dissolving. 
Conversely, if the obscuration increases, particles could be attaching themselves to the 
cell window due to surface charges (Merkus, 2009; Tinke et al., 2009).  
The dispersant should be a clear (at 633 nm wavelength), optically uniform liquid 
which does not interact with the sample causing it to change size (Lazghab et al., 
2005). Critically, the dispersant should not dissolve the material under test during the 
measurement. As an initial check of the suitability of the dispersant, the particles are 
observed microscopically and by laser diffraction over the course of the measurement 
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to ensure they do not dissolve or agglomerate, and that dispersion stability is achieved 
(Chander et al., 2007; Tinke et al., 2009). In addition, the polarity of the dispersant 
should also be considered since preferential adhesion of particles to glass surfaces 
could occur due to inadequate dispersant selection (Merkus, 2009). 
2.1.1.2. Dry Analysis 
Dry powder dispersion has the advantages of measurements being performed on the 
powder in its original state and removing the need for additional chemicals to be used 
as dispersants. It is particularly suitable for formulations that comprise both 
hydrophilic and hydrophobic components, since finding a mutual dispersant can be 
difficult (Bosquillon et al., 2001b). To obtain suitable dispersion of powders, a steady 
flow of powders through the measuring zone is required; this is typically achieved by 
use of a vibratory feeder – a conical hopper connected to a chute that allows feed rate 
across the cell window to be controlled. 
2.1.2. Dynamic Vapour Sorption 
Dynamic vapour sorption (DVS) studies allow a range of applications to be investigated 
through the controlled exposure of samples to vapour sources. Precisely controlled 
concentrations of vapours flow over a sample suspended from an ultra-microbalance, 
which measures the change in mass caused by sorption or desorption of the vapour 
molecule. These dynamic flow conditions enable the sorption/desorption behaviour of 
samples to be investigated. 
The interaction of organic solvents and water with pharmaceutical powders is highly 
important for the understanding of many processes that such products undergo. In 
particular, information about crystallisation, drying, and predictions of product 
stability and shelf life can be made using information gained from the shape of vapour 
sorption isotherms (Columbano et al., 2002; Mackin et al., 2002). 
2.1.2.1. Water Sorption Studies 
Water sorption studies allow a range of properties to be investigated including: 
moisture uptake and sorption of materials, stability, and degradation of powders, and 
the determination of amorphous content. 
High-energy processing of pharmaceutical material, including the HSB and 
micronisation processes employed in this thesis, may induce particle surface changes, 
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an example of which is the development of amorphous material. Amorphous materials 
in pharmaceutical formulations produce complex and challenging problems that 
influence the performance, processing, and storage of these products. The presence of 
amorphous materials may or may not be beneficial, depending on the (un)desired, 
unique properties of the amorphous state. 
Sorption isotherms describe the amount of vapour adsorbed (or desorbed) by a sample 
at different equilibrium concentrations in the gas phase. The shape of an adsorption 
isotherm is governed by the interaction between the vapour molecules and the solid; 
from this, the sorption mechanism can be determined. Isotherm shapes are described 
by the BDDT classification (Brunauer et al., 1940), which suggests there are six types of 
isotherm (although only four are relevant to pharmaceutical powders). Monolayer 
adsorption is characterised by significant uptake of vapour at low and high partial 
pressures, with relatively low adsorption at intermediate vapour concentrations. 
Conversely, cluster adsorption is characterised by low uptake at low vapour 
concentrations, with greater adsorption at high vapour concentrations. 
2.1.2.2. BET Surface Area Studies 
The DVS instrument can be employed to calculate the surface area of powders 
available for adsorption of gas molecules. Historically, the Brunauer Emmet Teller 
(BET) method of adsorption of gases onto the surface of solids used inert gases such as 
nitrogen, krypton, and argon to form a monolayer on the surface of the particles 
(Brunauer et al., 1938). However, more recently developed methods use organic 
vapours as the probe molecules, thus eliminating the need to work at the low 
temperatures associated with the boiling points of gases mentioned above. Using 
organic vapours such as octane allows analysis to be performed at ambient 
temperatures (~300 K), rather than the very low boiling point of inert gases (the 
boiling point of nitrogen is ~77 K). 
The BET equation, 
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 Equation 2.1 
where, P and P0 are the equilibrium and the saturation pressure of adsorbates at the 
temperature of adsorption (hence P/P0 is the partial pressure of vapour), v is the 
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adsorbed gas quantity, and vm is the monolayer adsorbed gas quantity. c is the BET 
constant, which is expressed by: 
RT
EE
c L1exp  Equation 2.2 
where, E1 is the heat of adsorption for the first layer, and EL is that for the second and 
higher layers and is equal to the heat of liquefaction. Plotting 1/[v([P0/P]-1)] as the 
ordinate and P0/P as the abscissa produces a straight line, with the gradient and y-
intercept used to find vm, the amount of gas adsorbed in the formation of a monolayer, 
and c, a constant used to describe the strength of the adsorbate-adsorbent interaction. 
2.1.3. Scanning Electron Microscopy (SEM) 
Electron microscopes were developed to overcome the limitations of light 
microscopes, which due to the wavelength of light, can only resolve images to 10-7 m. 
This limit was reached in the 1930s, however the demand to observe the structures of 
organic cells required magnifications greater than 10,000x, hence the need for a more 
powerful microscopy technique. 
SEM allows various information to be determined regarding the specimen material, 
this includes: surface topography, which in turn allows material properties such as 
hardness and reflectivity to be understood; surface morphology, which allows 
information regarding ductility, strength and reactivity to be found; composition which 
has a direct relationship to melting point, reactivity, hardness of materials; and 
crystallographic information which allows electrical properties and strength to be 
inferred (Cosgrove, 2005). SEM images are extensively used in DPI literature to assess 
formulations, and (dis)prove hypotheses, however it remains a subjective assessment 
method and firm conclusions are difficult to make; therefore should always be treated 
with a degree of scepticism. Recent examples of the use of SEM in DPI literature 
include: Donovan and Smyth, (2010) who assessed the influence of size and surface 
roughness of large lactose particles in DPI formulations; Ógáin et al., (2011) who 
observed spray-dried particles engineered from larger trehalose crystals; and Jones et 
al., (2010) who tested the effect of blending regimes on the impact of drug-carrier 
interactions. 
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2.1.4. Shear Cell Analysis 
It is widely known that particulate properties strongly influence the behaviour of bulk 
powders. Without adequate control of particulate properties, batch-to-batch variability 
of bulk powders and APIs can be large. Variations in raw materials can result in 
processing difficulties and produce large financial losses. The need for more consistent 
particulate properties of powder batches has resulted in tighter controls and the 
development of new grades of excipients to enhance flowability and dispersion 
(Crowder and Hickey, 2000). In addition, reliable and consistent flow from hoppers 
and feeders with minimal spillage and dust generation is required throughout the 
pharmaceutical industry.  
Edwards et al., (2009) investigated the relaxation effects on lactose/API blends 
produced using a high shear blender by comparing the flow functions of formulations 
stored over periods of time. Poor powder flow properties can result in reduced 
productivity and financial losses. A common approach used to improve the powder 
flow properties is to increase the size of the particles (i.e. granulation), although other 
methods involve increasing the powder density or altering the shape of the particle. It 
is known that more dense particles have improved flow properties, along with 
spherical particles rather than elongated, irregularly shaped particles (Danjo et al., 
1989; Popov et al., 2003). 
Shear cell tests of cohesivity compare flow functions (FF) of materials; the FF of a 
powder is the inverse of the gradient of the graph of unconfined yield stress ( ), 
against the consolidation stress ( ). A greater FF is indicative of superior bulk solid 
flow. Powders are often classified as being: free flowing, easy flowing, cohesive, very 
cohesive, or non-flowing (Table 2.2). Example plots of  against  with Mohr’s circles 
are shown in the Appendix, pages  227 and 228. 
With decreasing particle size, the gradient of the FF line should increase (Table 2.2), 
hence suggesting worsening flow conditions. If FF is plotted against particle size, i.e. 
d10, d50, and d90, of the same material, then the slope of the FF will decrease with 
increasing particle size. The unconfined yield strength (fc) represents the strength of 
the powder upon consolidation that needs to be overcome to initiate powder flow. 
Greater strength represents stronger particle-particle interactions, since the van der 
Waals forces and hydrogen bonds increase when the distance between particles 
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reduces. An increase in external stress consolidates powders and brings the particles 
close together. The closer arrangement and the increase in contact points between 
particles increases the strength of particle-particle interactions; and consequently the 
unconfined yield strength increases with increasing external stress. The stress 
required to induce particle-particle relative movement (i.e. shear failure in shear cell 
tests) is therefore higher if the powder bed is consolidated under a higher normal 
stress. This is comparable to the increase in friction forces when the normal stress is 
increased during the sliding of two touching surfaces; and is the reason behind the 
positive gradient of FF. If a powder is not subjected to significant consolidation by an 
external stress, the gradient of its FF line should be close to zero (Hou and Sun, 2008). 
The overall strength of surface interactions amongst particles is governed by three 
main factors: the total area of contact; the chemical nature of the surfaces, and the 
separation between the particles. 
 
Table 2.2. Classification of flow functions and their properties. 
Flow function, FF Flow characteristic 
FF < 1 Non-flowing 
1 < FF < 2 Very cohesive 
2 < FF < 4 Cohesive 
4 < FF < 10 Easy flowing 
10 < FF Free flowing 
 
2.2. Materials and Methods 
2.2.1. Lactose 
Lactose (4-O-β-D-galactopyranosyl-D-glucose) is a disaccharide sugar consisting of 
galactose and glucose fragments which is most commonly found in milk. The grade of 
lactose used throughout this thesis is Lactohale (GSK Description: Lactose for MDPI 
Grade 5) (Friesland Foods, Zwolle, The Netherlands). It is commonly available in three 
forms: -monohydrate, -anhydrous and spray-dried; this study focuses on the -
monohydrate form since it is often the material of choice as a DPI excipient. Samples of 
this material used throughout the study were taken from batches stored in the original 
packaging (foil bag within a cardboard box) at 20°C and 40% RH in humidity-
controlled cabinets (Binder, Germany). 
Investigation into the Effects of High Shear Blending and Storage on Powders for Inhalation 62 
Analytical Method Development 
2.2.2. Development of a Protocol For Laser Diffraction Particle Size 
Measurements (Wet Dispersion Systems) 
The laser diffraction instrument used in this study was a Malvern Mastersizer 2000 
connected to a Hydro SM small volume pump/stirrer dispersion unit (both Malvern 
Instruments, UK). This allows samples in suspension to be passed across the laser 
beam through a glass cell window. The setup of the pump and stirrer allows samples to 
be re-circulated, thus allowing multiple measurements to be made on the same sample 
to improve reliability of results. The lens used by this instrument had measurement 
range 0.02–20 000 m. 
In order to ensure consistency in results, the obscuration limits were set by the 
standard operating procedure (SOP) to be between 15 and 18% for lactose 
measurements and between 4 and 8% for micronised material, as recommended by 
the manufacturer’s operating manual. 
Prior to particle size measurements being made, a quality audit was performed to 
validate performance of the instrument. This involved dispersing glass beads 
(refractive index 1.52) of well-defined particle size in distilled water (refractive index 
1.33); the theoretical defined limits and actual measurements from three independent 
tests are shown in Table 2.4. 
2.2.2.1. Investigation Into Appropriate Dispersant 
The method proposed by Adi et al., (2007) was investigated in order to determine the 
optimal method for dispersion of the lactose used throughout this study. In order to 
achieve this, propan-2-ol and ethanol (both analytical reagent grade, Fisher Scientific, 
Loughborough, UK) were used as dispersants to test the stability of results over time. 
This test involved the dispersion of approximately 500 mg lactose in 5 ml of each 
solvent and gently shaking by hand before adding drop-wise to the dispersion unit 
(filled with approximately 200 ml solvent) until an obscuration between 15 and 18% 
was achieved. The stirrer speed was set at 1500 rpm for each experiment with 
measurements taken at regular intervals to determine the stability of results over time. 
Each time-course experiment was performed three times. Reference refractive indices 
of lactose (1.533), propan-2-ol (1.378), and ethanol (1.361) were used, with an 
estimated imaginary refractive index of lactose of 0.1 (Adi et al., 2007). 
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2.2.2.2. Use of Sonication to Aid Dispersion 
Samples were prepared and measured using the method described in section 2.2.2.1, 
using propan-2-ol as dispersant before being placed in an ultrasonic bath for 2, 5, 10, 
15, 20, 30, 40, 50 and 60 minutes to aid dispersion. Following sonication, samples were 
measured immediately to determine the effects of sonication on particle size. A further 
test was performed to describe the relaxation of the effects on lactose particle caused 
by sonication, this involved exposing a sample to ultrasound for 30 min then 
measuring the particle size at: 10 s, 30 s, 1 min, 5 min, 10 min, 20 min, 30 min, 60 min, 
2 hr, 3 hr, 4 hr and 5 hr following this. 
2.2.3. Development of a Protocol for Laser Diffraction Particle Size 
Measurements (Dry Systems) 
The instrument used for this method was the Sympatec HELOS laser diffraction 
system, with RODOS dispersion unit and VIBRI vibrational feeder used in this study (all 
Sympatec, Germany). 
2.2.3.1. Effect of Pressure 
The major drawback using dry dispersion systems - in particular the compressed air 
that produces the dispersion - is the possibility of particle breakage or fracture 
(Merkus, 2009). In order to determine the degree of fracture, a simple pressure 
titration experiment was performed to test the effect of pressure on the PSD of 
unprocessed lactose carrier (Fig. 2.6). 
Unprocessed lactose was measured using the R3 lens with a focal length of 100 mm 
and 0.5-175 m detection range – suitable for the finest particles within the excipient 
PSD, at a range of pressures to determine the ability to disperse agglomerates. Approx 
1 g of material is typically required to obtain a recommended laser obscuration of 5-
8% (recommended by manufacturer). 
2.2.4. Dynamic Vapour Sorption  
Water sorption and specific surface area (SSA) measurements made throughout this 
study were performed using a DVS Advantage II (Surface Measurement Systems, UK) 
using previously well-developed methods (Bridson et al., 2007). Results from these 
analyses can be found in chapters 3, 4, and 5. 
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2.2.4.1. Calibration 
In order to validate the mass flow controller, salt validation trials allowed partial 
pressures to be accurately generated. These calibrations were based on the principle 
that the vapour pressure above a saturated salt solution in equilibrium with its 
environment is constant at fixed temperature. Several salts were used for validation 
covering a range of partial pressures (Table 2.3), with the saturated salt solution 
(~50 mg) made with distilled water and placed in the sample pan. 
To perform validations, the temperature was held at the temperature required for 
standard experiments, and then the partial pressure set at approximately 5% above 
the salt solution partial pressure (P/P0) before being subsequently reduced to 5% 
below the salt solution partial pressure over a period of five hours. Finally, the partial 
pressure was returned back to the starting pressure, over a three-hour period. By 
plotting (Fig. 2.1) the target %P/P0 against dm/d(%P/P0), and finding when 
dm/d(%P/P0) = 0, the generated %P/P0 was calibrated against the actual partial 
pressure above the saturated salt solution at this temperature – therefore ensuring the 
partial pressure accuracy of the system. 
 
dm/d(%P/P0) = 0
dm/d(%P/P0) = 0
%P/P0Change in
mass (%)
Time
Saturated partial 
pressure of 
salt solution
 
Fig. 2.1. Change in mass and partial pressure generated by DVS system as a function of time. The points at 
which dm/d(%P/P0) = 0 correspond to the saturated partial pressure of the salt solution. 
 
 
Table 2.3. Saturated salt deliquescence points (Greenspan, 1977). 
Salt Water%P/P0 at 25°C Water%P/P0 at 40°C 
Lithium chloride 11.3 11.2 
Magnesium chloride 32.8 31.6 
Magnesium nitrate 52.9 48.4 
Sodium chloride 75.3 74.7 
Potassium nitrate 93.7 89.0 
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2.2.4.2. Water Sorption Studies 
120  1 mg samples were dried for 4 hours using oxygen-free nitrogen (BOC, UK) 
before being subjected to increasing humidity steps from 0-90% in 10% increments 
whilst being kept at constant 25°C  0.1°C. Samples were allowed to reach a near-
equilibrium state (%dm dt = 0.0002% min-1) at each humidity step before progressing to 
the next stage. 
2.2.4.3. BET Surface Area Analysis 
Application of the Brunauer Emmet Teller (BET) equation was performed using octane 
(HPLC grade, Fisher Scientific, UK) as the probe molecule that allowed the SSA of 
lactose samples to be determined. For these experiments, dry, oxygen-free nitrogen 
(BOC, UK) was purged over the 120 mg  5 mg sample for four hours. The partial 
pressure was then sequentially increased from 0 to 96% in 3% increments, with the 
sample being allowed to reach a near-equilibrium (% dm dt = 0.0002% min-1) at each 
partial pressure stage before progressing to the next. All stages of the experiment were 
performed at 25°C  0.1°C and were repeated three consecutive times on each sample. 
2.2.5. Scanning Electron Microscopy 
PSD and particle morphology were investigated throughout this study using SEM to 
produce images of material before and after processing. Images of the surface 
morphology and uniformity of material were taken using a JEOL 6060 Scanning 
Electron Microscope (JEOL, Japan) at 10 keV accelerating voltage. Each sample was 
mounted on a carbon sticky tab (carbon is used since it absorbs electrons rather than 
re-emitting electrons, hence reducing background noise) and gold coated (10 nm 
thickness), prior to analysis (Young et al., 2007a). Gold sputter coating was performed 
using an Emscope SC 500, Elexience, Paris, France. SEM images of mimic formulations 
can be found in chapters 4, 5 and 6. 
2.2.6. Shear Cell Method 
Cohesivity of materials was determined using a Ring Shear Tester, (RST-XS, Dr. 
Dietmar Schulze, Wolfenbüttel, Germany). A small volume of material (~30 cm3) was 
loaded into a shear cell with the excess powder scraped off by a spatula, ensuring that 
no force was applied to the powder surface; the powder was then weighed before a lid 
was placed on top of the bed and a loading rod inserted to apply the normal stress to 
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the bed. Two tie rods were then used to apply a shear stress and are attached to two 
load cells. To test the cohesivity of materials used in this study, a preshear stress of 20 
kPa was applied before consolidation stresses of 2, 3, 5, 10, 15 kPa to determine at 
which points the bed fails. These values were chosen to correspond to consolidation 
stresses experienced by pharmaceutical formulations during handling and device 
filling (Schulze, 2005). 
Tests of the cohesivity of materials are employed throughout this study. Chapter 3 
utilises the shear test method to compare the cohesivity of materials prior to blending, 
and the mimic APIs post-micronisation used in this study. Chapter 4 describes the 
effect of specific energy input (SEI) during HSB on the cohesivity of -lactose 
monohydrate, whilst chapter 5 assesses the cohesivity of mimic API-containing 
formulations exposed to different blending and storage regimes. 
2.3. Results 
2.3.1. Wet Dispersion Results 
The calibration of the instrument was performed on a regular basis to ensure 
consistent performance. Table 2.4 shows an example of such a test. 
Table 2.4. Quality audit of Mastersizer 2000 using glass beads as standards. Values are averaged from three 
independent measurements  SD. 
 d10 ( m) d50 ( m) d90 ( m) 
Manufacturer’s Lower limit 27.58 45.86 74.69 
Manufacturer’s Median 28.43 46.8 77 
Manufacturer’s Upper limit 29.28 47.74 79.31 
Measured value 28.61  0.03 47.04  0.05 76.69  0.09 
 
2.3.1.1. Appropriate Dispersant Selection  
Fig. 2.2 shows the differences in d10 (used to describe the FPF of the PSD) and d50 
particle size measurements using ethanol and propan-2-ol as dispersants. It can be 
shown that the use of propan-2-ol as dispersant produced more stable results over 
time than ethanol, despite the two producing similar results during the initial 
measurement. Since the particle size measurements performed throughout this study 
required stability over time, propan-2-ol was the preferred option for lactose, in 
agreement with the work by Adi et al., (2007). 
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Fig. 2.2. Comparison between ethanol and propan-2-ol for particle size measurements of unprocessed 
lactose. Results show the change in d10 and d50 particle size as a function of measurement time from three 
samples  SD.  - d10,  - d50 (ethanol);  - d10,  - d50 (propan-2-ol). 
 
2.3.1.2. Sonication Results 
Fig. 2.3 shows the effect of sonication on lactose in propan-2-ol suspensions; such that 
sonication aids dispersion of particles and creates a homogeneous suspension more 
suitable for size analysis.  
Fig. 2.4 shows the effect of sonication on the d10 
and d50 particle size of unprocessed lactose – the 
results show that application of ultrasound 
significantly reduces the particle size of the 
material, however, does not provide information 
on the mechanism that causes this. Either 
particles may be fracturing, or de-agglomeration 
is being enhanced by ultrasound, thus producing 
smaller free particles than by simply wetting the material. 
 
Fig. 2.3. Lactose in propan-2-ol 
suspensions; without sonication (left); 
1 min after sonication for 3 min (right). 
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Fig. 2.4. Effect of sonication time on the d10 -  and d50 -  particle size of unprocessed lactose. These 
results suggest that either agglomerates are being broken up, or particles are fracturing due to 
sonication. Results shown are averaged from three independent batches of unprocessed lactose  SD. 
 
In order to check which mechanism occurs, the relaxation of the suspended lactose 
particle size was determined by PSD measurements at time intervals following 
sonication (Fig. 2.5). This shows that the particle size returns to the original size after 
several hours, thus suggesting that particles are not being fractured and that 
sonication simply improves the de-agglomeration of particles in suspension. Should 
particle fracture occur, it is unlikely that the size distribution would return to its 
original state. It is important to note that application of ultrasound is only intended as 
a dispersion aid for measurement and not to be used in the production of micronised 
drug particles (Kinnarinen et al., 2003). Re-agglomeration of particles is initiated 
through particulate collisions caused by settling and mixing within the dispersion unit 
(Adi et al., 2007). 
These results correlate with those found in a previous study by Adi et al., (2007), who 
reviewed several dispersion mechanisms and their effect on PSD of fine lactose in 
order to develop a suitable methodology for size measurements using laser diffraction. 
The results found dispersion in propan-2-ol combined with 3 min sonication was 
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suitable for fine lactose particle size measurements. Sonication was required to 
achieve suitable de-agglomeration and detachment of fines from larger carrier 
particles, however, extended sonication was found to potentially cause particle 
fracture, whilst dispersion in both ethanol and butan-1-ol caused time-dependent 
changes in particle properties that were attributed to possible dissolution and 
recrystallisation. 
Time since end of sonication (s)
1 10 100 1000 10000
P
ar
ti
cl
e 
si
ze
 (
m
)
0
2
4
52
56
60
Initial d50
Initial d10
 
Fig. 2.5. Time dependent relaxation of unprocessed lactose to its original size following sonication for 30 min. 
Results are averaged from three independent experiments  SD. d10 - , d50 - . 
 
2.3.1.3. Wet Dispersion Conclusion 
As a result of the experiments performed above, the experimental conditions used in 
determining the PSD of lactose were suspension in propan-2-ol followed by 15 min 
sonication and immediate measurement post-sonication. The stirrer speed was set at 
1500 rpm and obscuration settings were dependent on the material being analysed. 
Based on manufacturer’s specifications, obscuration of 12-20% is suitable for particles 
<50 m, whilst an obscuration of 3-5% is suitable for particles <10 m.  
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2.3.2. Dry Dispersion Results 
Regular quality audits of the detector were performed using silicon carbide reference 
material (P600, Sympatec, Germany). The theoretical defined limits and an example of 
actual measurements from three independent tests are shown in Table 2.5. 
 
Table 2.5. Quality audit of Sympatec HELOS using silicon carbide reference material (R3 lens). 
Values are averaged from three independent measurements  SD. 
 d10 ( m) d16 ( m) d50 ( m) d84 ( m) d90 ( m) 
Lower limit 16.54 18.62 27.23 38.72 41.74 
Median 17.05 19.19 28.08 39.91 43.03 
Upper limit 17.56 19.77 28.92 41.11 44.32 
Measured value 17.21  0.29 19.49  0.28 28.49  0.27 39.23  0.07 42.15  0.19 
 
2.3.2.1. Effect of Pressure on Particle Size of -Lactose Monohydrate 
Fig. 2.6 shows that dispersion of particles is enhanced with increasing pressure up to 
2 bar, at which point further de-agglomeration is not observed. This is particularly 
noticeable at the fine end of the size distribution, suggesting that unprocessed lactose 
consists of a number of fine particle agglomerates and fines attached to larger carriers. 
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Fig. 2.6. Pressure titration test to determine the effect of increasing pressure on the d5 - , d10 -, d50 - , and 
d90 -  particle size of unprocessed lactose using RODOS/L dispersion unit with HELOS sensor.  
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This pressure titration experiment showed that the PSD of lactose is not adversely 
affected by the range of dispersion pressures obtainable by the system. Differences 
were observed at the fine particle region of the distribution, suggesting that pressures 
lower than ~2 bar were not as efficient at de-agglomeration or removing fines adhered 
to larger particles, hence a d5 particle size of 4.15 m is achieved at 0.5 bar dispersion 
pressure compared to 3.15 m at 2 bar.  
As a result of this pressure titration test described above, dry dispersion 
measurements were performed using a dispersion pressure of 2 bar, as used 
previously by Bridson et al., (2007).  
2.4. Conclusion 
Throughout this thesis, particle size data will be reported using measurements from 
both wet and dry dispersion laser diffraction devices. The choice of device was 
dependent primarily on the degree of dispersion required. When enhanced dispersion 
was required (for particularly cohesive powders), and knowledge of primary particle 
sizes desired, wet dispersion was used, whereas dry dispersion allowed more accurate 
representation of particles in their natural (often agglomerated) state. The sample size 
to be analysed was also considered. When the amount of material was not limited, dry 
dispersion was used as this is the most common technique used in literature (for ease 
of comparison), two such examples include Bridson et al., (2007) and Deng et al., 
(2010) and allowed for more rapid analysis.  
Table 2.6 shows a comparison between the d10, d50 and d90 particle sizes produced by 
dry and wet dispersion laser diffraction techniques of unprocessed lactose taken from 
20 samples throughout the batch of powder used in this study. The results show that 
the wet dispersion method with suspension in propan-2-ol and 5 min of sonication 
offers greater dispersion efficiency than 2-bar compressed air, 
 
Table 2.6. Comparison of wet and dry dispersion techniques on particle size values of unprocessed lactose. 
 Sympatec dry dispersion (2 bar) Mastersizer wet dispersion (propan-2-ol) 
d10 9.55  0.57 m  3.43  0.21 m 
d50 68.46  0.89 m 56.05  0.34 m 
d90 134.40  1.42 m 132.81  0.78 m 
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3.0. Mimic API and Formulation Production and 
Characterisation 
ABSTRACT 
A key requirement for the delivery of therapeutic drugs to the lower airways is an 
aerodynamic diameter of 1-5 m. Producing this size of particles is often a difficult 
process, typically involving the high energy micronisation of larger particles. This 
chapter describes the production and characterisation of two compounds with 
different physicochemical properties, cholesterol and vitamin C, along with the 
rationale behind their choice as mimic active pharmaceutical ingredients (APIs) 
throughout this study. 
This work focuses on the use of a planetary ball mill to micronise the compounds, and 
describes the characterisation techniques used to ensure the micronised material 
behaves consistently throughout the course of the experiments. 
The final part of this chapter describes the production of formulations using high shear 
blending (HSB) and the characterisation of these formulations, including the test used 
to determine if, and when, blend content uniformity had been achieved. 
Results showed that micronised cholesterol and vitamin C were stable (in terms of 
particle size, chemical composition, and crystallinity) over the course of a typical long-
term storage study (5 months) when stored at 40% RH and 20°C. Since their 
physicochemical properties were not affected by controlled long-term storage, they 
were deemed suitable for use in tests to determine the effects of blending and storage 
regimes on the adhesion between API and carrier (chapter 7). 
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3.1. Introduction 
3.1.1. Mimic API selection 
The drugs used in DPIs can broadly be split into two groups: corticosteroids used to 
treat diseases of the bronchi and lungs, and 2 adrenergic agonists – either long acting 
or short acting – used to cause smooth muscle relaxation, resulting in the dilation of 
blood vessels and bronchial passages. These drugs may be administered solely, or in 
combination, providing both relief and symptom control to the patient. APIs have a 
wide range of physicochemical properties, for example, different APIs are known to 
exhibit a range of affinities to moisture. Salbutamol sulphate is a common short-acting 
2 adrenergic agonist which exhibits hydrophilic nature (Brodka-Pfeiffer et al., 2003), 
whilst the long-acting salmeterol xinafoate (Murnane et al., 2008) and the 
corticosteroid triamcinolone acetonide (Williams et al., 1999) possess hydrophobic 
properties. 
Inhaled corticosteroids (ICSs) such as budesonide, fluticasone propionate, and 
beclomethasone dipropionate belong to the steroidal group of organic compounds that 
comprise four carbon rings joined together, as shown in Fig. 3.1. The sterane core 
comprises seventeen carbon atoms bonded together to form four rings – three 
cyclohexane rings and one cyclopentane ring. The differences between the steroids 
arise from the functional groups attached to the four rings, and their oxidation states. 
Due to their similar sterane cores, cholesterol was proposed as a suitable choice for 
mimic steroid-based API. 
Cholesterol (3β-cholest-5-en-3-ol) is a waxy steroid metabolite found in the cell 
membranes and blood plasma of all animals. It is an important component for the 
manufacture of steroid hormones and fat-soluble vitamins. It was chosen as a mimic 
drug due to its hydrophobicity and steroidal core (Fig. 3.1) similar to drugs used in DPI 
formulations, particularly the corticosteroids such as budesonide and salmeterol. The 
chemical structure of cholesterol is given in Fig. 3.2. 
Investigation into the Effects of High Shear Blending and Storage on Powders for Inhalation 74 
Mimic API and Formulation Production and Characterisation 
A B
C D
 
Fig. 3.1. Steroid core skeleton found in budesonide and other inhaled corticosteroids.  
 
Vitamin C (L-ascorbic acid) is an antioxidant required for a range of essential metabolic 
reactions in plants and animals. It is a water-soluble vitamin naturally present in some 
foods; it is however also added to other foods and used as a dietary supplement. It was 
proposed as a mimic drug due to its water solubility in contrast to the hydrophobicity 
of cholesterol. The chemical structure of vitamin C is given in Fig. 3.3.  
Other mimic drugs used in inhalation studies include: bovine albumin serum (Adi et al., 
2008), salicylic acid (El-Hagrasy et al., 2006); ethenzamide (Takano et al., 2003); and 
disodium cromoglycate (Braun et al., 1996; Young et al., 2007a). 
 
 
Fig. 3.2. Chemical structure of cholesterol Fig. 3.3. Chemical structure of vitamin C 
 
3.1.2. Micronisation 
Micronisation of API particle size is achieved through either top-down processes, in 
which particle size is reduced, or bottom-up processes where particles are produced 
by increasing droplets of the API to the desired size (Ennis and Litster, 1997; Hu et al., 
2004). 
3.1.2.1. Top-down processes 
Milling is a frequent choice of mechanical reduction (Merisko-Liversidge et al., 2003; 
Müller et al., 2000), of which there are several alternative methods, typically consisting 
of fluid-energy (jet) mills (Bentham et al., 2004), high-peripheral-speed mills (Nakach 
et al., (2004), and ball mills (Snow et al., 1999). These high-energy processes often 
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generate forces that are likely to induce lattice defects, weaken intermolecular bonds, 
and alter the physicochemical stability of crystalline materials (Ticehurst et al., 2000).  
Planetary ball mills are commonly used in laboratory-scale applications for ultra-fine 
milling (defined as milling to <10 m). Milling is primarily achieved through the high-
energy impact of the grinding balls and chamber. Within the grinding bowl, the 
grinding media and feed material rotate around its own axis on a main disc, which 
rapidly rotates in the opposite direction (Fig. 3.5). At a certain speeds, the centrifugal 
force causes the ground sample material and grinding balls to separate from the inner 
wall of the grinding bowl and cross the bowl at high speed to further grind the material 
by impact against the opposite bowl wall. An impact between the balls themselves also 
adds to the size reduction process. Milling conditions to be considered include, 
grinding media size, grinding time and grinding speed (Dudognon et al., 2006). 
Ball mills consist of a cylindrical tube into 
which the grinding media and material to 
be ground are filled. Size reduction occurs 
when the loose media slides and rolls 
about in a parabolic arc within the 
rotating cylinder (Müller et al., 2001). 
Some of the grinding balls are pushed to 
the outside of the chamber by the 
centrifugal force and are raised upward in 
the cylinder. When these particles fall, they impact on the feed material. During slower 
rotation, the balls mainly roll against each other. The balance between rolling and 
tumbling is a function of operating speed, and the amount of media present. Decisive 
factors affecting the success of size reduction include correct choice of media, size of 
media, and mix ratio of media according to size (Merisko-Liversidge et al., 2003).  
The desired PSD of the feed material is dependent on the grinding media size. A coarse 
end product requires larger grinding media, whilst a fine end product requires small 
grinding media. Wet size reduction is preferential for size reduction to <30 m, since 
shear forces of the surrounding medium assist the size reduction between two solid 
surfaces and the deagglomeration of compacted particles. This enhances the fineness 
of particles that can be achieved, prevents dust formation and is suitable for suspended 
Grinding media
Mill axis
Grinding chamber
Primary axis
 
Fig. 3.4. Operating principles of planetary ball mill 
(Fisher, 2007). 
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feed materials or if the end product is required as a suspension for downstream 
processing (Merisko-Liversidge et al., 2003). Approximately 30% less energy is 
required for wet processing, and wear to the milling equipment is 3-5 times less than 
dry processes. This has several advantages over dry milling methods in that heat-
sensitive materials can be milled conveniently, since the slurry removes heat 
generated by the friction generated in the milling process (Fisher, 2007). Despite being 
a slow method and difficult to scale up, ball milling is efficient at producing small-scale 
batches for laboratory purposes (Hu et al., 2001). 
Generally, harder materials have a greater grindability (i.e. a finer particle size can be 
achieved) – Fisher, (2007). Particle toughness affects the size reduction of particles by 
resisting the propagation of cracks through the material. In tough materials, excess 
strain energy induces plastic deformation, rather than the production of new cracks. 
Mechanical size reduction is difficult for very ductile materials, whilst brittle materials 
are readily reduced; the point at which plastic and brittle transformations is 
recognised as important by Shariare et al., (2011) in their work on lactose 
micronisation. The size reduction of tough materials can be enhanced by reducing the 
temperature of the material, hence reducing its ability to flow plastically and rendering 
the particle more brittle (Fisher, 2007). 
3.1.2.2. Bottom-up processes 
Two commonly used bottom-up processes include spray-drying and supercritical fluid 
crystallisation (Rogers et al., 2001). Spray drying involves drug dissolved in solvent 
being sprayed as a fine mist into a heated expansion chamber (Chawla et al., 1994; 
Sarkari et al., 2002). The droplets dry, leaving tiny particles of drug that are collected 
at the bottom of the chamber. Spray-drying produces particles with greater sphericity 
than milling; however, the particles are mostly amorphous (Vidgren et al., 1987). 
Supercritical fluid crystallisation employs the liquid-like density and gas-like transport 
properties of supercritical fluids to recrystallise drugs. They allow the solubility to be 
controlled by altering the pressure of the (anti)solvent (typically carbon dioxide or 
propane) to produce small particles (Schiavone et al., 2004). 
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3.2. Materials 
Cholesterol was obtained from Sigma Aldrich, UK, and stored below 0°C prior to 
micronisation and blending. Granulated vitamin C was also obtained from Sigma 
Aldrich, UK and stored in ambient conditions prior to micronisation and blending.  
3.3. Methods 
3.3.1. Characterisation 
Individual batches of both cholesterol and vitamin C were combined and gently shaken 
to produce a single batch to be used throughout the study in order to normalise the 
characteristics of the mimic API, since controlling the particle size of several batches is 
known to be difficult during micronisation (Ticehurst et al., 2000). Particle size data of 
combined batches is given in Table 3.2. 
3.3.1.1. Particle size 
PSDs were obtained using the Mastersizer 2000 with Hydro SM small volume 
dispersion unit (section 2.2.2). This was chosen over the dry dispersion technique due 
to its greater ability to disperse cohesive materials. Vitamin C was suspended in the 
non-polar isooctane (Analytical Reagent Grade – Fisher Scientific, Loughborough, UK), 
whilst cholesterol was suspended in distilled water (Chen et al., 2009).  
In order to stabilise suspensions and aid de-agglomeration for measurement, 
surfactants were added to the micronised mimic APIs. Cholesterol particles were 
measured via the addition of polysorbate 20 surfactant whilst vitamin C particles were 
measured via the addition of sorbitan trioleate (both in 1% w/w ratios) (Tee et al., 
2000). Each sample was resuspended in the dispersant/surfactant and sonicated to 
enhance de-agglomeration, mixing was performed via a vortex mixer (Vortex Genie 2, 
Scientific Industries) for 30 s prior to measurement1. Table 3.2 shows particle size 
statistics for cholesterol and vitamin C before and after micronisation. Results are 
averaged from three individual experiments on combined micronised batches. 
Images of milled mimic drug particles were obtained in order to confirm PSD data. 
Images were obtained by placing a small drop of drug suspension on a clean 
                                                     
 
1
 Surfactant was added to samples for measurement purposes only, no surfactant was used on the batches 
used in formulations due to surface adhesion effects. 
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microscope slide and using an Olympus BX50 light microscope in conjunction with a 
Leica Q500IW camera attached to a PC. Images were taken at 1000× magnification. 
3.3.1.2. FTIR chemical composition analysis 
Infrared spectroscopy utilises the property of molecules that makes them vibrate or 
rotate depending on the specific frequencies linked to their discrete energy levels 
(vibrational modes). These resonant frequencies are determined by the shape of the 
molecular potential energy surfaces, the masses of the atoms and, by the associated 
vibrational coupling. In addition, resonant frequencies can be related to the strength of 
the bond, and the mass of the atoms at either end of it. Thus, the frequency of the 
vibrations can be associated with a particular bond type (Paradkar and Irudayaraj, 
2002). 
FTIR analysis was employed to determine if the micronisation process required to 
reduce the particle size of vitamin C and cholesterol affected the chemical composition. 
The FTIR instrument used in this study was the Nicolet 380, Thermo Electron 
Corporation. The wavenumber range for cholesterol was based on that used by Kleiner 
et al., (2002) and Schafmayer et al., (2006); whilst the wavenumber range used for 
vitamin C followed that used by Chen et al., (2006). 400-4000 cm-1 with resolution of 
4 cm-1 was the wavenumber range used in both cases. Measurements required approx 
100 mg sample and were performed in triplicate. 
3.3.1.3. Water sorption studies 
Water sorption studies were performed on micronised cholesterol and vitamin C post 
milling and after prolonged storage at 40% RH and 20°C, and compared to the water 
sorption profiles of the unprocessed material to detect changes in surface 
characteristics. This method was also used to determine whether amorphous material 
was created due to the milling process, especially during increased milling times 
(Young et al., 2007b). Even relatively low levels of amorphous material (<10%), may 
have a detrimental impact on the stability, dissolution and adhesive characteristics of 
the formulated drug product. The water sorption study performed on these samples 
matched that used for lactose, as described in section 2.2.4.2. 
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3.3.1.4. Cohesivity of Micronised Mimic APIs 
The cohesivity of APIs is an important consideration in the design of DPI formulations. 
Cohesive and adhesive compounds differ in their behaviour both during manufacture 
and on their fluidisation, entrainment, and deposition performance.  
Many studies have shown that the flowability of powders can be linked to their 
cohesiveness (Kawashima et al., 1998a,b; Kumon et al., 2006; Zhou et al., 2009), 
however, only Zhou et al., (2010) have linked the aerosolisation performance of 
powders to their intrinsic cohesion. In their work, salbutamol sulphate, salmeterol 
xinafoate, triamcinolone acetonide were used based on their differing physicochemical 
properties, with cohesion being measured by an established shear cell method, and 
aerosolisation performance analysed by a twin-staged impinger. 
The method used to test the cohesivity of micronised mimic actives is described in 
section 2.2.6. 
3.3.2. Micronisation 
Size reduction was performed using a planetary ball mill (Pulverisette 6, Fritsch, 
Germany) described in section 3.1.2.1. A 45 ml grinding bowl was half filled with 1 mm 
grinding media, based on recommendation by Fisher, (2007) in order to achieve a 
product size of ~1 m. A 1:3 w/w cholesterol:water ratio was used with the bowl filled 
to the top to minimise the “foaming” of material caused by insufficient wetting of the 
material (Czekai and Seaman, 1999) and enhance the efficiency of the milling 
procedure. Without filling the bowl, particles rise to the surface and escape the 
impaction events that cause fracture, and hence size reduction. The procedure lasted 
~2 hours (Fig. 3.7) with intermittent breaks to avoid the product and equipment 
overheating (Choi et al., 2004), rotation was set at 400 rpm.  
Following milling, water was removed by a Büchner funnel, using 0.4 m filter paper 
(Whatman, UK) before drying. Particle size was verified by laser diffraction and light 
microscopy (section 3.3.1.1). 
Isooctane was used as dispersant medium for vitamin C to fulfil the criteria of being 
non-dissolving and for safety reasons, having relatively high boiling and flash points; it 
also has low viscosity, enabling shear forces to be imparted on the material. The same 
grinding media were employed as in the wet milling of cholesterol since the same 
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product size was desired. The length of milling time required was explored by checking 
the particle size of the product at regular intervals (Fig. 3.7). Following milling, solids 
were filtered and dried using a rotary evaporator. Particle size was verified by laser 
diffraction using the method described in section 3.3.1.1. 
3.4. Results 
3.4.1. Particle Size Data 
Initial PSD data (Fig. 3.6) showed that unprocessed cholesterol contained ~10% 
material in the desired size range of 1-5 m (Newman and Clarke, 1983). It was found 
that cholesterol suspensions separated on storage – larger particles floated on the 
surface of the liquid, whilst the smaller particles formed a suspension with the liquid 
(Fig. 3.5).  
Fig. 3.6 and Table 3.1 show PSD data of unprocessed cholesterol, a sample of the 
particles that form the foam, particles in suspension and a homogenised sample (5 min 
at 10,000 rpm – IKA® T25 digital homogeniser, Ultra Turrax, UK). Particle size 
measurements were performed following 10 min sonication to aid de-agglomeration. It 
is clear from Fig. 3.6 that size reduction is required to produce a significant amount of 
particles in the desired size range. Homogenisation is not sufficient to reduce the PSD 
and although it removes the distinction of foam and suspension, the particles soon 
re-separate. 
Table 3.1. Cholesterol PSD post milling, following filtration, drying and resuspension, after 5 min sonication. 
 Particle size ( m) 
 d10 d50 d90 
Unprocessed 4.11 29.60 103.58 
Suspension 0.45 1.51 67.66 
“Foam” 11.53 98.75 252.94 
“Homogenised” 6.24 63.49 221.26 
 
 
   Foam 
 
 
    Suspension 
Fig. 3.5. Cholesterol particles settling on surface of water to form a foam and suspension. 
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Fig. 3.6. PSDs of unprocessed cholesterol, homogenised cholesterol, material held in suspension, and 
material found in the foam on the surface of the suspension. 
 
3.4.2. Micronisation 
Fig. 3.7 shows that the optimum particle size for vitamin C could be achieved after just 
~30 min compared to ~2 hours for cholesterol, possibly due to the hardness of 
vitamin C with respect to cholesterol, thus making the material more susceptible to 
fracture. Particle failure is the aim of size reduction; the particles are subjected to 
contact forces, between both themselves and the grinding media (Hennart et al., 2010). 
Contact forces deform particles and generate stress, which, if sufficient can produce 
fractures and cracks in the particle. The number and direction of these fractures 
determine the size and the form of the fragments and the surface of the particles (Chen 
et al., 2004). The type of deformation that occurs depends on the strain exerted on the 
particle; hence, either inelastic deformation or fracture may occur. Splits and cracks in 
the material are the source of inelastic deformation and fracture, with decreasing 
particle size, the elastic behaviour decreases as the plastic behaviour increases. This is 
the limit of the grindability and is dependent on the hardness of the material. 
Generally, harder materials have a greater grindability (i.e. a finer particle size can be 
achieved) – Fisher, (2007). 
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Fig. 3.7. Effect of milling time on the d50 particle size of cholesterol () and vitamin C (). Graph shows a 
plateau of particle size >120 min for cholesterol, and >30 min for Vitamin C, thus showing the maximum 
milling time required for each material.  
 
The initial and final particle sizes of the combined batch of cholesterol and vitamin C is 
given in Table 3.2. Both batches fall within the limits of 1-5 m for average particle size 
for APIs in DPI formulations defined by Newman and Clarke, (1983) and Zanen et al., 
(1994). Light microscope images are shown in Fig. 3.8 and verify the laser diffraction 
PSDs. 
 
Table 3.2. Cholesterol and vitamin C PSD post milling, following filtration, drying and 
resuspension with surfactant, after 5 min sonication. 
  Particle size ( m) 
  d10 d50 d90 
Cholesterol 
Average 1.51  0.19 4.45  0.29 11.47  3.39 
Unprocessed 4.11 29.60 103.58 
Vitamin C 
Average 1.13  0.21 3.21  0.18 7.59  0.75 
Unprocessed 1.50  32.90 99.51 
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Fig. 3.8. Light microscope image of milled cholesterol (left), suspended in 1% w/w polysorbate 20:water solution, 
and milled vitamin C (right) suspended in 1% w/w sorbitan trioleate:isooctane solution. 
 
3.4.3. FTIR analysis 
Fig. 3.9 (cholesterol) and Fig. 3.10 (vitamin C) show FTIR spectra of micronised and 
non-micronised mimic drugs along with a description of the structural features that 
produce characteristic shape for each compound. FTIR analysis of both cholesterol and 
vitamin C showed that the micronisation process did not affect the chemical 
composition of either compound, with the absorbance spectra showing similar shapes 
and intensities across the wavenumber range for unprocessed material, material 
immediately post micronisation, and material stored under controlled conditions over 
the duration of this study (5 months). 
Had any changes in the chemical composition of the micronised drug occurred from 
the micronisation process, this could have affected adhesion between drug and lactose 
particles, hence affecting the ability to relate changes in the adhesive properties to 
blending and storage regimes. The use of these micronised drugs is described in 
chapter 7. 
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3.4.4. Water Sorption Studies 
Water sorption isotherms for cholesterol are shown in Fig. 3.11. These isotherms show 
classic type II isotherm behaviour according to the BDDT classification (Brunauer et al., 
1940), where a significant uptake of vapour occurs at low partial pressures, followed 
by relatively low uptake at intermediate vapour concentrations, and then a further 
relatively large uptake at high partial pressures. 
Micronised cholesterol shows a greater water sorption profile (greater uptake of 
water) than unprocessed cholesterol. The most likely explanation is an increase in 
surface area due to the reduction in particle size, or possibly the formation of 
amorphous regions on the particle surfaces (Ahlneck and Zografi, 1990). However, the 
formation of amorphous material was not detected via this method, unlike the work by 
Mackin et al., (2002) (Fig. 3.13), as no apparent collapse of isotherm due to any 
recrystallisation event was observed (Saleki-Gerhard et al., 1994; Buckton, 1995).  
It can also be seen from Fig. 3.11 that no changes in the shape or magnitude of the 
isotherms can be observed due to storage at 40% RH and 20°C for five months, 
suggesting that the material is stable over this time period. 
As with cholesterol, neither micronisation nor controlled storage of vitamin C 
appeared to induce any major changes in the crystallinity of the powder. The increased 
mass change of the micronised powder compared to the unprocessed vitamin C can 
again be attributed to the increased SSA (Bridson et al., 2007). 
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Fig. 3.11. Water sorption isotherms for unprocessed and micronised cholesterol – post micronisation and 
following five months storage at 20°C and 40% RH (control). Results show the average from three 
independent experiments ± SD.  
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Fig. 3.12. Water sorption isotherms for unprocessed and micronised \vitamin C– post micronisation and 
following five months storage at 20°C and 40% RH (control). Results show the average from three 
independent experiments ± SD.  
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Fig. 3.13. Comparison of the moisture sorption profiles of milled xemilofiban active batches immediately 
after milling (taken from Mackin et al., 2002). This shows the “collapse” in isotherms above 50% RH due to 
the introduction of amorphous material caused by the high energy milling process. 
 
3.4.5. Cohesivity 
Fig. 3.14 shows the normal stress vs. shear stress measurements for all powders used 
in this study in their original state, and - in the case of the mimic active ingredients 
cholesterol and vitamin C - following micronisation.  
3.4.5.1. Deliberately coarsened samples 
For comparison, deliberately coarsened samples of lactose were prepared by removing 
fine particles less than 25 and 71 m by use of an air jet sieve (AJS). This provided 
samples had noticeably different flow properties. Many examples exist of previous 
work that employ an AJS to produce samples of lactose of a specific size fraction; 
Flament et al., (2004) and Dickhoff et al., (2006) are two such examples. 
To produce these samples, 10 g of unprocessed lactose was sieved for 30 min at the 
maximum backpressure (3400 Pa) available, using the 25 m and 71 m sieves. 
3.4.5.2. Results 
Table 3.3 shows the calculated flow functions from the shear tests performed in order 
to compare cohesivity of powder used in this study. The materials used in this thesis 
have FFs that compare with materials used in previous DPI literature. 
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Zhou et al., (2010) used micronised salbutamol sulphate and salmeterol xinafoate in 
their study and found flow function values of 1.91 and 1.27 respectively for the 
untreated powder.  
Edwards et al., (2009) found the flow function of a 25:75 fine (d50 = 8 m):coarse (d50 = 
61 m) lactose mixture to be 3.10 (2.50 following four weeks of storage at ambient 
conditions).  
Tuley et al., (2008) found a flow function of 7.30 for lactose with 6% fines <15 m 
(d50 = 80 m), and a flow function of 2.45 for lactose with 16% fines <15 m 
(d50 = 70 m) – the latter being more akin to the unprocessed lactose used throughout 
this study.  
Mullarney and Leyva, (2009) find flow functions between 1.2-28.5 for APIs, excipients 
and blends of the two with volume mean diameters between 2-457 m.  
All results found in the literature described above fit with the typical ranges described 
for powdered bulk materials (Jenike, 1964). 
Differences in flow functions of micronised cholesterol and vitamin C can be attributed 
to differences in particle size and cohesivity. The flow functions of micronised 
cholesterol and vitamin C cannot be affected by particle size alone since cholesterol 
shows inferior flow properties despite being a coarser material. Therefore, particle 
shape and chemistry must play a role in the cohesivity of these materials. However, for 
the purpose of this study, they have notably different cohesivities, which should affect 
the behaviour of their constituent formulations in the physical tests described in the 
following chapters.  
 
Table 3.3. Flow functions (fc) of powders used in this study. Results show average from three independent 
experiments on each material with error the SD of the mean and are rounded to two decimal places. 
Material Symbol (Fig. 3.14) Gradient Flow function, fc 
Unprocessed lactose  0.23 3.92  0.44 
25 m lactose  0.06 17.86  2.02 
71 m lactose  0.03 33.22  2.22 
Unprocessed vitamin C  0.03 32.26  4.44 
Unprocessed cholesterol  0.20 5.05  0.58 
Micronised vitamin C  0.51 1.94  0.34 
Micronised cholesterol  0.72 1.39  0.23 
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3.5. Blend Homogeneity 
A key objective of any blending process is to achieve a uniform mixture of all 
ingredients including both active and excipient(s); homogeneity is a key property of 
high quality formulations (El-Hagrasy et al., 2001). A lack of content uniformity often 
leads to product recall by the FDA for sub- or super-potency. Recalls for sub-potency 
represented the second most common reason for drug recalls in 19991. 
Formulation homogeneity is often defined to be achieved when the coefficient of 
variance (CV) value is <6% (Crooks and Ho, 1976). Recent literature CV values for DPI 
formulations are shown in Table 3.4 and have been used as a basis to assess the 
formulations produced throughout this study. 
CV is defined as the normalised measure of dispersion within a probability 
distribution, calculated as the ratio of the standard deviation ( ), to the mean ( ) 
(Equation 3.1). 
CV  Equation 3.1 
Table 3.4 shows a selection of recent publications and typical CVs produced by their 
blending regimes. 
 
Table 3.4. Typical blend homogeneity results from previous work, showing coefficients of variation and 
mean recovery related to the nominal dose to describe the homogeneity of the blend  
(TBS = terbutaline sulphate). 
Paper Carrier/drug blend 
Average content of 
drug ( g) 
Mean recovery 
related to the 
nominal dose 
Thi et al., (2008) Inhalac 120/spray-dried TBS  499.47 (CV = 1.84%) 99.9% 
 Inhalac 230/spray-dried TBS  488.56 (CV = 0.92%) 97.7% 
 Lactohale 100/spray-dried TBS  477.49 (CV = 0.77%) 95.5% 
 Lactohale 200/spray-dried TBS  482.74 (CV = 1.30%) 96.5% 
Flament et al., 
(2004) 
Lactose A (63–90 m)  
Surface Roughness 3605 ± 657 
491.25 (CV = 4.5%) 98.2% 
 Lactose B (63–90 m)  
Surface Roughness 2691 ± 462 
492.5 (CV = 14.33%) 98.5% 
 Lactose C (63–90 m)  
Surface Roughness 3135 ± 742 
500.5 (CV = 7.35%) 100.1% 
Flament et al.,  Pearlitol 100 SD/terbutaline sulphate 483.45 (CV = 2.25%) 96.69% 
(2006) Pearlitol 110 C/terbutaline sulphate 478.00 (CV = 4.79%) 95.6% 
 Lactose 250 SD/terbutaline sulphate 504.57 (CV = 0.76%) 100.9% 
                                                     
 
1
 http://www.fda.gov/cder/reports/ rtn00-3.htm 
Investigation into the Effects of High Shear Blending and Storage on Powders for Inhalation 92 
Mimic API and Formulation Production and Characterisation 
3.5.1. UV Spectroscopy 
Ultraviolet (UV) spectroscopy was used to determine average drug content in 
formulations. The mimic drug compounds both exhibit UV absorbance at specific 
wavelengths, on the other hand, lactose does not possess a UV absorbing chromaphore 
in its structure. Therefore, the presence of lactose does not affect the UV absorbance of 
the mimic drug compounds (Hegedüs et al., 1999; Ganesh et al., 2009; Shahi et al., 
2008). Drug content methodologies were important to this project as they were 
required for two separate measures of formulation performance – the homogeneity of 
the formulation post-blending, and determination of the average drug content during 
drug detachment studies - FBE (chapter 5), AJS (chapter 6), and cascade impactor 
(chapter 7). 
3.5.2. Cholesterol Assay Method 
The average content of cholesterol in a blend was determined by UV spectroscopy at 
205 nm (Brown, 1986; Hoving, 1995; Choudari et al., 1996; Mazalli et al., 2006). Being 
hydrophobic, a non-polar solvent is required, Choudari et al., (1996) used methanol, 
which proved to be the best solvent for this application. Acetone, propan-2-ol and 
ethanol were also investigated; however, they either produced excessive absorbance at 
the desired wavelength (acetone), or gave unstable measurements (propan-2-ol and 
ethanol). As a non-polar solvent, methanol does not dissolve lactose; hence, the lactose 
particles remain in suspension and will adversely affect the UV absorbance by 
physically blocking the light. To remove the lactose particles, the use of solvent 
mixtures were investigated (water and methanol/propan-2-ol/acetone/ethanol), 
however, despite being miscible, the UV absorbency remained unstable and repeatable 
results could not be obtained. 
As an alternative, the lactose particles were removed by a centrifuge in a method 
similar to that used by Waites and Morgan, (2001), de Boer et al., (2004) and Dickhoff 
et al., (2006). 
The methanol/cholesterol solution and suspended lactose particles were centrifuged 
for five minutes at 3000 rpm (de Boer et al., 2004; Dickhoff et al., 2006) and the 
supernatant was removed using a pipette. Cholesterol concentrations were analysed 
using a UV spectrophotometer (Jasco, UK) at a wavelength of 205 nm. A linear 
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calibration curve was produced for cholesterol concentrations below 100 g ml-1, and 
is shown in Fig. 3.15. 
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Fig. 3.15. Calibration curve for cholesterol/methanol solution, after centrifugation to remove suspended, 
non-dissolved lactose particles. The different drug:lactose ratios of 1.5% () and 15% () show that the 
presence of lactose does not have an effect on UV absorbance (measured at 205 nm). 
 
3.5.3. Vitamin C Assay Method 
The average content of vitamin C in a blend was determined by UV spectroscopy at 
225 nm following a wavelength scan between 200 and 300 nm that showed peak 
absorbance at 225 nm. Many studies report peak UV absorbance of vitamin C across a 
range of wavelengths; hence, a spectrum scan was required. The use of UV 
spectroscopy for vitamin C assays is difficult due to its instability in aqueous solutions 
(Kwakye, 1997, 2000) due to its reversible oxidation to dehydroascorbic acid, and 
subsequent, irreversible oxidation to 2,3-diketo-L-gulonic acid. Antioxidants can be 
added to these solutions to inhibit these reactions by providing a hydrogen atom or 
electron (Lachman et al., 1976), thus, sodium phosphate (0.5% w/w) was added to the 
water as a buffer solution in order to stabilize the UV absorbance. Unlike the 
cholesterol assay, the solvent dissolves both lactose and vitamin C, thus centrifugation 
is not required to separate suspended particles. 
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A linear calibration curve was produced for vitamin C concentrations below 
100 g ml-1 with the presence of lactose shown to have no effect on UV absorbance at 
this wavelength. A linear calibration curve was produced for cholesterol 
concentrations below 100 g ml-1, and is shown in Fig. 3.16. 
Vitamin C concentration ( g ml-1)
0 20 40 60 80 100
U
V
 A
b
so
rb
an
ce
 (
A
U
)
0.0
0.5
1.0
1.5
2.0
2.5
y = 0.0386x + 0.0363
R2 = 0.9949
 
Fig. 3.16. Vitamin C calibration curve for 1.5% vitamin C:lactose solution in 0.5% w/w sodium phosphate 
buffer solution. UV absorbance measured at 225 nm. 
3.6. Conclusion 
This chapter has described the production and characterisation of the mimic APIs to be 
used throughout this study. Both cholesterol and vitamin C have been micronised such 
that their average particle size is within the 1-6 m size range, as recommended 
throughout DPI literature. Tests have shown that the cohesivity of these drugs is 
noticeably different, and coupled with their different affinities to water, their adhesive 
behaviour with respect to lactose is likely to be different. In addition, the stability of 
the micronised compounds is not affected by long term storage at controlled 
conditions (40% RH and 20°C), therefore these mimic actives are suitable for use in the 
final chapter, which assesses the effect of blending and storage on fine particle 
adhesion. 
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4.0. Effects of High Shear Blending on -Lactose 
Monohydrate 
ABSTRACT 
-lactose monohydrate is an important excipient used in dry powder inhaler (DPI) 
formulations. It is commonly blended with active ingredients in a high shear blending 
(HSB) process – required to disperse effectively the cohesive, micronised drug 
particles. This study explores the effect of HSB on some of the physicochemical 
properties of -lactose monohydrate such as particle size distribution (PSD), surface 
area and morphology. 
Experiments were carried out using laboratory-scale HSB equipment with initial trials 
performed to determine optimal blending regimes characterised by good powder 
turnover and bowl stability. A series of formulations were produced using a range of 
blending conditions with the sampling of powder performed at regular intervals in 
order to determine the effects of specific energy input (SEI) on the physicochemical 
properties of lactose. The final part of the study involved the production of 
formulations containing mimic API in order to determine the SEI required to achieve 
chemical homogeneity.  
Results showed that lactose exposed to low SEIs underwent de-agglomeration, which 
then reversed, subsequently increasing the particle size by agglomeration with 
additional energy input. This effect was observed across all scales, although the rate at 
which this phenomenon occurred varied, with larger equipment showing a more rapid 
increase of particle size with respect to SEI.  
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4.1. Introduction 
The key secondary manufacturing step in the production of dry powder inhaler (DPI) 
formulations is the blending of excipient with active pharmaceutical ingredient (API). 
This is commonly achieved through use of high shear mixing – primarily to facilitate 
the dispersion of the extremely cohesive, micronised, API in order to achieve a 
homogenous, well-ordered product. This chapter will investigate the effect of specific 
energy input (SEI) on PSD of inhalation-grade -lactose monohydrate and covers the 
blending scale-up effect produced by different equipment geometries. 
Blade shape, size, and height is known to affect the torque generated by a blade 
impeller (Equation 4.1), but these blade variations are not studied in the current work. 
In the experiments described throughout this study, fixed impeller geometry was used 
for each scale to determine the effect on energy addition due to changes in the impeller 
speed and blending time (Knight et al., 2001).  
Blade geometry and speed are considered the primary factors that determine the shear 
rate and, consequentially, the power imparted to the powder, one of the factors that 
may influence the particulate cohesive/adhesive strength (Wagner et al., 2009). 
Specific energy input is then dependant on the time for which the particular power is 
delivered (Equation 4.2). 
4.1.1. Secondary Manufacturing of DPI Formulations 
Pharmaceutical powder blending is a key process in the manufacture of DPI 
formulations. HSB is used when the effects of impaction are desired to produce an 
ordered mixture, which is difficult to create using low shear blending which produces 
more random outcomes (Wagner et al., 2009). HSB exposes powders to a variety of 
forces, both attractive (van der Waals forces, electrical forces and – during granulation 
– liquid bridges) and dispersive (rotation, shear and gravitational). These forces are 
strongly influenced by a range of blending parameters (Knight et al., 2001), thus 
studies to characterise and understand the effects of blending on the formulation and 
the impact on powder properties are necessary. Blend parameters are carefully 
monitored in order to control the critical quality attributes of the final inhaled 
formulation, such as emitted dose, chemical homogeneity, and fine particle fraction 
(FPF) (Pilcer and Amighi, 2010).  
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Bridson et al., (2007) showed that total energy input in the blending process could 
have profound consequences on the final product. The primary effect observed was an 
agglomeration of powder with increased SEI; it was proposed that this could lead to 
decreased FPF and poorer particulate dispersion. The power supplied to the impeller 
in a high shear blender is considered the primary source of this energy input into the 
material (Equation 4.1 and Equation 4.2, section 4.2.3). 
High-shear processing of pharmaceutical powders can potentially cause changes in the 
physicochemical properties of the active ingredient, the excipient, and the interactions 
between the two. HSB processes have been preferred over low shear processes due to 
its ability to improve dispersion of fine materials, and hence can produce a beneficial 
effect on dose content uniformity (Malcolmson and Embleton, 1998). Conversely, HSB 
processes may damage particles thus generating intrinsic fines and/or induce high-
energy biding sites on the surface that can affect the formulation properties. In 
addition, blends manufactured using a high shear process are likely to change over 
time with varying storage conditions as material “relaxation” occurs, potentially 
causing inconsistent formulation performance (Edwards et al., 2009). 
As described throughout chapter 1, slight changes in the properties of these materials 
can have profound implications on the performance of DPI formulations, thus careful 
consideration needs to be made regarding the magnitude of these effects caused by the 
blending procedure. 
4.1.1.1. Importance 
Powder blends can be classified into two main types: free-flowing and cohesive. Free-
flowing powders comprise particles that do not tend to agglomerate and are not 
strongly affected by interparticle forces. On the other hand, cohesive powders do not 
flow readily due to the strong interparticle forces between the particles, causing 
agglomeration of multiple particles. The type of cohesive force (electrostatic, van der 
Waals, etc.) determines the overall cohesiveness of the material; this is influenced by 
surface charge, moisture, and particle size and particle shape (Muzzio and Alexander, 
2005). Cohesive nature increases as the particle size decreases, and this generally 
occurs during micronisation of drug substances. Micronisation of drug substances can 
result in an increased risk of segregation within the blend, reducing chemical 
homogeneity; thus, shear forces are often used to improve the dispersion of the drug 
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substance and overcome the cohesiveness of the formulation. The importance of blend 
homogeneity is described in section 3.5. 
4.1.1.2. Scale-up of blending procedures 
Systems that are geometrically-similar have constant ratios of linear dimensions. 
Kinematic scale up enables systems of different size to have similar ratios of velocities 
between two points in the systems. However, equipment of different sizes are 
geometrically similar if, in addition to being geometrically and kinematically similar, 
the ratios between corresponding points in the systems are equal (Wang and Fan, 
1974). During dynamic scale-up, as the batch size is increased, the forces experienced 
by the powder are also increased, partly due to the increase in formulation mass, but 
also due to the increased impeller tip speeds. Cohesive forces between particles have 
been shown to reduce as the blender size is increased and a result of the greater shear 
forces experienced. This study will explore the effect of changing equipment geometry 
on the characteristics of lactose. Using different equipment geometries allows factors 
such as Fr and tip speed to be investigated at different scales.  
To improve mixing, it is preferable to have equally dispersed ingredients throughout 
the blender. Layering or “sandwiching” the small amounts of active ingredients 
between excipient (Fig. 4.6) has been shown to be useful in producing a uniform blend 
(Sudah et al., 2002b). Since the mixing of cohesive powders is primarily influenced by 
shear rate (dependent on material and equipment) and blender speed (dependent on 
equipment only) (Muzzio and Alexander, 2005), intensifier bars have been shown to 
enhance the shear forces experienced, whilst strategically-placed baffles introduce 
asymmetry into the mixing regime which has also increased the mixing efficiency 
(Brone and Muzzio, 2000). 
A “blending window” can be found by experimental design to determine the optimum 
conditions for producing a homogeneous blend. Blade speed, blender fill volume, blend 
time and blender geometry all influence blend uniformity (Alexander and Muzzio, 
2005). The Froude number (Fr) has been suggested for use in scale-up processes, along 
with the tangential (linear) velocity of the impeller, especially when similar geometries 
are considered (Fig. 4.1). The linear velocity remains constant if the rotational speed is 
adjusted in line with the size of the bowl (inversely proportional). Deviations from 
predictions using Fr can often be experienced if scale-up is between blenders with 
different geometries of if different fill volumes are used (Alexander and Muzzio, 2005). 
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Fig. 4.1. Definition of Froude number (Fr) with respect to the equipment used throughout this study.  is 
the angular velocity of the impeller, g is the acceleration due to gravity, R is the impeller radius, and RT is 
the distance between the centre of the bowl and the force transducer. 
An understanding of the impact of changes that occur during scale-up is vital in 
maintaining optimum mixing efficiency. Blend uniformity sampling is an important 
step in this process since the homogeneity of the final powder blend will correlate to 
the uniformity of the final drug product (although significant post-blend processing 
may also affect the distribution) (Kraemer et al., 1995). Problems with the sample thief 
method for measuring blend uniformity have been discussed (Kreamer et al., 1999; 
Garcia et al., 2001) and recent developments have proposed alternatives. Process 
Analytical Technologies (PAT) (see section 1.7) such as near infrared (NIR) methods 
have enhanced the way in which blend uniformity and scale-up effects have been 
monitored (Liew et al., 2010). PAT enables a more rigorous, scientific approach to 
scale-up to be performed, whilst NIR can be used to produce instant results to control 
variability in blend homogeneity (Hailey et al., 1996; El-Hagrasy et al., 2001). 
4.2. Materials and Methods 
4.2.1. Lactose 
As the most frequently used excipient in DPI formulations, this study uses the 
inhalation-grade lactose described in section 2.2.1. As APIs typically comprise less than 
2% of the formulation by weight, effects of blending on pure lactose should not be 
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significantly affected by the absence of drug. The initial particle size data for lactose 
used in this chapter is: d5 = 3.10  0.02 m; d10 = 9.32  0.10 m; d50 = 68.65  0.01 m. 
4.2.2. Micronised Mimic APIs 
Tests were performed using cholesterol and vitamin C (Sigma Aldrich, UK) as mimic 
APIs (section 3.2), the methods for micronisation and characterisation of these 
materials is described in section 3.3. The d50 particle size of these mimic actives lay 
within the 1-5 m aerodynamic diameter specifications defined by Newman and 
Clarke (1983): d50 (cholesterol) = 4.45  0.29 m; d50 (vitamin C) = 3.21  0.18 m. 
500 g blends containing 1:67.5 w/w (common payload used in previous literature - 
Table 1.2) mimic actives were prepared using the method described in section 4.2.4 
using the small bowl with impeller speed 500 rpm. Samples of formulation were taken 
at regular intervals using the method described in section 4.2.5, and assayed via the 
methods described in section 3.5.1. 
4.2.3. High Shear Blending Equipment 
Cylindrical, stainless steel bowls, with a flat base, vertical side walls and internal 
diameter 0.13, 0.16 and 0.21 m (Fig. 4.2) were mounted on bearings supporting them 
and allowing free rotation in the horizontal plane. 
 
 
Fig. 4.2. Three bowls used throughout the study. 
 
In order to measure the torque generated, rotation was prevented by an arm attached 
to the bowl that rested against a load cell that was fixed to the apparatus structure. The 
torque was calculated from the measured load. The drive shaft was projected into the 
centre of the bowl, and was driven by a 7.5 kW three-phase DC motor (Fig. 4.3), which 
allowed rotational speeds of 30-1100  5 rpm to be achieved. Instantaneous torque 
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measurements were recorded at regular intervals (5 min) and averaged over the 
duration of the blend (Knight et al., 2001).  
 
 
 
Fig. 4.3. Small bowl with lid shown resting on 
bearings driven by the 7.5 kW motor. 
Fig. 4.4. Three-blade impellers for the small and 
large bowls used in study. 
 
Three-blade impellers were used (Fig. 4.4) with a constant width in the horizontal 
plane of 50 mm, and 10 mm depth. Blades with bevelled with 11° angle with 1 mm of 
the leading edge left vertical, so that the blades were not sharp. Both the blades and 
bowls were finished with a machined surface. 
The power input P (W) into the powder during blending can be given by the equation: 
60
2 FNR
P T  Equation 4.1 
where, RT is the radial distance from the axis of rotation to the force transducer (m), F 
is the force measured by the transducer (N), and N is the rotational speed of the 
impeller in (rpm). The force applied to the powder formula is dependent upon the 
impeller speed and the mass of powder used. The greater the mass or rotational speed, 
the greater the force applied to the system. 
Since power is defined as the work done in unit time, the energy applied to the blend 
can be given by: 
 
Equation 4.2 
where, t is the period of time for which the force is applied to the system.  
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The impeller speed and mass loadings were in line with other HSB work on lactose 
using similar equipment (Bridson et al., 2007; Wagner et al., 2009). Bridson et al., 
(2007) employed the same equipment (0.13 m diameter bowl) used in this study with 
impeller speeds between 200 – 600 rpm and mass fills in the range 300 g – 700 g. 
Wagner et al., (2009) used 0.75 kg and 1.2 kg mass fills in 1-litre and 2-litre vessels, 
with a constant impeller speed (400 rpm or 700 rpm) and constant vessel fill volume 
(50% or 80% fill volume). The mass loadings used in this study are described in the 
experimental procedure section below.  
In order to calibrate the load cell, the transducer was removed from its horizontal 
location on the apparatus frame and placed in an upright position and subjected to 
various weight forces from known masses. Three calibration curves (the calibration 
was repeated at regular intervals throughout the study and showed the load cell 
response was consistent) used to determine the force applied to the load cell during 
blending experiments are shown in Fig. 4.5.  
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Fig. 4.5. Three separate load cell calibration curves used in determining the force produced during blending. 
 
4.2.4. Bowl Filling 
Formulations containing mimic API were prepared by filling the bowl in a stratified 
manner (Popo et al., 2002), with three equal layers of drug sandwiched between four 
equal layers of lactose (Fig. 4.6). As each successive level was added, the powder was 
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levelled by gently shaking the bowl, with sampling performed via a powder thief at 
vertically and radially different locations throughout the bowl. 
Lactose Drug
 
Fig. 4.6. Stratified filling of lactose and drug in bowl (Not to scale). 
4.2.5. Sampling Procedures  
Powders can be defined as free-flowing or cohesive. Free-flowing powders are prone 
to segregation during handling and storage, and individual samples are rarely 
representative. Cohesive powders are more likely to retain their bulk characteristics 
during handling, but are still prone to segregation during manufacture or packaging. 
Handling of free-flowing powders can result in size segregation, thus the size 
distribution of particles in a powder is influenced by its previous history. Free-flowing 
powder poured into a heap will show a tendency for the fine particles to percolate 
through the powder and allow the coarse particles to roll on the fines – this even 
occurs if the larger particles are denser than their smaller particles. This results in an 
abundance of fine particles in the centre of the mound, with proportionally more large 
particles on the outside Fig. 4.7. 
Surface sampling of cohesive powder can be 
performed if the bulk material had been mixed prior 
to storage. Accuracy can be increased by taking 
multiple measurements from different regions 
throughout the batch. For this, a sampling spear 
(thief) can be used (Fig. 4.8); this consists of a 
sampling chamber at the end of the spear that generates a spot sample for compacted 
powders. Several samples can be extracted at different depths, which can then be 
blended to from a composite sample. The spear is inserted into the powder with the 
inner chamber closed off, and when in the desired position, the outer tube is rotated, to 
 
Fig. 4.7. Segregation of fine (light grey) 
and coarse (dark grey) particles. 
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allow the powder to fall into the inner chamber. When the chamber is full, the inner 
tube is again turned to the closed position, and the spear is withdrawn. The 
International Standards Organisation (ISO) recommends several samples from 
differing depths be taken from the front and rear of the batch (Barber, 2000). 
 
Fig. 4.8. Principle of operation of powder thief used for sampling bulk formulations. 1 - Closed powder thief 
is inserted into bulk powder; 2 – Outer sleeve is removed allowing powder to enter chamber; 3 – Sleeve is 
lowered to enclose powder sample; 4 – Powder thief is removed from bulk powder; 5 – Outer sleeve is 
raised allowing powder sample to be removed. 
4.2.6. Particle Size Measurements 
Particle size measurements were performed using laser diffraction. Both wet and dry 
dispersion techniques were used as described in sections 2.2.2 and 2.2.3. The propan-
2-ol used in wet particle size analysis was analytical reagent grade, obtained from 
Fisher Scientific, Loughborough, UK.  
4.2.7. Surface Area and Characteristics 
Specific surface area was measured using a DVS Advantage II (Surface Measurement 
Systems, UK) using octane as probe molecule whilst water sorption studies were 
performed using the same instrument to identify changes in surface characteristics 
(see sections 2.2.4.2 and 2.2.4.3 for respective methods). Both the octane and water 
used in these studies were HPLC grade, obtained from Fisher Scientific, Loughborough, 
UK. Before analysis samples were dried in order to remove moisture from the powder 
surfaces, this was achieved by purging oxygen-free nitrogen (BOC, UK) over the sample 
for four hours.  
4.2.8. Scanning Electron Microscopy 
Scanning electron microscopy was used to verify particle size measurements, and as an 
indicator of changes in the population of particles that comprised the size distribution. 
Investigation into the Effects of High Shear Blending and Storage on Powders for Inhalation 105 
Effects of High Shear Blending on -Lactose Monohydrate 
The microscope employed was a JEOL 6060 SEM (JEOL, Japan) with accelerating 
voltage 10 keV (section 2.2.5). 
4.2.9. Cohesivity of Blends 
The cohesivity of blends produced in this chapter was determined by a shear cell test 
method described in section 2.2.6. 
4.2.10. Blend Content Uniformity 
Content uniformity was measured using UV spectroscopy with the assay for 
cholesterol being described in section 3.5.2, and the method for vitamin C described in 
section 3.5.3. For each method, a 34.25 mg sample of formulation was taken which 
corresponded to a nominal drug dose of 500 g. The final study incorporated 
micronised mimic hydrophobic (cholesterol) and hydrophilic (vitamin C) drugs to 
create “active” formulations. A key quality and one of the indicators of performance of 
active formulations is the chemical homogeneity of the product (Pilcer and Amighi, 
2010), thus the relationship between homogeneity and SEI was investigated using 
common, previously-studied parameters, namely: 0.13 m diameter bowl, 500 rpm 
impeller speed and 160 kg m-3 mass fill ratio.  
4.2.11. Experimental Procedure 
Initial experiments were performed to identify suitable blending regimes in which 
good mixing can be achieved. These principles overlap with those utilised in wet 
granulation procedures, focusing on the importance of good bed turnover in order to 
maximise the API/excipient interactions. “Regime maps” are commonly used when 
predicting granule growth in equipment such as rotating drums and HSB for 
granulation (Tu et al., 2009). It is important for both granulation and HSB processes to 
occur in good blending regimes to ensure suitable turnover and mixing of powders 
(Litster et al., 2002). Good blending regimes were determined by two methods. Firstly, 
visual inspection of powder movement within the bowls, and secondly, the fluctuation 
of torque at given impeller speeds and mass loadings. Large torque fluctuations give 
rise to unstable mixing conditions, and make accurate calculations of SEI difficult, thus 
need to be avoided whilst producing formulations. For the purposes of this experiment, 
low torque fluctuations were considered to be <5% (from trial experiments) over a 
fixed time period between removal of samples (typically 10 min). A longer period of 
time is difficult to interpret as the torque imparted on the powder can be affected by 
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the removal of samples for analysis, thus it is necessary to monitor using constant 
mass. Percentage torque variations were chosen rather than absolute variations in 
order to compare across geometric scales (larger mass fills produce larger torque 
values).  
Once good blending regimes had been identified, the second part of this study involved 
producing lactose-only blends using a range of parameters including bowl size 
(internal diameters 0.13, 0.16 and 0.21 m; impeller speed (300-700 rpm) and mass fill 
ratios (120-250 kg m-3). The impact on physicochemical properties of lactose due to 
these changes was studied at regular intervals described by the SEI applied to the 
system. 
4.3. Results and Discussion 
4.3.1. Regime Maps 
For this study, good mixing conditions have been described by “regime maps” for each 
bowl (Fig. 4.10); these contour plots from torque fluctuation measurements have been 
overlaid with regions corresponding to visual observations of blending conditions 
described in Fig. 4.9.  
In vertical shaft mixers, two flow regimes are observed (Fig. 4.9). At low impeller 
speeds, the powder is vertically displaced as the impeller blade passes underneath, this 
causes slow, bumpy powder motion in the vertical direction. There is very little vertical 
turnover of the powder bed in this “bumping” regime. 
Good blending conditions can be clearly identified in the regime maps since areas 
where both visual observations of good “roping” behaviour and low torque 
fluctuations clearly overlap. These regions showed good bed turnover and hence 
suitable mixing conditions. Toroidal motion, where the centrifugal acceleration of 
particles overcomes their gravitational force can be observed during the blending in 
these regions – as identified by Plank et al., (2002) and Ng et al., (2008).  
It can also be seen from the regime maps in Fig. 4.10 that both bowl instability and 
poor powder movement are associated with high torque fluctuations. At low impeller 
speeds and low mass loadings, torque fluctuations were often low, but turnover of 
material was poor and bumping was observed, indicating poor blending conditions 
(Chandratilleke et al., 2010).  
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On the other hand, at high impeller speeds and insufficient mass loadings, the bowl 
became unstable, leading to large torque fluctuations and often causing the equipment 
to shake vigorously. This was clearly unsuitable for controlled blending conditions. 
Another problem encountered by insufficient powder and excessive impeller speed 
was the aeration of powder, causing material to be entrained into the headspace above 
the bulk powder – similar findings were recognised by Sebti et al., (2007). Although a 
lid was used to contain material within the bowl, aeration of powder is still undesirable 
as it could affect the quality of the formulation by reducing either the fine particle 
fraction or chemical homogeneity. 
Regions of poor blending conditions were also observed when the impeller speed was 
low and mass loadings were high – these produced large torque variations and powder 
movement and turnover was clearly restricted. In this operating region the impeller 
was unable to lift the mass of powder in the bowl sufficiently, thus only the powder 
immediately above the impeller experiences shear forces thus likely to cause a 
heterogeneous mixture of powders (Litster et al., 2002).  
 
Fig. 4.9. “Bumping” and “roping” powder regimes during HSB. Taken from Litster et al., (2002). 
 
At higher impeller speeds, a transition to “roping” behaviour occurs – this is where 
material from the bottom of the powder bed is forced up the vessel wall and tumbles 
down the angle of the bed surface towards the centre of the bowl. In this regime, there 
is good rotation of the bed and good vertical powder turnover. 
In the bumping flow regime, the powder surface velocity increases proportionally with 
the impeller speed, however in the roping regime; the surface velocity stabilises and 
becomes less sensitive to impeller speed (Litster et al., 2002). The transition from 
bumping to roping is attributed to the change in balance between the powder’s 
rotational inertia, which pushes the powder to the outside of the bowl, and gravity.  
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Similar patterns of bumping and roping were observed across all scales, there was no 
apparent propensity for a particular scale to show more or less bumping or roping at a 
particular mass fill or impeller speed.  
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Fig. 4.10. Blending regime maps for small bowl (top), medium bowl (centre) and large bowl 
(bottom). 
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4.3.2. Blending Conditions 
In order to explore the impact of bowl size, impeller speed and overall SEI on 
(primarily) the PSD of inhalation-grade lactose, a range of blending experiments were 
carried out using conditions that fell within the “good” blending regimes described in 
Fig. 4.10. 
Table 4.1. Blend conditions used in this study. 
Blend code Bowl size 
Mass fill 
(g) 
Fill ratio 
(kg m
-3
) 
Impeller 
speed (rpm) 
A Small 370 120 300 
B Small 370 120 500 
C Small 520 170 300 
D Small 520 170 500 
E Small 680 220 300 
F Small 680 220 500 
G Small 750 250 600 
H Small 750 250 600 
I Small 600 200 400 
J Small 500 160 600 
K Small 500 160 600 
L Small 500 160 600 
M Small 400 120 500 
N Small 500 160 600 
O Medium 500 120 600 
P Medium 600 140 600 
Q Medium 800 190 600 
R Medium 500 120 450 
S Medium 800 190 450 
T Large 900 120 600 
U Large 1300 190 600 
V Large 1300 190 600 
W Large 1600 220 700 
X Large 1200 160 700 
 
These particular blend conditions were chosen to investigate a range of mass loadings 
and impeller speeds across the three geometric scales employed. For example, blends 
A and B, C and D, E and F, G and H, and J and K compare different impeller speeds 
whilst maintaining a similar mass fill ratio for the small bowl. Repeat experiments 
were performed to examine the variation within the process (blends J, K, L; blends O 
and R; and blends U and V are all repeats).  
4.3.3. Effect of Specific Energy Input on Particle Size 
The results presented in this section describe the effects of SEI - calculated by Equation 
4.1 and Equation 4.2 - on the particle size of -lactose monohydrate. Primarily, the 
results are described by d5 particle size – the size below which 5% of all particles in the 
distribution reside. This is a particularly useful indicator of fines content within the 
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powder, and since the roles of fine particles in DPI formulations has been widely 
acknowledged as an important factor in performance (Hersey et al., 1975; Staniforth, 
1996; Lucas et al., 1998; Zeng et al., 1998), it is useful to describe particle size changes 
by this measurement. Previous work has recognised the importance of this statistic in 
size distribution descriptions; Bridson et al., (2007) uses d5 to describe the effects of 
blending on -lactose monohydrate, whilst Watling et al., (2010) reports findings 
regarding entrainment mechanisms of DPI formulations in terms of the percentage 
number of particles below 5 m – again recognising the importance of the fine portion 
of the size distribution. 
4.3.3.1. Small (0.13 m Diameter) Bowl 
Fig. 4.11 shows the change in d5 particle size as a function of SEI using the small 
(0.13 m diameter) bowl for a series of blends described in Table 4.1. 
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Fig. 4.11. Change in d5 particle size as a function of SEI using the small (0.13 m diameter) bowl. 
 
SEI is seen to have a pronounced effect on the d5 particle size of lactose. Generally, 
results show that the d5 particle size initially decreases following the onset of blending, 
and then subsequently increases with additional SEI.  
The degree of change in particle size values varies with different mass fills and 
impeller speeds, and the total SEI (Fig. 4.11). The greatest reduction of particle size is 
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observed in blend H with a reduction in d5 of 0.62 m following an energy input of 
117 kJ kg-1. In comparison, the greatest reduction in d5 for blend D is just 0.01 m 
(achieved at 60.8 kJ kg-1). On the other hand, the greatest increase in d5 is observed in 
blend I (1.05 m after 487 kJ kg-1 input), whereas blend L achieves just a 0.35 m 
increase in d5 following an energy input of 750 kJ kg-1. Comparable energies also 
produce widely different results, for example blends A and B at 62 kJ kg-1 produce 
show d5 changes of 0.09 and -0.35 m respectively, whereas blends D and G at 
109 kJ kg-1 show d5 changes of 0.13 and -0.21 m respectively. At greater SEIs, the d5 
changes between blends E and F at 227 kJ kg-1 are -0.02 and 0.27 m, and the d5 
changes for blends H and N at 659 kJ kg-1 are 0.70 and 1.03 m.  
Blends produced using the same experimental parameters, i.e. mass loading and 
impeller speed (for example, blends J, K, and L) show the extent of the differences in 
particle size produced by HSB. The reduction in d5 particle size at ~125 kJ kg-1 (127, 
125 and 124 kJ kg-1) is -0.24, -0.37 and -0.33 m for blends J, K and L respectively. At 
the other end of the scale, the increase in d5 particle size at ~700 kJ kg-1 (698, 698 and 
702 kJ kg-1) is 0.29, 0.53 and 0.35 m. This highlights the inherent, variable nature of 
the HSB process, hence the need to characterise powders both before and after 
blending. 
4.3.3.2. Medium (0.16 m Diameter) Bowl 
Fig. 4.12 shows the change in d5 particle size as a function of SEI using the medium 
(0.16 m diameter) bowl for a series of blends described in Table 4.1.  
d5 particle size data using the medium (0.16 diameter) bowl (Fig. 4.12) follows a 
similar trend as the data for the small bowl described above such that an initial 
decrease in particle size is observed at low SEIs, which, with additional energy input 
produces an increase in particle size. The greatest reduction in d5 is observed in blend 
O (-0.34 kJ kg-1 at 36 kJ kg-1), however blend Q shows similar reductions (-0.33 m) at 
energy inputs of 31.3 and 53.6 kJ kg-1. Blend S clearly displays the greatest increase in 
d5 particle size – the two greatest changes in d5 (1.35 and 1.52 m) are produced by 
SEIs of 386 and 447 kJ kg-1 respectively. In comparison, blend O produces a change in 
d5 of just 0.73 m at an energy input of 622 kJ kg-1.  
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Fig. 4.12. Change in d5 particle size as a function of SEI. Medium (0.16 m diameter) bowl. 
 
4.3.3.3. Large (0.21 m Diameter) Bowl 
Fig. 4.13 shows the change in d5 particle size as a function of SEI using the large 
(0.21 m diameter) bowl for a series of blends described in Table 4.1.  
Studies using the large (0.21 m diameter) bowl again showed similar trends to the 
small and medium bowls in that d5 particle size appeared to decrease at low SEIs, 
which was then followed by a gradual increase to larger particle sizes. The changes in 
particle size (both reduction and increase) were more pronounced using the larger 
bowl (the greatest reduction was -0.785 m (blend V, 83 kJ kg-1), compared to 
-0.62 m for the small bowl and -0.34 m for the medium bowl. In addition, an 
increase of 2.05 m was observed using the large bowl (blend X) with just 460 kJ kg-1 
SEI; this compares to the maximum increases for the small bowl of 1.05 m (487 kJ kg-1 
input – blend I) and 1.52 m for the medium bowl (447 kJ kg-1 – blend S). As identified 
at the other scales there is a degree of scatter amongst change in d5 at comparable 
energy inputs. For example, Table 4.2 highlights the differences at selected SEIs; 
particularly large differences are experienced at ~320 kJ kg-1 – blend V shows a d5 
change of -0.28 m, yet blends W and X show changes in d5 of 1.68 and 1.66 m 
respectively. 
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Fig. 4.13. Change in d5 particle size as a function of SEI. Large (0.21 m diameter) bowl. 
 
 
Table 4.2. Examples of change in d5 particle size at comparable SEIs using medium (0.16 m diameter) bowl. 
Specific energy 
input 
Blend 
T U V W X 
~155 kJ kg
-1
 0.16 m 
(154 kJ kg
-1
) 
-0.15 m 
(155 kJ kg
-1
) 
-0.67 m 
(158 kJ kg
-1
) 
0.87 m 
(160 kJ kg
-1
) 
-0.16 m 
(153 kJ kg
-1
) 
~215 kJ kg
-1
 0.55 m 
(224 kJ kg
-1
) 
-0.04 m 
(207 kJ kg
-1
) 
-0.64 m 
(215 kJ kg
-1
) 
1.38 m 
(214 kJ kg
-1
) 
0.75 m 
(219 kJ kg
-1
) 
~320 kJ kg
-1
 1.06 m 
(314 kJ kg
-1
) 
0.54 m 
(326 kJ kg
-1
) 
-0.28 
(325 kJ kg
-1
) 
1.68 m 
(323 kJ kg
-1
) 
1.66 m 
(321 kJ kg
-1
) 
 
4.3.4. Effect of Mass Fill Ratio on Particle Size 
The effect of mass fill ratio of the rate of change of d5 particle size does not show any 
trends across any of the geometric scales studied. As can be seen from Fig. 4.11, blends 
that were produced using the same impeller speed but with varying mass fill ratios did 
not follow any trend in terms of change in particle size. For example, blends B, D and F 
were produced using impeller speed of 500 rpm and mass fill ratios of 120, 170 and 
220 kg m-3 respectively. However, their d5 particle sizes at ~120 kJ kg-1 showed 
changes of -0.42, 0.13, and -0.1 m respectively. In addition, their d5 particle sizes at 
~230 kJ kg-1 (specifically 230, 233 and 228 kJ kg-1) showed changes of -0.03, 0.37 and 
0.27 m – indicating no definite trend with respect to mass fill ratio.  
This is also observed for the medium bowl (Fig. 4.12) where blends O, P and Q were 
produced using a fixed impeller speed (600 rpm) but with mass fill ratios of 120, 140 
and 170 kg m-3 respectively. Their d5 particle size following ~50 kJ kg-1 (specifically 46, 
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55 and 54 kJ kg-1) SEI showed changes of -0.34 m, -0.14 m and -0.33 m 
respectively, whereas at ~220 kJ kg-1 (specifically 220, 225 and 225 kJ kg-1), the 
changes were 0.1 m, 0.58 m and 0.32 m respectively. In addition, the changes at 
~380 kJ kg-1 (384, 381 and 379 kJ kg-1) were 0.2 m, 0.63 m and 0.88 m 
respectively.  
4.3.5. Effect of Bowl Size on Particle Size Distribution 
It can be shown from Fig. 4.15 and Table 4.3 that the rate of change of d5 is greater as 
the bowl size is increased. Fig. 4.15 shows the same data as Fig. 4.17, however, 
trendlines have been added for the maximum and minimum “agglomeration gradients” 
for each bowl size. These agglomeration gradients are simply trendlines that describe 
the overall rate of increase of d5 particle size as a function of SEI. 
It is clear that the greater rate of change of d5 can be seen with the larger bowl than the 
smaller bowls whilst an overlap is found between the large and medium bowls, and the 
medium and small bowls. However, the average gradients for each bowl follow the 
trend that as the bowl size increases, so does the rate at which d5 increases with 
respect to SEI. A possible explanation for this would be the greater tip speed (linked to 
Froude number) of the larger bowl impeller creates more energetic collisions between 
particles towards the outside of the bowl, thus increasing the d5 particle size more 
rapidly. This has implications for scale-up of blending processes in order to be able to 
control the properties of the final product. 
4.3.6. Effect of Impeller Speed on Particle Size 
Fig. 4.14 describes the effect of a fixed impeller speed (600 rpm) on the d5 particle size 
across three geometric scales. Comparison of impeller speeds over different geometric 
scales shows a noticeable increase in the rate of change of d5 particle size with respect 
to SEI as bowl diameter is increased. For example, blend J (small bowl) shows an 
increase of just 0.29 m following application of 698 kJ kg-1, whereas blend O (medium 
bowl) shows an increase of 0.73 m following application of 622 kJ kg-1, and blend T 
shows an increase of 2.04 m after being subjected to just 528 kJ kg-1 SEI. Since the 
impeller speed is fixed, this cannot be the sole factor in causing the trend observed in 
Fig. 4.14.  
Investigation into the Effects of High Shear Blending and Storage on Powders for Inhalation 116 
Effects of High Shear Blending on -Lactose Monohydrate 
O
P
Q
T
U
V
J
K
L
Specific Energy Input (kJ kg
-1
)
0 200 400 600 800
C
h
an
ge
 in
 d
5
 p
ar
ti
cl
e
 s
iz
e
 (
m
)
-1.0
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
Blend
 
Fig. 4.14. Effect of impeller speed on d5 particle size across three geometric scales with  
fixed impeller speed (600 rpm). Triangles represent small bowl, diamonds represent medium bowl, and circles 
represent large bowl. 
Specific Energy Input (kJ kg-1)
0 200 400 600 800
C
h
an
ge
 in
 d
5
 p
ar
ti
cl
e 
si
ze
 (
m
)
-1.0
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
Large bowl, 
upper specification
Large bowl, 
lower specification
Medium bowl, 
upper specification
Medium bowl, 
lower specification
Small bowl, 
upper specification
Small bowl, 
lower specification
 
Fig. 4.15. All data, with trendlines showing the maximum and minimum rates of change of d5 with respect to SEI 
for each bowl. Small bowl – short dashes; medium bowl – solid line; large bowl – large dashes. 
 
Table 4.3. Range and average gradients of the trendlines in Fig. 4.14. 
Bowl 
Gradient 
Range Average 
Small 0.0010-0.0033 0.00203  0.0010 
Medium 0.0017-0.0045 0.00340  0.0013 
Large 0.0034-0.0066 0.00508  0.0014 
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4.3.7. Comparison With Previous Literature 
The results throughout this study - summarised in Fig. 4.17 - differ from those seen in 
previous work, (Bridson et al., 2007), in that a noticeable reduction in d5 particle size is 
observed at low SEI – a phenomenon that was apparent using all bowls, mass loadings 
and impeller speeds. This contrasts to the previous study that found a steady, linear 
increase in d5 particle size as a function of SEI and no apparent reduction in particle 
size at the initial stages of blending (Fig. 4.16). This marked difference in results 
proved interesting since they occurred despite the experimental, measurement and 
characterisation conditions and instruments being constant across the two studies. 
However, it was noticed that the characteristics of the starting material used in each 
study were different – despite being inhalation-grade lactose from the same 
manufacturer, the lactose used in the current study was significantly finer than the 
lactose used in the previous study (as observed by the d10, d16 and d50 values in 
particular (Fig. 4.16). This highlights the importance of characterising starting 
materials in order to predict and control behaviour of the final formulation – even 
slight changes in the starting material may have considerable effects on the 
performance and characteristics of the final product. 
 
 
 Particle size ( m) 
 
Bridson et al., 
(2007) 
Current study 
d5 3.04  0.04 3.10  0.02 
d10 15.47  0.03 9.32  0.10 
d16 27.15  0.05 18.92  0.12  
d50 79.14  0.10 68.65  0.01 
d84 127.80  0.11 118.20  0.06 
 
Fig. 4.16. Results and starting material particle size statistics from previous work (Bridson et al., 2007) and 
those found in the current study (Fig. 4.17), using identical experimental conditions. 
 
Fig. 4.17 and Fig. 4.18 show the change in d5 and d50 particle size respectively as a 
function of SEI. Both measurements show the same trend in that an initial reduction in 
particle size at low SEIs is followed by an increase at greater energy inputs. Both 
measurements show similar-sized changes overall; the typical reduction in both d5 and 
d50 being around 0.5-1 m. However, d5 increases at ~400 kJ kg-1 range from -0.15 m 
(blend J – 447 kJ kg-1) to 1.98 m (blend X – 427 kJ kg-1), compared to typical d50 
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increases ranging from 0.32 m (blend I – 390 kJ kg-1) to 1.73 m (blend Q – 
399 kJ kg-1). Thus, the spread of d5 increase is far more pronounced than d50 that shows 
less variation in change in d50 particle size at higher SEIs than d5. 
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Fig. 4.17. Change in d5 particle size at low SEIs (all data). 
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Fig. 4.18. Change in d50 particle size at low SEIs (all data). 
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Max reduction of d50 = -0.84 m (blends G and V – 81.7 and 158 kJ kg-1 respectively), 
whereas the max reduction of d5 was -0.79 m (blend V – 83.3 kJ kg-1). The maximum 
increase of d50 was found to be 1.95 m (blend V – 669 kJ kg-1), compared to the 
maximum d5 increase of 2.05 m (blend X – 460 kJ kg-1). It is also noticeable that 
following the initial reduction, the return to original d50 particle size occurs at lower 
SEI than the d5 particle size.  
4.3.8. Effect of Blending on Cohesivity of -Lactose Monohydrate 
The effects of HSB on the cohesivity of lactose was studied by analysing the flow 
functions of samples taken from blends exposed to various SEIs. Fig. 4.19 and Table 4.4 
show example results from blend K (chosen due to the wide SEI range and average 
trend observed) with samples taken at low, intermediate and high SEIs, incorporating 
material which had shown a reduction in particle size, similarity to original particle 
size, and an increase in particle size. Results from other blends showed similar results, 
such that no statistically significant (Kruskal-Wallis non-parametric hypothesis test for 
multiple samples, with chosen level of significance, α = 0.05) differences could be 
observed between blends exposed to varying SEIs across the geometric scales, impeller 
speeds and mass loadings used. As seen in the initial characterisation of starting 
materials (Fig. 3.14), the Schulze shear cell test method is able to discriminate between 
samples with clear differences in cohesivity (namely AJS-coarsened lactose with fine 
particles <25 and <71 m removed). However, despite differences in the PSD observed 
by laser diffraction (Fig. 4.17 and Fig. 4.18), and differences in the specific surface area 
observed by BET analysis (Fig. 4.21), cohesivity differences could not be observed 
using the shear cell test method. 
Table 4.4. Flow functions (fc) of samples from blend K. Results show average from three independent 
experiments  SD. Results are rounded to two decimal places. 
Material Energy Input (kJ kg
-1
) Symbol (Fig. 3.14) Gradient Flow function, fc 
Unprocessed lactose 0  0.23 3.92  0.44 
Low energy blended 1 115  0.23 4.44  0.51 
Low energy blended 2 234  0.25 4.03  0.53 
Mid energy blended 474  0.23 4.31  0.37 
High energy blended 726  0.24 4.14  0.35 
25 m lactose N/A  0.06 17.86  2.02 
71 m lactose N/A  0.03 33.22  2.22 
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4.3.9. Mechanisms for Particle Size Distribution Change 
The mechanism behind the initial decrease and subsequent increase in particle size 
with increasing SEI cannot be determined by dry laser diffraction alone. There are 
several possible mechanisms to describe these events. Firstly, the reduction in particle 
size could be attributed to de-agglomeration, or particle fracture – producing more fine 
particles and hence reducing the fine portion of the PSD. The increase in PSD could be 
attributed to agglomeration or re-agglomeration (if de-agglomeration had previously 
occurred) or loss of fines from the system. The following sections attempt to explain 
the mechanisms behind the observed change in PSD due to increasing SEI. 
4.3.9.1. Particle Size Distribution of Primary Particles – “De-agglomerated” and 
“Agglomerated” Lactose 
Further verification of these results can be achieved through use of wet dispersion 
laser diffraction. Preliminary studies (section 2.3), showed that wet dispersion 
produces a finer PSD than dry dispersion (even at the maximum dispersion pressure). 
Therefore, wet dispersion is likely to give a stronger indication of the primary particle 
sizes in each sample, as opposed to dry dispersion that may not fully de-agglomerate. 
Fig. 4.20 shows the d10 and d50 particle size data of unprocessed lactose and “de-
agglomerated” and “agglomerated” lactose exposed to varying SEIs. In this thesis, the 
terms “agglomerated” and “de-agglomerated” particles refer to the particles displaying 
a reduced PSD and increased PSD respectively. Until the true mechniasm behind the 
increase/decrease can be determined, these terms will be used. Following application 
of the Kruskal-Wallis test (page 119), it can be shown that there are no statistically 
significant differences between samples exposed to differing SEIs. As shown in section 
2.2.2, the use of propan-2-ol and sonication is suitable for adequate dispersion of 
particles, thus it can be assumed that the particles measured are “primary” particles 
and no agglomerates are being measured. Fig. 4.20 shows that there are no differences 
between the samples with regards the distribution of primary particles; this suggests 
that particles are not being lost from the system, and HSB causes a redistribution of 
particles which can be identified using dry dispersion, however is not detectable using 
wet dispersion. 
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Fig. 4.20. Particle size analysis (wet dispersion) of unprocessed, “de-agglomerated” and 
“agglomerated” material. d10 - solid; d50 - hatched. Results shown are the average values from three 
independent experiments of six blends (B, H, I, O, Q, S - Table 4.1), with error bars showing the 
standard error of the mean. These blends were chosen as they displayed distinct de-agglomeration 
and agglomeration of particles with increasing SEI. 
 
4.3.9.2. Specific Surface Area Studies 
BET surface area analysis of “de-agglomerated” material was performed along with 
analysis of unprocessed lactose and “agglomerated” material in order to gain more 
insight into the mechanism behind the increase and decrease in particle size observed 
during blending. Fig. 4.21 shows the results of this surface area analysis and it can be 
shown that there are no statistically significant differences (using the Kruskal-Wallis 
test - page 119) between the unprocessed and the “de-agglomerated” material, 
however, significant differences exist between these, and “agglomerated“ material. 
These samples reported were chosen as they represented a blend with distinct de-
agglomeration and agglomeration of particles with increasing SEI; however, the trend 
is applicable to all blends used in the study. 
This suggests that initially, fine particles are weakly attached to the surface of coarse 
particles (unprocessed lactose), and low SEIs simply de-agglomerate these particles. 
Hence, the octane molecules employed in BET analysis are able to “see” these weak 
agglomerates as discrete particles and thus once they do become separate entities, the 
combined surface area is not significantly affected. However, following high SEIs, these 
fine particles become strongly bound due to the press-on forces caused by the blending 
process, forming multiplets with other fine particles (Lucas et al., 1998), or adhering to 
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the surface of larger particles. These attractions are likely to be sufficiently strong that 
neither octane molecules are able to identify the individual particles, nor dry 
dispersion is able to separate the particles – thus coarsening the PSD. 
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Fig. 4.21. BET surface area analysis of unprocessed, “de-agglomerated”, and “agglomerated” material 
produced from HSB. Results shown are the average values from three independent experiments of 
six blends (B, H, I, O, Q, S - Table 4.1), with error bars showing the standard error of the mean. As 
with Fig. 4.20, these blends were chosen as they displayed distinct de-agglomeration and 
agglomeration of particles with increasing SEI. 
 
4.3.9.3. Loss of Fines 
Further evidence to show that lactose particles were being redistributed rather than 
fine particles being lost was gained by analysing particles that adhered to the bowl or 
impeller surfaces during HSB. Since a lid was placed on the bowl during blending, fines 
were not lost via the headspace (no particles were observed coating the lid); however, 
there was the possibility that fine particles were preferentially adhering to the 
impeller and bowl surfaces, thus affecting the PSD of the bulk lactose. Fig. 4.22 
compares the d10 and d50 sizes of unprocessed lactose with lactose subjected to a large 
SEI (660 kJ kg-1 – blend N) that had adhered to the impeller and bowl and the bulk 
powder. It can be shown that no statistically significant differences (Kruskal-Wallis test 
- page 119) can be observed between the PSDs of material adhered to the side of the 
bowl or impeller, and that in the bulk material, thus suggesting that the change in 
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particle size due to HSB is attributed to agglomeration and not loss of fines from the 
system. 
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Fig. 4.22. PSD of the bulk formulation, those adhered to the sides of the bowl and the impeller compared 
to unprocessed lactose. Solid bars - d10; hatched bars - d50. 
 
4.3.9.4. Water Sorption Profiles 
It is well-known that high energy processing of pharmaceutical material can induce 
changes in the surface characteristics, notably the introduction of amorphous regions 
(Waltersson and Lundgre, 1985; Mackin et al., 2002). Water sorption isotherms were 
produced in order to determine if any changes in the crystal structure had occurred 
during the blending process. As can be seen from Fig. 4.23, the shape of the water 
isotherm does not change due to blending; the inflection points of the curve appear at 
the same partial pressures, thus suggesting that any changes in crystallinity had not 
occurred. In addition, there are no statistically significant (Kruskal-Wallis test - page 
119) differences in the overall water adsorption (at all humidity stages) with respect to 
SEI, also indicating that changes in the crystal structure could not be detected.  
Work done by Mackin et al., (2002), identified changes in the crystallinity of 
xemilofiban and a benzyl ether derivative pharmaceutical compound by changes in the 
water sorption profiles, such that the percentage change in mass due to increased 
exposure to humidity was greater for amorphous material when compared to 
crystalline material. Therefore, if HSB created amorphous regions on the surface of the 
lactose particles, it is likely that the water sorption isotherms would show a decrease 
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in percentage mass change with increased humidity for material exposed to greater 
SEI. 
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Fig. 4.23. Example moisture sorption profiles representative of unprocessed, “de-
agglomerated” and “agglomerated” lactose subjected to differing SEIs. Error bars represent 
the SD from three independent experiments of sample from blend N.  
 
4.3.9.5. Surface Morphology Studies 
Finally, SEM images were produced of representative unprocessed, “de-agglomerated” 
and “agglomerated” material to determine if the subtle changes in PSD could be 
detected visually (Fig. 4.24). The images show that slight differences in the population 
of particles can be observed – the key feature is that more “free” fines can be observed 
in the “de-agglomerated” sample than in the unprocessed and “agglomerated” samples. 
The “agglomerated” sample shows a different distribution of particles than the 
unprocessed sample in that small multiplets of fines appear to have been formed and 
the number of free fines appears to have reduced. With greater magnification, Fig. 4.25 
shows the formation of a fine particle multiplet from extended HSB. It is possible that 
this multiplet is bound by strong interparticle forces that cannot be separated by dry 
dispersion sizing techniques (RODOS), hence the coarsening of PSD and reduction in 
specific surface area measured by BET analysis. However, the dispersion caused by 
propan-2-ol in wet size analysis allows this multiplet to de-agglomerate and the 
primary particles are observed – as in the case of both unprocessed and de-
agglomerated lactose. Whilst SEM images are a powerful tool in qualitatively assessing 
surface morphology and other particle characteristics, it remains a subjective 
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assessment method. Firm conclusions are difficult to make and should always be 
treated with a degree of scepticism. 
 
 
 
More free fines – 
fewer and smaller 
agglomerates of fine 
particles 
 
More agglomeration 
of fine particles – 
fewer free fines 
Fig. 4.24. Representative SEM images of unprocessed (top), “de-agglomerated” (middle), and 
“agglomerated” (bottom) material. Samples taken from blend N, with x200 magnification and 10kV 
potential. 
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Fig. 4.25. Representative SEM image of “agglomerated” lactose. Sample taken from blend N, with x1500 
magnification and 10kV potential. 
 
4.3.10. Blend Homogeneity Studies 
The blend homogeneity results as a function of SEI from three independent 
experiments using each mimic API are shown in Fig. 4.26 (cholesterol) and Fig. 4.27 
(vitamin C). 
As seen during lactose-only tests, the initial de-agglomeration of particles is observed, 
before an increase in particle size with increased SEI (Fig. 4.17). As expected, the 
addition of mimic drugs did not alter the impact of SEI on the PSD of the formulation 
since they comprise less than two percent (by mass) of the mixture. In addition, there 
are no significant differences between the PSD of the cholesterol formulations and the 
vitamin C formulations – compare Fig. 4.26 and Fig. 4.27 at corresponding SEIs.  
However, results show that the onset of homogeneity is achieved following a SEI of 
approximately 200 kJ kg-1 in the case of cholesterol, and 150 kJ kg-1 in the case of 
vitamin C (these results are obtained through analysis of three independent 
experiments of each mimic drug). It is clear that changes in the PSD of the formulation 
continue to occur with increasing energy input, despite there being no impact on the 
drug homogeneity. Since no improvement on the formulation homogeneity can be 
identified, the importance of applying further energy to the formulation depends on 
the effect produced regarding aerosolisation and deposition efficiency. This work led 
to tests to determine the significance of SEI on the in vitro performance of mimic API 
formulations – the results from these tests are described in chapter 7. 
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Fig. 4.26. Blend homogeneity () and change in d5 particle size () with respect to SEI for three 
independent 1:67.5 w/w cholesterol:lactose blends  SD. 
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Fig. 4.27. Blend homogeneity () and change in d5 particle size () with respect to SEI for three 
independent 1:67.5 w/w vitamin C:lactose blends  SD. 
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4.4. Conclusions 
It has been shown that extended HSB has a noticeable and consistent effect on the PSD 
of inhalation-grade lactose (Bridson et al., 2007; Tu et al., 2009). This occurs across a 
range of laboratory-scale bowl sizes, albeit at different rates. However, the importance 
of changing the size distribution of lactose particles regarding the performance of DPI 
formulations is uncertain. Blending is primarily required to form a stable, 
homogeneous mixture of drug and carrier - in particular, HSB is used to obtain an 
ordered mix of two fine powders (Yip and Hersey, 1977). However, the extent to which 
this process is required remains uncertain. 
Several conclusions can be drawn from the results presented in this chapter. Firstly, it 
is clear that when using HSB as a means to produce DPI formulations, SEI is the 
dominant factor regarding PSD; trends across the several laboratory scales employed 
in this study are similar, such that an increase in SEI results in an overall reduction in 
fines particle content (characterised by an increase in d5 particle size), although 
absolute changes may increase with scale. It remains to be seen if this effect occurs 
beyond the laboratory-scale sizes used in this study, or even if it has implications for 
the manufacture of DPI formulations. It is recognised that an effective DPI formulation 
can be characterised by its emitted dose, chemical homogeneity, and FPF (Pilcer and 
Amighi, 2010), thus this study has shown that the point at which a homogeneous 
mixture has been achieved does not correspond to an end-point regarding changes in 
excipient PSD. Whilst the aerodynamic properties of the formulation (emitted dose and 
FPF) are considered in chapter 1, the results in this chapter potentially show that 
unnecessary powder changes are implicated by continuation of the blending process 
beyond the point at which chemical homogeneity is achieved. 
Tests have been performed to eliminate or substantiate hypotheses relating to the 
cause of the reduction in fines content. One possibility was the loss of fines from the 
system – either by entrainment through the headspace of the bowl or by adherence to 
blending equipment – this has been eliminated by confirmation of the primary PSD of 
material adhered to the blending equipment and the bulk powder. 
Finally, it is clear that lactose is a variable material – rigorous characterisation prior to 
blending is essential, as it has been shown that even slight changes in the starting 
properties of the input material can have significant effects on the performance of the 
formulation during blending. The differences in behaviour observed between the 
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material used in this study and a previous study (Bridson et al., 2007) – notably the 
reduction in d5 particle size at low SEI - was found to likely be caused by de-
agglomeration, rather than particle fracture. 
There is currently a paucity of information regarding the impact of this secondary 
manufacturing process on the performance of DPI formulations, thus chapters 5 and 6 
will follow on from this work and detail the development of tests to assess the impact 
of blending on DPI formulations and use mimic formulations to test the effects 
different blending and storage regimes have on mimic DPI formulations. 
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5.0. Design and Use of a Novel Fluidised Bed Elutriation 
Technique to Assess the Changes in DPI Formulation 
Properties due to High Shear Blending 
ABSTRACT 
High shear blending (HSB) has been shown to affect the properties of dry powder 
inhaler (DPI) formulations. These changes may have adverse effects on the 
performance of such formulations, and thus a greater understanding of such effects 
will help enhance quality and efficacy of the product. A small-scale bulk method to 
assess the detachment of fine API particles from coarse excipient and to detect changes 
that arise from blending and storage of formulations was desired, with the use of a 
novel fluidised bed elutriation (FBE) technique proposed for development and use. 
This chapter is split into two sections – the design considerations and initial trials 
forming a proof-of-concept study are described in section A, whilst tests on lactose-
only formulations exposed to various blending regimes are reported in section B.  
The FBE method involved consideration of the cohesivity of the material causing poor 
fluidisation conditions that were improved by control of fluidising gas humidity and 
bed vibration to reduce interparticulate forces. Consideration was also made regarding 
the bed dimensions and the superficial gas velocity (SGV) as this influenced the particle 
size that could be elutriated from the bed. 
Although no apparent differences were observed in the bulk fluidisation behaviour of 
lactose exposed to different HSB regimes (or unprocessed lactose), the method showed 
that it could distinguish between grades of lactose that had been deliberately 
conditioned. In addition, this method showed that by subjecting inhalation-grade 
lactose excipient to various HSB specific energy inputs (SEIs), subtle differences could 
be observed in the elutriated powder, from which properties of formulations can be 
inferred, thus having possible implications for the production of such products. 
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5.1. Introduction 
Based on the characteristics and operating principles of fluidised beds - in particular 
the elutriation of fine particles from the top of the column - it was proposed that a 
fluidised bed could be utilised to study the ability of fine particles (including APIs) to 
separate from the coarse carriers in DPI formulations. The first part of the chapter 
describes the considerations made in designing apparatus to study FBE of DPI 
formulations, whilst the second part uses this method to study the elutriation 
characteristics of lactose-only blends subjected to various specific energy inputs (SEIs) 
during HSB. Although fluidisation has been recently suggested as an important 
mechanism in the generation of an aerosol during an inhalation event (Tuley et al., 
2008; Shur et al., 2008), no previous literature has utilised FBE performance as an 
indicator of DPI performance. 
5.2. Materials and Methods 
5.2.1. Lactose 
Inhalation-grade lactose was provided by Friesland Foods Domo, Netherlands (section 
2.2.1). Samples of this material used throughout the study were taken from batches 
stored in the original foil packaging (foil bag within cardboard box) at 20°C and 40% 
RH in humidity-controlled cabinets (Binder, Germany). 
5.2.2. Particle Size Distribution 
PSDs were determined using both wet and dry dispersion laser diffraction methods 
(see sections 2.3.1 and 2.3.2). 
5.2.3. Dynamic Vapour Sorption 
BET SSA analyses were performed using a DVS Advantage II (Surface Measurement 
Systems, UK) instrument following the methods described in section 2.2.4.3. 
5.2.4. Scanning Electron Microscopy 
SEM images were produced using the method described in section 2.2.5. 
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Section A                                                                                              
Development of a Fluidised Bed Elutriation Technique
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5.3. General Fluidised Bed Design 
 
Fig. 5.1 shows the final design and setup of the fluidised bed used in this study. The 
glass column was of circular internal diameter 25 mm and height 400 mm. This section 
will describe key features of the equipment, along with the experimental and 
theoretical considerations behind their use. 
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Fig. 5.1. Setup of humidifying rig and fluidised bed equipment. 1. Central compressor; 2. Valves; 3. Oil 
filter; 4. Pressure regulator; 5. Pressure gauge; 6. Rotameters; 7. Humidifying tank; 8. Temperature / 
humidity probe; 9. Fluidised bed; 10. Particulate filter; A. Vibrational feeder; B. Air inlet; C. Distributor; 
D. Clamps; E. Pressure taps; F. Fluidised bed column; G. Flanges to fill bed; H. Elutriated material to filter. 
5.4. Transport Disengagement Height 
In order to design the column height, the terminal velocity, Ut of particles was 
considered to determine a suitable transport disengagement height (TDH) for the 
column. 
In order to elutriate particles of a given size, first the terminal velocity of particles 
needed to be estimated to give an indication of the fluidising gas velocity required. 
Application of Stokes’ Law (Equation 5.1), allows the terminal velocity of particles to 
be approximated for systems with low Reynolds number (Re <1). 
18/)(2 gdU gppt  Equation 5.1 
Investigation into the Effects of High Shear Blending and Storage on Powders for Inhalation 135 
Development of a Fluidised Bed Elutriation Technique 
Here, Ut is the terminal velocity (m s-1), g is the acceleration due to gravity (m s-2) dp is 
the particle diameter (m), p and g are the densities of the particle and gas 
respectively (kg m-3), and  is the gas viscosity (kg m-1 s-1). This calculation allows the 
SGV to be set according to the desired particle cut size, since elutriation will only occur 
when the terminal velocity is smaller than the SGV (Saxena and Jadav, 1983). For a cut 
size of 25 m, the minimum required gas velocity was found to be  2.5 cm s-1 
therefore, based on the recommendation that during air classification by FBE, the 
fluidising velocity should be at least twice the terminal velocity of the fines cut size 
(Heath and Aconsky, 1963), a gas velocity corresponding to a volumetric flow rate of 
2 l min-1 was chosen (6.27 cm s-1). 
When the SGV exceeds the terminal velocity of the particle, it is able to entrain from the 
bed. Often the terms elutriation and entrainment are used to describe the same 
phenomenon, however they have similar meanings and are often confused. 
Entrainment describes the flux of solids carried away from the powder bed by the gas 
and is related to the cross-sectional area of the bed, elutriation describes the 
classifying effect of the fluidised bed entrainment – it characterises the selective 
removal of particles of individual sizes from the system (Hartge and Werther, 2003). 
Leva, 1951 measured elutriation from a bed of particles with a bimodal size 
distribution and found that: 
i) when the column height is small, elutriation rate is high, but if the height 
exceeds a minimum size, the elutriation rate is a constant, minimum value. This is due 
to small particles, which have a high velocity, and hence require greater distance to 
slow down and return to bed, being expelled, and: 
ii) elutriation causes a decrease in particle concentration. 
An estimation for the TDH was made by Zenz and Weil (1958), and Kunii and 
Levenspiel (1991), who relate TDH to column diameter, dt and superficial gas velocity, 
USGV: 
gd
U
d
TDH
t
sgv
t
2
171.23  Equation 5.2 
this could be rearranged to give: 
0432.0
2
TDHg
Usgv
 Equation 5.3 
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The constant in Equation 5.3 is dependent on the properties of the material. Fournol et 
al., (1973) determined that for fine catalyst with average particle size 58 m (similar 
particle size to the material used in this study); 
001.0
2
TDHg
Usgv
 Equation 5.4 
Based on a SGV of 6.27 cm s-1, the TDH necessary from Equation 5.4 is approximately 
37 cm. 
5.5. Vibration 
Visual observations of channelling and general poor fluidisation were made whilst 
performing initial fluidisation trials. The cohesivity of the powder prevented good 
fluidisation; channelling cannot be described as good fluidisation since the individual 
particles within the bed cannot be entirely supported by the pressure drop. Therefore, 
a method was required to enhance the fluidisation performance. 
Various methods have been described in literature to improve the fluidisation regime 
of cohesive powders. These primarily focus on the reduction of the strong interparticle 
forces that predominate in cohesive powders. Park et al., (2002) explore methods for 
reduction of electrostatic charges in gas-solid fluidised beds; whilst Ma and Kato 
(1997) and Li and Kato (2001) study the effect these forces have on elutriation of fines. 
Zhou and Li, (1999), describe the effect of adding different sized particles on the 
fluidisation of cohesive powders and relate them to the interparticle forces that affect 
gas fluidisation of fine powders in several ways. Micron-sized particles in the Geldart 
group C class form channels and spouts, rather than the bubbling regime associated 
with larger group A particles. The fluidisation of unprocessed lactose is difficult to 
predict due to its wide PSD, with its considerable fine particle fraction making the 
powder cohesive in nature. Dutta and Dullea, (1991); Jaraiz et al., (1992); Mawatari et 
al., (2000); Mori et al., (1990); and Wang et al., (2000) have all explored the possibility 
of applying both horizontal and vertical mechanical vibrations to the powder bed in 
order to enhance fluidisation performance. 
5.5.1. Method 
Based on the work by Mawatari et al., (2003), and Levy and Celeste, (2006) apparatus 
was built to apply vibrations to the fluidised bed to enhance the fluidisation ability of 
the cohesive lactose formulations. For this, a small vibrational feeder (Retsch Vibratory 
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Feeder DR 100, Newtown, PA, USA) was modified by removing the chute and attaching 
a stand with clamps to hold the fluidised bed column; vibrations were applied with 
oscillations in the range of 30-45 Hz, and amplitudes of 0.5-1.5 mm. 
To test the ability of the bed to fluidise Group A powders, the fine particle population of 
particles were removed by air jet sieving unprocessed lactose for 30 min using 25 m 
and 71 m sieves. A standard pressure drop vs. SGV experiment using 20 g  0.1 g was 
performed without vibration to compare the performance of cohesive powder against 
more free-flowing material. 20 g was used as the initial mass based on work by Kim et 
al., (1999) who suggest that the bed length:diameter ratio should be greater than 2 to 
ensure good aeration of the bed. As bed height increases in comparison to diameter, 
wall effects are more prominent and it becomes more difficult to fluidise powder (Rao 
et al., 2010), thus, based on the 25 mm diameter column, a mass of 20 g unprocessed 
lactose provided a bed height of approximately 70 mm– thus allowing good aeration of 
the bed.  
5.5.2. Results 
Fig. 5.2 shows pressure drop vs. SGV curves for samples of unprocessed lactose both 
with, and without the aid of vibration. Results show that even with the aid of vibration, 
a good fluidisation regime is difficult to achieve with the cohesive unprocessed 
inhalation-grade lactose used in this study. However, vibration allows a more stable 
bed to form by reducing the channelling which causes pressure drop to be both 
unstable and much lower than for a packed bed; this is consistent with results found by 
Xu and Zhu, (2006) who found that vibration of cohesive powders reduced their 
propensity to channel and lift as a plug. Vibrating the powder bed also produced a 
fluidisation curve more akin to the theoretical curve shown in Fig. 1.6, due to the 
additional energy applied to overcome the interparticle forces. The large error bars are 
indicative of channelling since the pressure drop is erratic and uncontrolled, leading to 
large variations both during an individual experiment, and across several experiments. 
On the other hand, it can be seen from Fig. 5.3 that “25 m” and “71 m” grades of 
lactose do not require vibration of the bed to improve their fluidisation performance. 
Both grades of lactose are readily-fluidised, and their Umf correlate closely with those 
determined theoretically (Fig. 5.9 and Table 5.3). 
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Fig. 5.2. Effect of vibration on the fluidisation performance of 20 g  0.1 g unprocessed lactose. Results are 
averaged from three independent experiments  SD.  - With vibration,  - without vibration. 
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Fig. 5.3. Pressure drop vs. SGV for “25 m” () and “71 m” () grades of lactose, without vibration. 
Results are averaged from three independent experiments  SD. 
5.6. Superficial Gas Velocity 
The elutriation of fine particles is dependent on the balance between the particles’ 
terminal velocity and the SGV (section 1.6). To determine the effect on the fluidised 
bed used in this study, a simple experiment was performed to describe the extent to 
which SGV affects the mass of fine particles that can be removed from the bed. This 
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experiment also allowed a test of sampling time to be performed, as due to the limited 
size of the particulate filter (section Fig. 5.8), a suitable sampling time needed to be 
found to prevent the filter clogging, and producing adverse backpressure to the 
system. 
5.6.1. Method 
Two flow rates were used (2 l min-1 and 8 l min-1) corresponding to SGVs of 6.27 and 
25.08 cm s-1 respectively. These were chosen as they equated (approximately) to 
terminal velocities of 25 and 50 m particles (Equation 5.1). 20 g  0.1 g unprocessed 
lactose was exposed to the SGV in the vibrating bed for 10 min with elutriated samples 
taken at 1, 2, 5 and 10 min intervals, and filter emptied. Following this, the samples 
were left to fluidise until all possible material was elutriated. Samples were then 
weighed and sized using the wet dispersion laser diffraction method described in 
section 2.3.1.3. This experiment was performed in triplicate. 
5.6.2. Results 
Fig. 5.4 shows the cumulative mass elutriated at different SGVs. It can be shown that a 
greater SGV will remove more material more rapidly than a lower SGV. It takes 
approximately 1 hour to remove all available material at 25.08 cm s-1, whereas it takes 
over two hours to remove all material at 6.27 cm s-1. 
Table 5.1 describes the particle size and surface area of unprocessed lactose elutriated 
at different SGVs, highlighting the ability of the fluidised bed to act as an air classifier 
and its ability to separate particles by altering the SGV. 
Fig. 5.5 shows that, as expected, a greater SGV elutriates more material than a lower 
SGV. Following 10 min elutriation time, an average of 789 mg of lactose is removed by 
25.08 cm s-1, whereas just 253 mg is removed by a SGV of 6.27 cm s-1. The total amount 
of material elutriated (Fig. 5.4) was 1743  102 mg (8.7% initial material) when 
exposed to a SGV of 6.27 cm s-1, whereas when exposed to 25.08 cm s-1, the total 
elutriated material was 4855  239 mg (24.3% initial mass). Hence, these results 
suggest that 8.7% of particles are below 25 m Stokes’ diameter, whilst 24.3% are 
below 50 m; this compares to laser diffraction data (dry dispersion) suggesting 
17.5% particles are below 25 m, whilst 35% are below 50 m. It should be 
considered that the laser diffraction method used to size the elutriated fraction is 
known to cause de-agglomeration, thus producing a finer distribution, which does not 
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entirely represent this material. In addition, the elutriation method is much more 
subtle, operating at lower pressures than the RODOS device, thus de-agglomeration is 
unlikely, and agglomerates greater than the cut-off diameter will not be elutriated, 
hence their constituent particles do not appear in the distribution. 
Fig. 5.5 also shows that at the higher SGV, the sampling time needs to be shorter due to 
particulate filter filling up with the amount of material elutriated. It can be shown that 
the amount of material removed after 5 min was similar to that removed after 10 min, 
thus suggesting (and confirmed by observation) that the filter was full. However, this 
was not the case at the lower SGV since the cumulative amount of material elutriated 
after 10 min was similar regardless of the sampling intervals. 
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Fig. 5.4. Effect of fluidisation time on cumulative mass elutriated at different SGVs. Results are averaged from 
three independent experiments  SD. 25.08 cm s
-1
 (), 6.27 cm s-1  (). The difference in sampling time was 
due to the filling of the particulate filter at higher SGV, therefore requiring more frequent emptying. 
 
Table 5.1. Comparison of SSA and PSD for unprocessed lactose elutriated by different SGVs. 
Superficial gas velocity 
(cm s
-1 
) 
Specific surface area 
(cm² g
-1
) 
 Particle size ( m) 
d10 d50 d90 
6.27 6768  453 1.05   0.08 10.92  1.09 27.51  2.27 
25.08 4410  67 1.23  0.11 15.25  2.74 46.91  5.86 
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Fig. 5.5. Mass elutriated from fluidised bed as a function of sampling time at different SGVs. 
Top (25.08 cm s
-1
), bottom (6.27 cm s
-1
). 
5.7. Relative Humidity 
Relative humidity (RH) is known to affect the performance of DPI formulations (Chew 
and Chan, 2002; Young et al., 2007b; Guenette et al., 2009); therefore, control of the 
airstream RH is vital. In order to achieve this, a humidifying rig was used consisting of 
a series of valves and pipes in conjunction with a water tank to provide moisture (Fig. 
5.1). The air humidity was controlled by a valve situated on a bypass line across a 
humidifying tank of water. With the bypass valve open, the air is dry, as it chooses the 
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path of least resistance. When the bypass valve is closed, the air is forced through the 
water, thus picking up moisture en route. Humidity measurements were made to 2% 
RH accuracy with a HumidiProbe temperature and humidity sensor and data logging 
software (PicoLog, Pico Technology Ltd. UK). 
The sensitivity of the system was determined by varying the position of the valve on 
the bypass line to alter the amount of air flowing through the water tank. Fig. 5.6 
shows that humidity could be varied in 10% intervals with stability of approximately 
2%. 
Initial trials using fluidising gas of varying humidities showed that air with low 
moisture content produced strong electrostatic charging effects, causing particles to 
adhere to the column (Fig. 5.7), whereas using moist air, channelling readily occurred 
through the bed, and good fluidisation was difficult to achieve. 
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Fig. 5.6. Ability to manually control airstream humidity. 
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Particles adhered to 
column wall 
 
 
 
 
Settled bed  
of particles 
Fig. 5.7. Particles adhered to column wall following exposure to 10% RH fluidising gas for 30 min.  
5.8. Device to Collect Fines 
Cyclones are often used to collect fines elutriated from fluidised beds, in order to 
return them to the bed in circulating systems. 
Other methods: Callen et al., (2007) describe the 
use of charged parallel plates to collect elutriated 
fine particles from a fluidised bed. Since no 
recirculation of fines is required, and the fraction 
of particles likely to be entrained is small, a 
cyclone would be cumbersome and inefficient 
given the relatively small scale of the fluidised 
bed used. As relatively low flow rates and SGVs are to be employed, a 12 mm stainless 
steel tee-type particulate filter, with 0.5 m pore size was chosen to collect elutriated 
material (Swagelok, UK) (Fig. 5.8). 
5.9. Distributor 
A fluidised bed distributor serves two purposes: Firstly, it must support weight of non-
fluidised material, and facilitate effective distribution of fluidising gas over the cross-
sectional area. The gas must be distributed uniformly into the fluidised bed without 
causing attrition of the bed material (Pell, 1990; Perry and Green, 1997; Seville et al., 
1997). There needs to be a sufficient number of holes to ensure local uniformity across 
the cross-sectional area. Key considerations made included: correct sealing between 
distributor and wall (flanges were incorporated into design to “clamp” distributor and 
 
Fig. 5.8. Swagelok particulate filter 
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seal with PTFE), and plenum design – a tube entered the plenum from the side wall and 
was bent downwards at the centre to ensure adequate dispersion of gas (Pell, 1990; 
Perry and Green, 1997). 
Since the powder, fluidising gas and operating conditions (temperature, humidity, pH, 
etc.) were mild and only small masses, SGVs and pressure drops were experienced, 
Whatman Grade 1 Qualitative Cellulose Filter Paper (Whatman, UK) was cut to size and 
employed as gas distributor. In, addition, although the filter paper distributor produces 
a relatively large pressure drop (and hence energy loss) compared to that across the 
bed, the resultant energy loss is not important in this application, unlike industrial 
processes where minimising energy losses is vital.  
5.10.Temperature 
Wu and Baeyens (1991) and more recently, Xu and Zhu (2006) recognise the 
importance of controlling gas and powder temperature during fluidisation and 
describe the effects of gas temperature on the fluidisation ability of cohesive powders. 
All fluidising experiments in this study were performed at ambient temperatures. 
5.11.Flow Rate and Pressure Drop Measurements 
A rotameter is a device that measures the flow rate of a liquid or gas in a closed tube. 
The rotameters used in this study were made from tapered glass tubes with a float 
inside which are lifted by the force of the moving gas, against the gravitational force. 
The rotameters used in this study had optimal flow rate working ranges between 0-0.2 
and 0-5 l min-1 (Platon Series Rotameters, Muis Controls, Alberta, Canada). 
Differential pressure drop measurements across the powder bed were performed 
using a digital manometer (FC0510 Micromanometer, Furness Controls Limited, UK). 
5.12.Summary of Experimental Conditions Used 
Based on the findings above, tests of the effect of SEI on the elutriation and fluidisation 
performance of lactose blends were performed using a SGV of 6.27 cm s-1 (to 
correspond to particles with Stokes’ diameter of 25 m). Since fine particles are known 
to play an important role in the performance of DPI formulations (section 1.4.9.1), it 
was sensible to study the separation of the finest possible particles. Lower SGVs were 
difficult to use since the amount of material that could be removed was insufficient for 
size analysis. 
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Section B                                                                                      
Use of Fluidised Bed Elutriation Technique to Explore 
Blending-Induced Changes in -Lactose Monohydrate
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5.13.Materials 
The following study employed use of unprocessed lactose, and lactose exposed to 
differing blending regimes (obtained by varying the SEI – section 4.2.3). Formulations 
were prepared using the HSB equipment described in section 4.2.3 with sampling of 
powders performed using the method described in section 4.2.5. For this study, the 
small bowl with internal diameter 130 mm was employed with an initial mass loading 
of 500 g and rotational speed 500 rpm (a good blending regime – section 4.3, Fig. 4.10). 
Table 5.2 details the particle size data and SEI of lactose-only blends used in this study, 
along with a deliberately agglomerated sample conditioned through exposure to high 
humidity (70%) for two weeks. 
 
Table 5.2. Selected samples for FBE and AJS study. Particle size values are mean values of three 
measurements (dry dispersion) taken from at least three samples from the blended batch. 
 Sample Specific energy input  Particle size ( m) 
  (kJ kg
-1
) d5 d10 d50 
Unblended A 0 2.97 9.72 68.72 
 B 0 3.03 9.59 69.54 
 C 0 3.06 9.93 69.04 
Low energy input 1 A 24 2.80 8.79 70.14 
 B 31 2.79 8.46 68.19 
 C 35 2.84 8.76 68.7 
Low energy input 2 A 56 2.65 8.22 67.52 
 B 82 2.77 8.42 67.92 
 C 68 2.71 8.30 67.68 
Medium energy input A 189 3.06 9.93 69.16 
 B 210 3.18 10.04 70.11 
 C 223 3.29 10.25 70.24 
High energy input A 538 4.35 11.45 70.92 
 B 622 4.86 11.84 71.3 
 C 460 4.33 11.57 71.68 
Deliberately agglomerated A N/A 5.14 13.33 75.28 
 B N/A 5.20 13.47 75.44 
 C N/A 5.11 13.30 75.21 
5.14.Determination of Minimum Fluidisation Velocity and Pressure 
Drop 
For a settled bed, there is a point at which, as the gas velocity is increased, the drag 
force on the particles becomes equal to the buoyant weight of the bed. The bed is then 
supported by the gas flow and subsequently exhibits fluid-like properties; flowing 
easily, and showing an apparent viscosity. Since the drag force on the particles due to 
the gas flow is equal to the manometric pressure drop across the bed, then the 
manometric pressure drop ( P) is equal to the buoyant weight of the bed, or: 
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g
L
P
gpmf ))(1(  Equation 5.5 
where, L is the bed height, mf is the voidage at minimum fluidisation, and p and g are 
the gas and particle densities respectively. When combined with the Ergun (1952) 
equation (Equation 5.6) for the pressure drop through a settled bed of solids with 
particle diameter dp, 
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where,  and U are the gas viscosity and velocity respectively. It can be shown that: 
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The left hand side of Equation 5.7 is dimensionless and is known as the Archimedes 
number, Ar. This equation is difficult to use since there are no prescribed values for mf. 
Therefore, Wen and Yu (1966) described a simplified equation: 
2Re5.24Re1650 mfmfAr  Equation 5.8 
where, Remf is the Reynolds’ number of the system at minimum fluidisation – 
dependent on gas density, Umf, particle diameter and gas viscosity, , 
/Re pmfgmf dU  Equation 5.9 
thus, Umf can be more easily calculated. For particles smaller than around 100 m, and 
Remf << 0.5, the second term on the right hand side of Equation 5.8 can often be 
neglected, thus, 
1650
)(2 gd
U
gpp
mf  Equation 5.10 
This leads to a description of how the pressure drop across the bed increases with 
increasing SGV up to the Umf (Fig. 1.6). This pressure drop cannot exceed the buoyant 
weight of the particles, therefore, the bed voidage must increase in order to maintain 
pressure drop at or below this level. For comparison, Walker et al., (2007) estimate a 
Umf for lactose particles with average size of 50 m of 6.6  10-4 m s-1 in their work on 
the fluidised bed granulation of pharmaceutical powders. With a bimodal distribution 
of powders, especially over such a wide span of sizes, it is difficult to apply Equation 
5.10 accurately to the lactose used in this study; instead, it is more useful to determine 
the Umf experimentally. 
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5.14.1. Method 
20 g  0.1 g was exposed to increasing SGV with pressure drop recorded at each 
interval. Unprocessed lactose, low energy input (68  13 kJ kg-1), high energy input 
(540  81 kJ kg-1), deliberately agglomerated lactose (unprocessed lactose stored at 
70% RH for two weeks), “71 m” lactose, “25 m” lactose (both obtained through air 
jet sieve (AJS) removal of fines) were used to give materials with a range of cohesivity. 
See Table 5.3 for particle size data of these samples. 
5.14.2. Results 
As can be seen from Equation 5.10, the Umf across the bed is a function of particle size, 
thus a bed consisting of larger particle sizes theoretically produces a greater Umf. 
However, this only holds true for readily-fluidised material comprising non-cohesive, 
near-spherical particles, and is difficult to predict when powders with bimodal 
distributions and intrinsic cohesive fines are present, as is the case with the 
unprocessed and blended lactose used in this study (Perry and Green, 1997; Pell, 
1990). This occurs since the fine particles in the voids between the larger particles will 
fluidise before the larger particles as the SGV increases. This partial fluidisation will 
occur at a smaller velocity than the average Umf, thus making comparisons between 
theory and experiment difficult. 
The apparent Umf of lactose used in this study was determined approximately by the 
standardized method of Richardson (Richardson, 1971; Turki and Fatah, 2008), which 
corresponds to the intersection with the horizontal line representing fluidised bed 
operation, and the curve that exhibits packed bed operation (Fig. 1.6). The horizontal 
line and the curve are estimated to approximately fit the SGV value. Experimental 
values for “71 m” and “25 m” lactose are approximately 0.35 cm s-1 and 0.25 cm s-1 
respectively (Fig. 5.9). These results follow the predicted trends, with the theoretical 
values of Umf shown in Table 5.3 for “71 m” and “25 m” lactose such that the coarser 
material displays a greater Umf than the finer material. Since these grades of lactose 
have a monomodal distribution and are not particularly cohesive, a reasonable 
estimate of their Umf can be made, however this is not the case for unprocessed and 
blended lactose due to the cohesivity of the powder and bimodal distribution of 
powder.  
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Fig. 5.9. Pressure drop across bed as a function of SGV for various lactose samples. 
 - Unprocessed lactose,  - Low energy input (68  13 kJ kg-1),  - High energy input (540  81 kJ kg
-1
), 
 - Deliberately agglomerated lactose,  - “71 m” lactose,  - “25 m” lactose. 
Blue and red lines represent approximate determination of Umf of 25 and 71 m lactose respectively. 
Results shown are the SEM of three samples for each energy input/grade of lactose, with measurements 
performed in triplicate. 
 
Despite its smaller average particle size, reliable estimates of Umf for unprocessed and 
blended lactose are difficult to make. An increase in the interparticulate forces results 
in the finer, unprocessed and blended lactose showing a greater Umf than the 25 m 
and 71 m lactoses with fines removed.  
The change in bed height was also greater for this material than the coarser lactose 
due to the greater voidage of the bulk powder. This is supported by Räsänen et al., 
(2003) who found an increase in poor fluidisation behaviour and higher than expected 
Umf (from theory) due to the increased interactions and interparticulate forces of fine 
paracetamol particles. In addition, the sphericity of particles and the degree of 
agglomeration can cause differences between theoretical and experimental results 
(Turki and Fatah, 2008). As with both the blended (all energy inputs) and unprocessed 
lactose, the deliberately agglomerated lactose shows poor fluidisation behaviour due 
to the cohesivity of the material and propensity for channelling, despite vibration of 
the bed. 
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Table 5.3. Theoretical calculations of Umf based on mean particle size using Equation 5.10. 
 Mean particle size ( m) Umf (cm s
-1
) 
“71 m lactose” 96 0.463 
“25 m lactose” 75 0.282 
Unprocessed lactose* 68 0.233 
* difficult assumption to make due to wide, bimodal PSD and large proportion of fine material 
 
Pressure drops of the 71 m, 25 m, unprocessed, blended, and deliberately 
agglomerated lactoses show that a maximum value of ~375 Pa is achieved when all 
materials can be considered to be in the fluidised state, where the pressure drop is 
equal to the buoyant weight of the bed. However, the equation to estimate pressure 
drops (Equation 5.5) cannot be adequately applied to the systems used in this study as 
both the mf and L terms (representing the bed voidage and height at the point of 
minimum fluidisation respectively) were very difficult to accurately measure during 
operation. Instead, the pressure drop can be estimated by multiplying the bed mass by 
g (the acceleration due to gravity – 9.81 ms-2) and dividing by the bed area, this gives a 
value of approximately 400 Pa.  
The pressure drop vs. SGV curves shown in Fig. 5.9 show a noticeable difference to the 
curve described by Shur et al., (2008), where an argument is made that the tensile 
strength of a fixed bed needs to be overcome before the bed is fluidised. This “hump” at 
the top of the pressure drop curve is shown in the theoretical plot in Fig. 1.6, however 
was not observed in any of the experimental data shown above. 
To investigate the absence of the tensile strength “hump”, the hysteresis of the 
pressure drop was measured at both increasing and decreasing SGV. Fig. 5.10 shows 
this hysteresis effect on the pressure drop across a bed of unprocessed lactose (similar 
trends were observed for blended lactose and deliberately agglomerated lactose). It 
was found that the bed behaviour differs when reducing the SGV compared to 
increasing the SGV, such that the fluidisation state operates at lower gas velocities and 
channelling was less likely. In this type of regime, the bed is said to be acting in a 
dynamic state, where the interparticle forces and initial packing history have been 
reduced. This work supports the theory suggested by Shur et al., (2008), suggesting 
that the tensile strength of DPI powders, needs to be overcome in order to aerosolise 
the formulation for delivery to the lungs. However, due to the channelling observed in 
the powders in this study, the static and dynamic states have switched, with the static 
state operating at lower pressure drops for cohesive powders.  
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Features of unprocessed lactose fluidisation curves (Fig. 5.10): 
1. Channelling causes poor fluidisation state, the bed weight is not fully supported 
and the bed is prone to fracture with unstable pressure drops resulting in large error 
bars. 
2. High SGV allows “good” fluidisation – high level of mixing and good bed 
circulation. 
3. Reduction of SGV - fluidisation regime continues at lower SGV due to 
rearrangement of particles - less disruption by channelling. 
4. Difference in pressure drops at early fluidisation stage caused by removal of 
packing history - related to the tensile strength of the powder bed described by Shur et 
al., (2008). 
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Fig. 5.10. Increasing and decreasing pressure drop vs. SGV curves for three independent unprocessed 
lactose samples. Curves show hysteresis effect caused by removing the tensile strength of the bed 
during the initial fluidisation stage.  - increasing SGV,  - decreasing SGV. 
 
The absence of the tensile strength “hump” can be attributed to the wide size 
distribution of lactose and its irregularity in shape and hence packing ability. Much of 
the theoretical fluidisation curves showing the “hump” which characterises the tensile 
strength of the powder is based on fluidisation of powders with well-defined particle 
size and shapes that are often readily-fluidised. Saleh et al., (2006) conducted 
fluidisation tests on similar-sized group A and C powders to those used in this study 
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and the curves produced again showed a lack of “hump” without distinct packed bed 
and fluidised bed operations, similar to the unprocessed, blended, and deliberately 
agglomerated lactose. 
As a comparison, Fig. 5.11 shows a typical fluidisation hysteresis curve for 71 m 
lactose, which shows a more conventional pattern of fluidisation, as described by Shur 
et al., (2008) and in Fig. 1.6. On increasing the SGV, distinct packed bed and fluidised 
bed regimes are observed. Pressure drop increases linearly with SGV whilst the 
powder bed remains static (1), whilst at sufficiently large SGV, pressure drop during 
the fluidisation state is steady and fully supports the bed weight (2). The decreasing 
SGV curve falls below the increasing curve (3) due to the lack of channelling 
experienced on initial fluidisation, hence the greatly reduced experimental error with 
respect to unprocessed lactose. Although no tensile strength “hump” is observed, there 
is a clear difference in the pressure drop values (4) caused by hysteresis of the bed. 
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Fig. 5.11. Increasing and decreasing pressure drop vs. SGV curves for three independent 71 m lactose samples.  
 - increasing SGV,  - decreasing SGV. 
 
The work by Shur et al., (2008), Tuley et al., (2008) and Watling et al., (2010), 
suggested that the more cohesive formulations were more susceptible to fluidise 
following fracture of the powder bed, whilst less cohesive formulations were subject to 
a “layer-by-layer” erosion mechanism of fluidisation. This work shows a similar 
occurrence, however has been performed quantitatively, with the unprocessed and 
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blended formulations showing fracture (channelling), and the 25 m and 71 m 
lactose grades showing the erosion fluidisation representative of readily-fluidised 
materials. 
5.15.Effect of Specific Energy Input on Elutriation of Lactose Fines 
This section describes the effect of SEI applied through HSB on the elutriation 
characteristics of lactose.  
5.15.1. Method 
Samples from blends described in Table 5.2 were used in this experiment. 20 g  0.1 g 
of each powder was fluidised at 6.27 cm s-1 with elutriated material collected at 
10 minute intervals. This material was subsequently weighed, sized using the wet 
dispersion laser diffraction method described in section 2.3.1.3, and analysed for SSA 
using the BET technique described in section 2.2.4.3. A MATLAB code was written to 
find the particle size corresponding to the peak height of PSD curve. Six points around 
the peak of the curve were fitted to a 5th order polynomial, the peak of which was 
determined by differentiation. 
5.15.2. Results 
Fig. 5.12 shows the cumulative mass elutriated for unprocessed lactose, and lactose 
subjected to a range of SEIs through HSB. It is clear that applying energy and altering 
the PSD (as seen throughout chapter 4 and in Table 5.2) does not affect the amount of 
material that can be elutriated from a fluidised bed. There are no statistically 
significant differences between any of the blends in terms of total mass elutriated 
(Kruskal-Wallis test - page 119), although a small difference was found between “low 
energy input 2” lactose and the other samples at elutriation times 50-100 min (found 
by application of Nemenyi’s post-hoc statistical test). Should a trend have been 
observed with respect to the samples from other SEIs, a conclusion could have been 
made, however this appears to be an experimental anomaly. 
As a comparison, deliberately agglomerated lactose was subjected to the same 
experiment and a clear reduction in material elutriated was observed. This material 
had been exposed to a high (70%) humidity environment for several days before 
fluidisation, thus liquid bridges and capillary forces are likely to have created 
agglomerates between the particles, thus reducing their ability to be lifted from the 
bed.  
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Fig. 5.12. Cumulative mass elutriated as a function of time for lactose subjected to various specific blend 
energy inputs, and deliberately agglomerated lactose.  - Unprocessed lactose,  - Low energy input 1 
(30  5.5 kJ kg
-1
),  - Low energy input 2 (68  13 kJ kg-1),  - Mid energy input (207  17 kJ kg
-1
),  - High 
energy input (540  81 kJ kg
-1
),  - Deliberately agglomerated lactose. Results shown are averaged from 
three independent experiments on each sample described in Table 5.2,  SEM. 
 
Results from FBE suggest that there are subtle differences in the particle population of 
unblended and blended lactose. Despite there being no statistically significant 
difference between the total mass that can be elutriated from a bed, the PSDs of such 
material show slight differences.  
This is supported by the PSDs of elutriated material, Fig. 5.14, Table 5.4, and Table 5.5 
show the differences in the PSDs of the elutriated material from samples subjected to 
varying SEIs. It can be shown that the secondary peaks (see Fig. 5.13 for definition) of 
the elutriated material PSDs have a greater variation for unprocessed lactose than 
lactose that has been subjected to significant energy inputs. Blended material shows a 
very tight distribution of peak particle size, a possible hypothesis suggests that the 
elutriated material belongs to a small group of particle sizes (small, free agglomerates). 
Conversely, unblended material shows a range of size distributions, thus suggesting 
that there is a range of fine particle sizes elutriated – some individual particles and 
some small agglomerates. This could suggest there are different populations of 
particles that are present within the system, and that they are removed from the 
fluidised bed at different times. 
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The particle size of peak 2 elutriated size 
distributions have increasingly wide spread of 
values with increasing SEI. For example, 
unprocessed lactose has peak 2 values of its 
elutriated material ranging from 17.8 m to 
25.6 m, whereas the range of values for lactose 
subjected to higher energy inputs ranges from just 23.72 m to 25.75 m. This 
suggests that the blending process has subtle but noticeable effects on the population 
of particles in this mid-size range, not just on the very fine particles. These particles 
have been affected in a way that prevents them from elutriating out of the fluidised bed 
system, i.e. forming agglomerates that have aerodynamic size greater than 25 m. 
 
Table 5.4. “Peak 2” values from PSD data of elutriated material taken at various time points from samples 
subjected to varying energy inputs. Values represent mean peak heights from three independent blends 
at each energy, and three samples taken from each batch. 
 “Peak 2” Particle size values ( m) 
 
It is interesting to note that the point at which chemical homogeneity of formulations is 
achieved roughly corresponds to the specific energy input point described above 
where the elutriation particle size characteristics become more consistent with 
elutriation time. Along with the homogeneity results of the previous chapter (Fig. 4.26 
and Fig. 4.27) this suggests that increasing the specific energy input beyond this point 
~200 kJ kg-1 in both cases only has the effect of redistributing the population of lactose 
particles, rather than further dispersing of drug particles, an effect which may not 
necessarily affect formulation performance.  
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Fig. 5.13. PSD peak used in analysis of 
elutriated material 
Elutriation time 
Unblended 
(0 kJ kg
-1
) 
Low energy  
input 1 
(30 5.5 kJ kg
-1
) 
Low energy 
input 2 
(68 13 kJ kg
-1
) 
Mid energy  
input 
(207 17 kJ kg
-1
) 
High energy  
input 
(540 81 kJ kg
-1
) 
Non-fluidised 87.23  0.60 85.68  1.30 88.78  0.89 86.71  0.35 86.21  1.78 
10 min 17.80  0.27 20.89  0.83 18.63  0.83 23.72  1.22 24.63  0.73 
20 min 18.86  1.00 19.08  1.48 19.99  0.59 25.31  1.66 23.98  1.55 
30 min 18.09  0.78 20.32  0.71 19.31  2.57 24.86  1.26  23.72  0.73 
50 min 18.39  1.44 20.78  0.66 21.52  0.98 25.01  0.62 25.16  0.69 
110 min 19.20  1.01 24.86  1.36 24.24  0.60 23.98  1.92 25.75  0.79 
120 min 22.56  0.66 24.71  0.60 24.11  0.93 23.59  0.38 24.86  0.97 
130 min 25.60  0.82 24.79  0.84 24.05  0.91 23.08  1.02 24.37  0.70 
Average 20.07  2.91 22.21  2.49 21.69  2.46 24.22  0.84 24.64  0.70 
Non-elutriated 105.48  0.83 103.36  0.71 104.89  1.12 106.21  0.53 105.76  0.88 
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Table 5.5. Specific surface area (SSA) data of elutriated material taken at various time points from 
samples subjected to varying energy inputs. Values represent mean peak heights from three 
independent blends at each energy, and three samples taken from each batch.  
 SSA (cm
2
g
-1
) R
2 
(%) SSA (cm
2
g
-1
) R
2 
(%) 
Elutriation time 
Unblended 
(0 kJ kg
-1
) 
High energy input 
(540  81 kJ kg
-1
) 
Non-fluidised 1593  63 99.49 1556  100 99.52 
10 min  4283  97 99.79 4030  139 99.82 
20 min 4159  93 99.95 4008  96 99.93 
30 min 4096  106 99.91 3796  110 99.93 
50 min  4278  87 99.28 4003  143 99.91 
110 min  3910  141 99.88 3923  130 99.66 
120 min  3873  74 99.87 3752  102 99.94 
130 min  3872  116 99.90 3895  74 99.94 
Average 4067  183 99.78 3915  109 99.88 
Non-elutriated 834  23 99.75 864  34 99.64 
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Fig. 5.15 shows representative SEM images of unprocessed lactose that has been 
elutriated from the fluidised bed by a SGV of 6.27 cm s-1. It can be shown that elutriated 
material contains both individual particles and agglomerates of fine particles, however 
it appears that each entity (whether single particle or agglomerate) has a diameter <25 
m. However due to the cohesivity of such fine material, discrete particles cannot be 
identified, thus the images produced show agglomeration that is likely to have 
occurred post-fluidisation. 
Fig. 5.16 shows representative SEM images of non-elutriated lactose that remained in 
the fluidised bed following two hours of fluidisation at a SGV of 6.27 cm s-1. It can be 
shown that the non-elutriated material comprises both agglomerates of fine particles 
and coarse particles, both of which possess an aerodynamic diameter sufficiently large 
that their terminal velocity is greater than the SGV. Such images are evidence that the 
forces experienced in the fluidised bed are not sufficient to overcome all the 
interparticle forces of each agglomerate, thus only the most loosely attached and free 
fine particles can be elutriated from the system. 
  
Fig. 5.15. Representative SEM images of elutriated (unprocessed) lactose following fluidisation at 
6.27 cm s
-1
 for two hours. x200 (left) and x500 (right) magnification and 10kV potential. 
  
Fig. 5.16. Representative SEM images of non-elutriated (unprocessed) lactose following fluidisation at 
6.27 cm s
-1
 for two hours. x200 (left) and x500 (right) magnification and 10kV potential. 
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No differences could be observed between images from unprocessed, de-agglomerated, 
or agglomerated lactose. In addition, no differences could be observed between the 
lactose elutriated at different time intervals. For example, the SEM images of lactose 
elutriated initially appeared similar to that at the end of the fluidisation period. As 
expected, the images of non-elutriated lactose following short periods of elutriation 
contained significantly more fine particles than non-elutriated lactose taken from the 
bed after longer periods of fluidisation. 
The fine-particle agglomerates present in the non-elutriated material may have been 
formed from several processes. They may have been present in the initial unprocessed 
lactose, produced by the blending process, or formed from free fines liberated by the 
fluidisation process. Previous observations of fine particles generated by attrition 
during fluidisation have been shown to affect the elutriation of particles from mixtures 
of fine and coarse particles (Santana et al., 2005). 
5.16.Conclusion 
This chapter has shown that a small-scale fluidised bed has been shown to 
discriminate between samples of inhalation-grade lactose that had been deliberately 
conditioned (section 3.4.5.1) to show different performance on fluidisation (in terms of 
pressure drop as a function of SGV). However, it has been shown that this method 
cannot adequately differentiate between inhalation-grade samples exposed to various 
HSB SEIs. This is caused by the level of fines present in these powders that causes their 
cohesivity and poor fluidisation performance. Fig. 5.17 highlights the difference in 
fluidisation performance of readily fluidised powders (such as those deliberately 
coarsened by AJS in this study) to that suggested in the work by Shur et al., (2008), and 
the cohesive lactose powders used in this study. 
a
P
Usgv
b c
P
Usgv
P
Usgv 
Fig. 5.17. Sketches of pressure drop vs. SGV curves: red line – increasing SGV, blue line – decreasing SGV.  
a) idealised response; b) semi-ideal response showing tensile strength of bed and hysteresis effect when 
reducing SGV; c) inhalation-grade lactose used in this study showing channelling and reversed hysteresis 
effect. 
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This work has shown that a FBE method has been able to detect subtle changes in the 
behaviour of inhalation-grade lactose exposed to various blending regimes. The 
method was not designed to mimic an inhalation event; indeed the flow rates used are 
significantly lower than a typical inhalation event (~60 l min-1 is commonly used for 
inhalation studies (Harris, 2007; de Koning et al., 2002), whereas flow rates of 
~2 l min-1 are used in this study). Other differences to previous work studying the 
effects of fluidisation on the performance of DPI formulations include the quantity of 
powder tested and both the geometry and orientation of analysis equipment. Shur 
et al., (2008) use airflow applied below DPI formulations to observe the cohesivity 
through use of a powder rheometer, although no qualitative measures of pressure drop 
across the bed for various gas velocities are given, and the pressure drops calculated 
were measured with an external normal load applied to the system, causing the bed to 
consolidate. 
Shur et al. also use high speed imaging to analyse the fluidisation and entrainment 
mechanics of 33 mg DPI formulation. This qualitative approach allowed the fracture 
mechanisms to be explored of formulations exposed to different blending conditions; 
Tuley et al., (2008) also employ high-speed imaging to assess the differences in 
fluidisation behaviour for different powders (including lactose with various fines 
content). That study used airflows with a range of pressure gradients, applied to 
powder beds residing in a series of geometries, experiments were performed over a 
typical inhalation event timescale of 0.2 s. 
The FBE test is a novel tool that uses the principle of air classification to determine the 
amount of material in a formulation that is below a certain aerodynamic diameter. A 
similar study (Deng et al., 2010) uses the same principal to study the flow of a tablet 
formulation from a hopper; however, this study uses a SGV that is greater than the Umf 
of the formulation, whereas the previous study deliberately works in a sub-Umf regime. 
Chapter 7 will follow from this chapter and use the principles of air classification to 
determine the effects of HSB and storage on the separation of fine mimic drug particles 
from lactose carrier particles. 
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6.0. Design and Use of an Air Jet Sieve Technique to 
Assess the Changes in DPI Formulation Properties 
due to High Shear Blending 
ABSTRACT 
High shear blending (HSB) has been shown to affect the properties of DPI 
formulations, in particular the particle size distribution (PSD) of particles, which 
consequentially may affect performance of such formulations. Therefore, a greater 
understanding of these effects may help enhance quality and efficacy of the product. A 
small-scale bulk method to assess the detachment of fine API particles from coarse 
excipient particles was desired, with the use of an air jet sieve (AJS) method proposed 
for development and use. This chapter is spilt into two sections, with the first section 
detailing the method development, whilst the second section tests differences in 
behaviour on sieving of lactose-only formulations exposed to different blending 
regimes. 
The AJS method described in this chapter evaluated the initial mass, sieve aperture 
size, and both sieving pressure and time as factors affecting the separation of fine and 
coarse particles. 
Results showed that by subjecting the lactose excipient used in DPI formulations to 
various specific energy inputs (SEIs) by HSB, subtle differences were observed in the 
behaviour of the powder. In particular, the amount of fine material removed from the 
bulk powder varied depending on the amount of SEI imparted to the formulation 
during HSB.  
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6.1. Introduction 
An air jet sieve (AJS) is an analysis device for determining the particle size distribution 
(PSD) of bulk materials (Fig. 6.1). The sieving chamber is exposed to vacuum with the 
incoming air entering through a rotating nozzle where it disperses the bulk powder. 
The fine particles are conveyed through the apertures of the sieve by an underpressure 
determined by the amount of material and aperture size of the sieve. Coarse material 
remains on the sieve and can be further classified using larger sieves. Many 
applications exist for the use of AJSs in the pharmaceutical industry, notably for the 
assessment of drug-carrier adhesion (Iida et al., 2003; Flament et al., 2006; Dickhoff et 
al., 2006) or for the preparation of grades of lactose with certain fractions of particles 
removed in order to produce a consistent and coarse grade of powder (Lucas et al., 
1998; Zijlstra et al., 2004; Nguyen et al., 2010). The work in this chapter was based on 
the methods used in these previous studies such that the amount of material removed 
by the AJS was used to describe the formulation behaviour. However, the novelty of 
this study lay with designing optimal experimental AJS conditions for identifying 
blending-induced changes in lactose-based formulations. 
1. Housing
2. Rotating slotted nozzle
3. Analysis sieve
4. Plexiglass cover
5. Air and fines flow
1 
2
3
4
5
 
Fig. 6.1. Sketch of an Alpine Air Jet Sieve (Hosakawa Micron, Japan). 
6.2. Materials and Methods 
6.2.1. Lactose 
Inhalation-grade lactose was provided by Friesland Foods Domo, Netherlands (section 
2.2.1). Samples of this material used throughout the study were taken from batches 
stored in the original foil packaging (foil bag within cardboard box) at 20°C and 40% 
RH in humidity-controlled cabinets (Binder, Germany). 
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The lactose-only formulations used in this study match those used in chapter 5 and are 
listed in Table 5.2. All results shown are averaged from three independent experiments 
on each sample. 
6.2.2. Particle Size Measurements 
Particle size measurements were performed using laser diffraction. The dry dispersion 
technique used is described in section 2.2.3. 
6.3. Factors Affecting Mass Removed on Air Jet Sieve  
Key factors that affect the mass removed from an AJS consist mainly of the 
backpressure applied across the system, sieving time and initial mass to be sieved. The 
backpressure is application specific, whereas the sieving time and initial mass have a 
range of recommended values according to the manufacturer’s manual. 
Sources in the literature (Iida et al., 2003; Flament et al., 2004, 2006; Dickhoff et al., 
2006) use backpressures between 3.5 and 4 kPa – the upper limit of the Alpine AJS 
used in this study. However, there is no reported literature regarding the influence of 
backpressure on the amount of fines removed from formulations. 
The effect of sieving time varies according to the material to be analysed. Materials that 
are more cohesive lose mass less rapidly than free-flowing materials that consist of 
well-defined independent particles. The sieving time is the parameter that has the 
greatest influence on the result according to the manufacturer’s manual and can only 
be determined experimentally as there are no theoretical predictions that suggest 
when analysis would be complete for given powders. 
The mass of sample to be analysed is dependent on the sieve to be used, powder 
cohesivity, and the availability of sample. The amount of sample needs to be sufficient 
to perform suitable analyses, however cannot overload the system since this may 
reduce the pressure drop across the sieve, limiting the amount of fines that can be 
removed, and prolonging sieving time. 
6.3.1. Effect of Pressure on Mass Removed 
A study was performed to assess the ability of the AJS to remove fines at different 
backpressures. The initial mass of formulations exposed to different SEIs was kept 
constant (10g  0.1 g, as specified by manufacturer’s manual), along with the maximum 
sieving time (see section 6.3.2) of 30 min (1800 s). 
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6.3.2. Effect of Sieving time on Mass Removed 
The effect of sieving time on the amount of material removed on the sieve was tested 
by controlling the initial mass and pressure applied to the sieve and recording the 
residue mass at various time intervals. 
6.3.3. Effect of Initial Mass on Mass Removed 
Various initial masses were loaded onto the sieves over the range recommended by the 
manufacturer (10, 20 and 30 g  0.1 g) and exposed to 3400 Pa backpressure with the 
mass removed on the sieve determined at each time interval. 
6.3.4. Results 
6.3.4.1. Effect of Pressure on Mass Removed 
Fig. 6.2 shows the effect of sieve backpressure on the removal of fine particles smaller 
than 25 m from three independent batches of unprocessed lactose, lactose subjected 
to low SEI (~68 kJ kg-1) and lactose subjected to high SEI (~540 kJ kg-1). The purpose 
of this experiment was to determine the backpressure at which the greatest 
differences could be observed amongst the different batches of lactose. Sieving time 
was set at 30 min in order to remove all possible fines (Fig. 6.4). 
The results show that the greatest difference in mass removed between lactose 
subjected to varying SEIs can be found at low backpressure (600 Pa). At this pressure, 
it can be shown that the greatest mass can be removed from lactose subjected to low 
SEI; whilst the least amount of mass could be removed from lactose subjected to large 
SEIs. This appears to support the PSD data from dry dispersion laser diffraction results, 
which show a coarsening of particles with increasing SEI. However, it is important to 
consider that the RODOS dry dispersion system operates at 2 bar (200 kPa), a 
substantially-greater pressure than the AJS, thus agglomerates are far more likely to be 
broken up into individual particles during size measurements. HSB may cause mid-size 
agglomerates to form which are greater than 25 m and thus, due to the relatively low 
dispersion efficiency of 600 Pa, these agglomerates are not removed as readily as 
smaller agglomerates and the free fines present in unprocessed lactose. 
Fig. 6.3 shows SEM images of unprocessed lactose residue taken from the same batch 
subjected to just 10 s of sieving at 600 Pa and 3400 Pa to highlight the effect pressure 
has on removal of material. The greater sieving pressure clearly removes more fines, 
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and is therefore likely to remove any information held within the PSD of the residue 
regarding the effect of blending on lactose. 
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Fig. 6.2. Effect of sieve backpressure on the amount of fines removed from a 10 g  0.01g initial sample, 
expressed as residue mass. 25 m sieve, 30 min sieving time. Results shown represent the mean from 
three samples from each of three independent batches  SEM.  
 - Unprocessed lactose, - low energy input (68  13 kJ kg-1),  - high energy input (540  81 kJ kg-1). 
 
  
Fig. 6.3. SEM images of unprocessed lactose subjected to 600 Pa (left) and 3400 Pa (right) for 10 s using 
25 m AJS. 
 
6.3.4.2. Effect of Sieving time on Mass Removed 
Fig. 6.4 shows that a plateau of residue mass has been reached for the 71 m sieve 
soon after sieving begins. This suggests that it is relatively easy to remove particles 
<71 m, and that few particles undergo de-agglomeration in order to pass through the 
sieve apertures. Conversely, the 25 m sieve shows a more gradual reduction in 
residual mass (Fig. 6.5) as a function of sieving time. This suggests those particles 
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around 25 m consist of both individual particles and agglomerates, with the primary 
particles <25 m passing through readily, and the agglomerates taking time to de-
agglomerate in order to pass through the sieve apertures. Residue mass plateaus at 
sieving times >15 min for the 25 m sieve, thus suggesting that all de-agglomeration 
occurs before this point. 
Fig. 6.6 highlights the difference between residual unprocessed lactose following 
exposure to an AJS backpressure of 3400 Pa with 25 m sieve for varying periods of 
time (10 s and 30 min). It can be shown that sieving for just 10 s removes the majority 
of fine particles; however, there are still some “free” fines and agglomerates that can be 
removed by extending the sieving time. 
Fig. 6.7 highlights the ability of extended sieving times to remove fine particles 
adhered to coarser particles. Both individual and agglomerated fine particles are 
situated on the surface of carriers exposed to just 10 s of sieving, however the material 
exposed to 30 min sieving shows far fewer fine particles still adhered to the surface, 
and an absence of agglomerates. 
It is interesting to note the coarse AJS residue shows only single particles (Fig. 6.6) and 
an absence of fines or agglomerates. However, the analogous non-elutriated material 
from the FBE method shows the presence of agglomerates that were not elutriated 
from the bed (Fig. 5.16). Thus, despite the shear forces and frequent particle collisions 
experienced during fluidisation, the energy of such events was not sufficient to de-
agglomerate the whole bulk material. However, the AJS method appears to remove all 
agglomerates from the bulk material, suggesting that the FBE method is a more subtle 
technique for analysing size distributions of formulation particles. 
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Fig. 6.4. Effect of sieving time on the amount of fines removed from a 10 g  0.01g initial sample of 
unprocessed lactose expressed as residue mass, along with particle size data. Results shown represent the 
average from three samples using 71 m sieve at 3400 Pa (max operating pressure).  
 - d5 particle size;  - d10 particle size,  - d50 particle size,  - residue mass. 
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Fig. 6.5. Effect of sieving time on the amount of fines removed from a 10 g  0.01g initial sample of 
unprocessed lactose expressed as residue mass, along with particle size data. Results shown represent the 
average from three samples using 25 m sieve at 3400 Pa (max operating pressure).  
 - d5 particle size;  - d10 particle size,  - d50 particle size,  - residue mass. 
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Wide PSD; presence of 
agglomerates and individual 
particles. 
 
Greatly reduced number of fine 
particles and agglomerates, still 
some fine particles present. 
 
Complete absence of fine 
(<25 m) particles. 
Fig. 6.6 Representative SEM images of unprocessed lactose exposed to AJS with 25 m sieve and 3400 Pa 
backpressure for 0 min (top), 10 s (middle), and 30 min (bottom), (x200 magnification and 10kV potential). 
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Fig. 6.7 Representative SEM images of unprocessed lactose exposed to AJS with 25 m sieve and 3400 Pa 
backpressure for 0 min, (left), and 30 min (right)., with x1500 magnification and 10kV potential. 
 
6.3.4.3. Effect of Initial Mass on Mass Removed 
Fig. 6.8 shows that the percentage mass removed from initial samples between 10 and 
30 g does not differ significantly, thus the mass used would not affect the results 
generated. The initial sample mass does not affect percentage mass removed providing 
samples mass is between 10 and 30 g, therefore, 10 g was chosen to limit the amount 
of material used for this analysis.  
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Fig. 6.8. Effect of sample size on the% mass removed using a backpressure of 3400 Pa. Results shown 
represent the average from three samples of unprocessed lactose using both 71 m and 25 m sieves.  
 - 10g, 71 m sieve; - 20g, 71 m sieve;  - 30g, 71 m sieve;  
 - 10g, 25 m sieve;  - 20g, 25 m sieve;  - 30g, 25 m sieve. 
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6.4. Summary of Experimental Conditions Used 
As can be seen in sections 6.3.4.1 and 6.3.4.2, the AJS is most able to discriminate 
between samples exposed to different blending regimes at low sieving pressure, and 
that sieving time >15 min are required to remove all possible material. In line with 
previous AJS experiments (Flament et al., 2004; Saint-Lorant et al., 2006, Dickhoff et al., 
2006) on lactose-based formulations, a short sieving time of 10 s was used, along with 
an intermediate 5 min sieving, and long 30 minute sieving time to ensure all available 
material was removed. These sieving times matched those used in the previous studies 
named above. Since the results in section 6.3.3 show that the initial mass loading did 
not measurably influence the amount of fines removed, 10 g was chosen to conserve 
samples. The 25 m sieve was chosen for analysis as this gave the strongest indication 
of the behaviour of fines in the formulation following HSB. It also coincided with the 
cut size of particles determined by SGV in the FBE tests (section 5.12). 
6.5. Effect of Specific Energy Input on Air Jet Sieve Removal of Fines 
from Lactose Only Formulations 
6.5.1. Method 
The method used to determine the amount of fines removed from formulations 
exposed to different SEIs is described in section 6.4. 
The lactose-only formulations used in this study match those used in chapter 5 and are 
listed in Table 5.2. All results shown are averaged from three independent experiments 
on each sample. 
6.5.2. Results 
The effect of SEI on the amount of fines <25 m removed by the AJS is shown in Fig. 
6.9. These results show that at low pressure (600 Pa), at short sieving times, more 
material is removed from lactose subjected to low energy inputs than the lactose 
subjected to high energy inputs. This supports the theory that upon blending, lactose 
fines combine either with each other or with larger particles such that the AJS cannot 
easily remove them. On the other hand, unprocessed lactose and that subjected to just 
low SEI, contains free fine particles (or only weakly-attached) particles that are readily 
removed by the AJS. 
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Fig. 6.9 also shows that during extended sieving times, these results normalise, and the 
differences seen at short sieving times can no longer be observed. Prolonged sieving 
allows sufficient disturbances of particles to occur which removes all available 
particles, rather than just the weakly attached particles that are preferentially removed 
during short sieving times. No statistically significant differences can be observed 
between the amounts of fines removed from blends exposed to different SEIs (Kruskal-
Wallis test - page 119), when sieved for 30 minutes. 
However, when using the more discriminating shorter sieving times, a trend appears 
that is similar to the trend observed in the PSD of lactose with increasing SEI. Particle 
size data showed an initial decrease with low SEIs, followed by a subsequent increase 
(reagglomeration) with greater SEIs. These low SEIs corresponded to a reduction in 
the mass remaining (increase in mass removed) on the 25 m sieve after short sieving 
times, again suggesting that the powder was de-agglomerating, since more particles 
were able to pass through the sieve. This effect was not observed at higher sieving 
times as the AJS was able to break up loose agglomerates over a prolonged period, and 
any changes caused by blending were normalised by the sieve. 
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Fig. 6.9. Effect of SEI on the amount of fines removed and particle size using the 25 m sieve at 600 Pa for 
10 s () and 30 min (). Results are averaged from three independent experiments from three samples at 
each energy input described in Table 5.2. Horizontal error bars represent SD of SEI from three samples, 
whereas vertical error bars represent SEM of residual mass. 
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6.6. Conclusion 
AJS analyses of lactose-only formulations have showed differences between blends 
exposed to various SEIs through HSB. This chapter has found that the optimal 
conditions for observing the subtle differences between different blends requires short 
sieving times and low pressures, as extended times and high pressures normalise the 
blends and remove all possible material from the bulk powder. The more subtle 
technique only removes the most weakly bound fines and agglomerates, thus allowing 
more distinct differences to be observed. 
This chapter has also investigated the effects of SEI on the removal of fine lactose 
particles from lactose-only formulations. This is a novel feature of this work as 
previous literature focuses on removal of drug particles from carriers with various 
surface roughness (Flament et al., 2004; Iida et al., 2003); and separation of different 
drugs from different carriers (Saint-Lorant et al., 2006).  
However, the measurement of adhesion forces cannot be made by an AJS, since the 
turbulent, chaotic nature of the airflow that separates drug from carrier is difficult to 
control and measure effectively. The work above, which assesses drug-carrier 
adhesion, uses an AJS to empirically determine the adhesion between different drugs 
and grades of excipients, by calculating the mass of drug removed by the AJS system for 
various sieving regimes.  
The following chapter will describe the effects of HSB on the AJS removal of mimic 
actives from such formulations and explores the effect of energy input and storage 
regimes on formulation behaviour. 
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7.0. Effects of Blending and Storage on Fine Particle 
Behaviour 
ABSTRACT 
This chapter describes the effects of both high shear blending (HSB) and storage 
regimes on the properties of mimic DPI formulations containing mimic APIs. Specific 
energy input (SEI) is known to be the major factor that influences formulation 
characteristics during HSB, whereas different storage regimes (temperature and 
humidity) have been shown in previous studies to significantly affect the 
physicochemical properties of -lactose monohydrate – the excipient commonly used 
in such products. This chapter extends previous studies to examine the effect of SEI on 
the properties of such formulations using existing cascade impactor techniques and 
novel fluidised bed elutriation (FBE) and air jet sieve (AJS) tests developed and 
described earlier in this thesis.  
Blending of lactose with two mimic APIs (cholesterol and vitamin C) was performed 
using a laboratory-scale high shear blender, whilst formulations were stored post-
blending in controlled-climate chambers at 40% and 60% RH. Tests were performed 
via the FBE and AJS methods developed in chapters 5 and 6, along with a conventional 
Next Generation Impactor (NGI) method to assess the formulations’ fine particle 
fraction (FPF). 
Results showed no evidence of the behaviour of fine drug particles being affected by 
blending regimes, specifically, the SEI during blending was not observed to alter the 
ability of fine particles to separate from coarse carrier via any of the test methods. On 
the other hand, storage regimes were observed to induce subtle changes in the ability 
of fines to separate from coarse particles. In particular, storage of mimic formulations 
at 60% RH was seen to reduce the amount of vitamin C and cholesterol elutriated from 
the fluidised bed. In addition, fine particle deposition was seen to decrease with 
prolonged storage in the case of vitamin C using NGI analyses, with the effect of 
capillary forces being suggested as the mechanism responsible for this effect. Storage 
of formulations at 40% RH was not observed to have any effect on the fine particle 
delivery of drug using any of the methods developed in this thesis. 
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7.1. Introduction 
Following from the work in chapter 4, and by Bridson et al., (2007), an energy-
dependent loss of free lactose fines was shown to occur during the high shear blending 
(HSB) of inhalation-grade lactose. It was proposed that these blending-induced, 
energy-dependent changes observed might affect the fine particle fraction (FPF) 
associated with drug-containing active formulations. 
In addition to the effect of HSB, post-blending storage regimes are known to affect the 
fine particle fraction (FPF) (Young et al., 2007b; Kwok and Chan, 2007), and hence, 
formulation performance. The interaction between drug and carrier in various 
environments has been extensively studied, particularly via the cohesive-adhesive 
balance (CAB) method initially developed by Begat et al., (2004) and described in more 
detail in section 1.5. Despite this, relatively few methods have been used to assess the 
effect of blending and storage regimes on the bulk separation of drug from carrier. 
Three test methods were used in this chapter to assess the amount of fine (drug and 
lactose) particles that could be removed from mimic dry powder inhaler (DPI) 
formulations exposed to various blending and storage regimes; the fluidised bed 
elutriation (FBE) and air jet sieve (AJS) methods developed in chapters 5 and 6 
respectively, along with a conventional Next Generation Impactor (NGI) method 
commonly used to assess the FPF deposition following aerosolisation of a DPI 
formulation. 
7.2. Materials and Method 
7.2.1. Lactose 
Inhalation-grade lactose was provided by Friesland Foods Domo, Netherlands (section 
2.2.1). 
7.2.2. Mimic APIs 
Tests were performed using cholesterol and vitamin C (Sigma Aldrich, UK) as mimic 
APIs (section 3.1.1), the methods for micronisation and characterisation of these 
materials is described in section 3.4.2. The d50 particle size of these mimic actives lay 
within the 1-5 m aerodynamic diameter specification for DPI formulations defined by 
Newman and Clarke (1983): d50 (cholesterol) = 4.45  0.29 m; d50 (vitamin C) = 
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3.21  0.18 m. The aerodynamic diameter of particles is given by the equation 
2
1
0
p
ea dd , where da is the aerodynamic diameter, de is the equivalent volume 
diameter (value measured by laser diffraction), 0 is the standard particle density 
(1 g cm-3), p is the particle material density, and , is the shape factor of the particles. 
It is the diameter of a spherical particle of density 1000 kg m-3 with the same settling 
velocity as the particle in question (related to Stokes’ diameter). 500 g blends 
containing 1:67.5 w/w (common payload used in previous literature - Table 1.2) mimic 
active were prepared using the method described in section 4.2.4 using the 0.13 
diameter bowl with impeller speed 500 rpm. Samples of formulation were taken at 
regular intervals using the method described in section 3.5.1. 
7.2.3. Particle Size Distribution 
Measurement of particle size distributions (PSDs) were performed using both wet and 
dry dispersion laser diffraction systems (see sections 2.3.1 and 2.3.2 respectively). 
7.2.4. Chemical Assays 
Drug content and blend uniformity was measured using UV spectroscopy, with the 
assay for cholesterol being described in section 3.5.2, and the method for vitamin C 
described in section 3.5.3. For each method, a 34.25 mg sample of formulation was 
taken which corresponded to a nominal drug dose of 500 g. 
7.2.5. High Shear Blending 
Formulations were prepared using the HSB equipment described in section 4.2.3 with 
sampling of powders performed using the method described in section 4.2.5. For this 
study, the small bowl with internal diameter 130 mm was employed with an initial 
mass loading of 500 g and rotational speed 500 rpm (a good blending regime – section 
4.3, Fig. 4.10). Blends were performed based on data from Fig. 4.26 and Fig. 4.27 since 
these show the onset of homogeneity for each mimic API. Samples taken from lower 
SEIs were not used, as these will not be suitably homogeneous. Blends were performed 
in triplicate with SEI approximately 200, 400 and 600 kJ kg-1.  
Fig. 7.1 shows representative SEM images of vitamin C and cholesterol containing 
formulations blended with ~400 kJ kg-1 SEI. Although unable to distinguish between 
mimic drug and lactose, an even distribution of fine particles can be observed over the 
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surface of the larger carrier particles for both vitamin C and cholesterol containing 
formulations. 
  
Fig. 7.1 Representative SEM images of cholesterol/lactose (left) and vitamin C/lactose (right) formulations at 
~400 kJ kg
-1
 SEI with x1500 magnification and 10kV potential. 
 
7.2.6. Storage Conditions 
The effects of storage on the physicochemical properties and consequential 
performance of formulations are vitally important to the pharmaceutical industry 
(Callahan et al., 1982; Melveger and Huynh-Ba, 2008). Bridson et al., (2007) and Das et 
al., (2009) describe work conducted to investigate the effects of prolonged storage on 
the properties of lactose carrier and salmeterol xinafoate drug respectively; the study 
by Bridson et al., (2007) was performed over 21 weeks, whilst the study by Das et al., 
(2009) lasted three months - both typical of the timescales the pharmaceutical 
industry employs for storage of their products. The most common factors that need to 
be controlled in storage studies are temperature, and more importantly, relative 
humidity (RH) (Callahan et al., 1982; Melveger and Huynh-Ba, 2008). 
Storage studies post-blending were carried out in two humidity-controlled cabinets 
(Binder, Germany), with temperature maintained at 20°C, and humidity controlled at 
two separate values - 40% RH and 60% RH (as requested by project sponsoring 
company GSK). Formulations were stored at these conditions for twelve weeks, based 
on other similar storage studies on pharmaceutical ingredients by Ng et al., (2007). 
7.2.7. Fluidised Bed Elutriation Testing 
As described in chapter 5, a FBE method was shown to be successful in separating fine 
and coarse particles of inhalation-grade lactose. For this test, 20 g  0.1 g formulation 
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was placed in the column described in chapter 5, and exposed to a superficial gas 
velocity (SGV) of 6.27 cm s-1, which corresponded to a terminal velocity of 
approximately 25 m diameter lactose particles. Fluidisation was performed until all 
removable material was elutriated; this was subsequently weighed gravimetrically and 
assayed for drug content. 
7.2.8. Air Jet Sieve Testing 
An AJS method as described in section 6.4 was used to assess the amount of drug 
removed at various sieving times (10 s, 5 min, 30 min) using a back pressure of 600 Pa. 
10 g  0.1 g was used per sample, and drug assays were performed on coarse residue 
once sieving was complete to determine the amount of material removed by the sieve. 
7.2.9. Next Generation Impactor Testing 
Cascade impactors operate using the principle of inertial impaction. Each stage of the 
impactor comprises a single or multiple nozzles or jets through which the particles 
entrained in the air stream pass. Whether a particle impacts on a particular stage is 
dependent on its aerodynamic diameter. Particles with sufficient inertia will impact on 
that particular stage collection plate, whilst smaller particles with insufficient inertia 
remain in the air stream and pass to the next, smaller stage where the process is 
repeated. Since the stages are ordered in decreasing jet size, the air velocity increases 
and finer particles are collected. 
The Next Generation Impactor (NGI - Copley Scientific, Nottingham, UK) was launched 
in 2000 and accepted into the European Pharmacopoeia as Apparatus E and into the 
United States Pharmacopoeia as Apparatus 5 and 6 in 2005. At a volumetric flow rate 
of 60 l min-1 the cut-off points for stages 1-7 (Fig. 7.2) are 8.06, 4.46, 2.82, 1.66, 0.94, 
0.55, and 0.34 m respectively. The airflow passes through the impactor in a saw tooth 
pattern with particle sizing achieved by successively increasing the air velocity by 
passing through successively smaller jets. NGIs are becoming increasingly common 
tool for aerodynamic particle size analysis – Pitchayajittipong et al., (2010) and Taki et 
al., (2010) both highlight recent examples of NGI use for assessing DPI formulations. 
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Fig. 7.2. Next Generation Impactor stages and collection plates 
 
Aerosolisation testing was performed on a NGI with preseparator that was connected 
to a vacuum pump (Copley HCP5, Copley Scientific, Nottingham, UK). Prior to testing, 
the preseparator was filled with 15 ml solvent, as were the NGI cups to eliminate 
particle bounce upon deposition. 25  1 mg of each blend was accurately weighed into 
size three hydroxypropylmethyl cellulose capsules (HPMC, ShionogiQualicaps, UK). For 
each experiment, two individual capsules of the same formulation were discharged 
into the NGI at 60 l min-1 for two bursts of 1.5 s in order to fully discharge the 
formulation from device. Formulations were discharged via two separate devices; a 
generic sample holder made from stainless steel (Steckel and Bolzen, 2004), and a 
Cyclohaler® (TEVA Pharmaceuticals, The Netherlands) - Pitchayajittipong et al., 
(2010). Following aerosolisation, each part of the NGI was washed with known 
volumes of solvent and the mass of drug deposited on each stage was determined by 
UV spectroscopy. For this study, the FPF was defined as particles which deposited in 
stage 2 and below of the NGI (i.e. particles with aerodynamic diameter <4.64 m). 
7.3. Results 
7.3.1. Effect of Blending of Formulation Characteristics 
Particle size data of lactose prior to blending results performed in triplicate (dry 
dispersion): d5 = 2.97  0.03 m; d10 = 9.51  0.07 m; d50 = 68.87  0.34 m. Table 7.1 
and Table 7.2 show particle size data for cholesterol and vitamin C blends respectively 
at various SEIs, along with the formulation homogeneity, expressed in coefficient of 
variation (CV) (see section 3.5) and the average drug composition by mass (both 
expressed in percentage terms). 
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As seen in previous chapters (Fig. 4.11, Fig. 4.26, Fig. 4.27 and Table 5.2), and work by 
Bridson et al., (2007), an increase in SEI is generally associated with an increase in 
particle size. This is particularly apparent at the fine end of the distribution, where a d5 
increase of around 1.5 m is observed with a SEI of ~600 kJ kg-1 using this bowl size, 
impeller speed, and mass fill (0.13 m diameter bowl, 500 rpm, 500 g). Likewise, the 
same orders of change are observed in both the d10 and d50 particle sizes as previous 
chapters. This suggests that blending inhalation-grade lactose with the mimic APIs 
cholesterol and vitamin C does not affect the size distribution of the bulk formulation. 
This is to be expected since the mimic drugs only make up less than 2% of the 
formulation by mass, thus would not affect the size distribution substantially enough 
to be observed in laser diffraction particle sizing. 
Based on the previous work described in Fig. 4.26 and Fig. 4.27, chemical homogeneity 
(defined by CV <6% - Crooks and Ho, 1976) was observed in all the blends produced 
with SEI greater than ~200 kJ kg-1. Therefore, the formulations were suitably 
homogeneous for use in the fluidised bed, AJS, and NGI tests to assess the effect of 
blending on fine particles. There was no observed difference in the ability of the high 
shear blender to disperse the mimic drugs throughout the bulk lactose, despite there 
being differences in the cohesivity of cholesterol and vitamin C. As seen in section 
3.4.5, cholesterol is more cohesive than vitamin C, and thus may have been more 
difficult to achieve suitably cohesive formulations. In addition, there was no observed 
improvement in the cohesivity of the formulations beyond ~200 kJ kg-1 SEI, in line 
with the results found in section 4.3.10. 
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7.3.2. Effects of Blending on Fine Mimic API Particles 
7.3.2.1. Fluidised Bed 
The total amount of drug elutriated from a 20 g sample of formulation (corresponding 
to ~290 mg drug) typically ranged between 120 and 130 mg for both cholesterol and 
vitamin C at all SEIs – roughly 45-50% by weight of the formulation. Thus at this SGV 
(6.27 cm s-1), approximately half of the available drug can be removed from these 
formulations. As seen previously in chapter 5, the total amount of formulation (drug 
and lactose) elutriated was not affected by SEI either. Thus, the mass elutriated from 
the bed was similar for both cholesterol and vitamin C containing formulations, and 
was consistent with data from chapter 5 (mass was between 1600 and 1800 mg for 
each sample). 
AFM methods used in the CAB work reported by Begat et al., (2004) and Young and 
Price, (2004), amongst others, showed differences between the adhesive force holding 
drug-lactose pairs together, however these experiments were on single pairs of 
particles, unlike this bulk detachment method. It was shown in their work that the 
adhesive force between budesonide and lactose was smaller than the force between 
salbutamol sulphate and lactose, and that the cohesive forces between two budesonide 
crystals were greater than those between two salbutamol sulphate crystals; indicating 
that budesonide was far more cohesive than salbutamol sulphate. Based on that data, it 
would be expected that the less cohesive vitamin C used in this study would have a 
greater affinity to lactose than cholesterol, and thus elutriate less mass from the 
fluidised bed. 
Fig. 7.3 shows the amount of drug elutriated as a percentage of the initial amount in 
the bed for both cholesterol and vitamin C (data from Table 7.1 and Table 7.2). 
Interestingly, no significant differences were observed in the behaviour of cholesterol 
and vitamin C with regards the amount of drug elutriated from the fluidised bed. It 
could be the case that the cohesive and adhesive forces experienced between 
cholesterol and lactose, and vitamin C and lactose were largely similar, and therefore 
similar amounts of drug would be elutriated. On the other hand, the elutriation process 
used in this study may not be subtle enough to remove individual particles, which 
could possibly be used to identify differences in adhesive strength. Since the fluidised 
bed requires removal of particles of the order of 25 m, (sufficient airflow to suitably 
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fluidise the bed), it may be the case that the particles removed reside in entities 
(including lactose-drug agglomerates) that are readily removed, and separation of 
carrier and individual drug particle may not occur in this system. 
Jones et al., (2008) report that the micronisation process has the effect of normalising 
the physical properties of drugs, thus they may appear to behave in similar ways, 
despite their differences in properties in their natural state. It could be the case that 
upon blending with lactose (and only making up less than 2% of the formulation by 
weight) that elutriation from a fluidised bed is too crude to identify differences 
between the drugs when in formulation. 
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Fig. 7.3. Amount of drug elutriated as a function of SEI, using a fixed formulation mass of 20g. Error bars 
represent average of three independent experiments on each sample.  - cholesterol,  - vitamin C. 
7.3.2.2. Air Jet Sieve 
Results from the AJS experiments showed that at 30 s, approximately 70 mg drug could 
be removed from 10 g formulation – roughly half of the initial drug mass. After 5 min, 
this increased to roughly 90 mg (~60% initial mass), and after 30 min, about 140 mg 
could be removed (~95% initial mass). As with the fluidised bed results, there were no 
observed differences between the mass removed from formulations containing 
cholesterol or vitamin C. In addition, SEI did not affect the amount of formulation 
removed, such that formulations blended with ~200 kJ kg-1 displayed similar results to 
those blended with ~600 kJ kg-1 (Kruskal-Wallis test - page 119). The differences 
No significant differences observed between the amount 
of vitamin C and cholesterol elutriated from fluidised bed 
over range of SEIs 
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observed in the amount of mass removed between formulations exposed to low SEIs 
(~70 kJ kg-1) and high SEIs (~600 kJ kg-1) seen in chapter 6 were not observed with 
chemically homogenous formulations, thus suggesting that the differences seen in 
lactose-only formulations only apply to lower SEIs corresponding to the de-
agglomerated lactose (see chapter 4). This provides further evidence that blending 
beyond the point of homogeneity may not be beneficial, as no improvement in the 
delivery of drug has been observed. 
The same arguments hold for AJS data, with it being likely that the AJS is not 
discriminating enough to distinguish between cholesterol and vitamin C in terms of 
amount of drug removed, at any of the pressures or sieving times tested. As with the 
FBE method, the AJS method is designed to view bulk changes in formulation adhesion 
and cohesion, unlike the AFM methods, which measured single-particle pairs. 
7.3.2.3. Next Generation Impactor 
Differences between cholesterol and vitamin C 
Unlike FBE and AJS data, NGI data showed slight differences between formulations 
containing each compound. Using the Cyclohaler device, between 15 and 20% of the 
mass of vitamin C in the formulation at present was delivered beyond stage 2 of the 
NGI, whereas for cholesterol, between 24 and 28% of the formulation was delivered 
beyond stage 2 (Table 7.1 and Table 7.2). 
Although these raw values are much smaller than the percentage drug elutriated or 
removed by the AJS, it should be remembered that stage 2 represents particles with 
aerodynamic diameters <4.64 m. When compared to the cut off aerodynamic 
diameter and sieve aperture size of 25 m used in the fluidised bed and AJS techniques, 
these values are expectedly lower.  
Based on particle size alone, it would be expected that vitamin C had a greater delivery 
past stage 2 than cholesterol, since prior to blending, the particles were finer (see 
Table 3.2). There are two possible explanations which describe the superior FPF 
formulation performance of the more cohesive cholesterol over vitamin C. Firstly, a 
more cohesive system represents a weaker dug-carrier adhesion, thus a smaller force 
is required to detach a drug particle from the carrier, resulting in aerosolisation of a 
greater number of drug particles (Jones et al., 2008). Secondly, the formation of larger 
drug-only agglomerates can result in improved performance via an agglomeration 
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method proposed for other types of DPI formulations (Begat et al., 2004). Previous 
work focussing on CAB ratios suggests that as cohesive materials tend to form larger 
agglomerates, they experience greater shear and drag forces during aerosolisation (see 
Equation 7.1 and Equation 7.2). An explanation for this centred around the drag forces 
and kinetic energies experienced upon entrainment into an airstream. Equation 7.1 
and Equation 7.2 describe the drag force, Fdrag and kinetic energy, Ek of agglomerates in 
an air stream respectively. 
22
8
vCF
agggddrag
 Equation 7.1 
where, Cd is the drag coefficient, g is the gas density, agg is the effective diameter of 
the agglomerates, and v is the velocity of gas (in Equation 7.1, this is the gas velocity 
relative to the particle velocity, whereas in Equation 7.2 it is the absolute velocity of 
the particle). 
23
12
vE
aggaggk
 Equation 7.2 
where, EK is the kinetic energy of the agglomerate moving in the gas stream, and agg is 
the density of the agglomerate. It was hypothesized that the both the drag force which 
breaks up agglomerates and the kinetic energy which affects the drag efficiency by 
increasing the number and energy of collisions, increase in proportion with 3 and 2 
respectively, thus larger agglomerates are subjected to greater deagglomeration forces 
(Begat et al., 2004). Whilst this suggests that materials that are more cohesive may 
offer superior formulation performance, a balance needs to be made since excessive 
cohesivity could result in the formation of agglomerates that resist the separation and 
de-agglomeration forces, resulting in poorer formulation performance.  
Effects of SEI on formulation behaviour 
Despite differences being observed between cholesterol and vitamin C behaviour, in 
the FPF, effects of SEI on formulation aerodynamic behaviour were still not observed 
by the NGI. For both vitamin C and cholesterol, the delivery of fine drug particles 
showed no change with respect to increasing SEI (Fig. 7.4), backing up the results in 
chapter 4, and the elutriation and AJS results earlier in this chapter that suggest 
additional HSB beyond the point at which chemical homogeneity is achieved does not 
improve fine particle drug delivery. 
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Fig. 7.4. Percentage mass delivered to stage 2 and beyond (FPF) from NGI as a function of SEI for 
cholesterol and vitamin C formulations. 
Despite affecting the PSD of formulations, increased SEI has not been observed to alter 
the separation of fine drug particles from carrier particles. This suggests that the 
press-on forces attaching drug particles to carrier particles imparted during HSB do 
not increase beyond a certain point, and once the drug particles are attached – further 
application of blend energy will not increase the strength of attraction. Instead, the 
additional energy is used to create agglomerates of particles observed previously in 
this study. This has implications for the manufacture of DPI formulations since the 
primary indicator of performance is the amount of drug delivered to the respiratory 
zone, and if this amount is not seen to increase with additional SEI, it may be deemed 
unnecessary to perform extended blending.  
 
Effect of device in NGI trials 
In addition, the de-agglomeration and dispersion effects of the Cyclohaler® device 
were observed in this study, as an increased fine particle mass was observed with 
formulation delivered through the inhaler, rather than the generic stainless steel 
device. Typically, around 25% of the drug loaded into the Cyclohaler® capsule was 
delivered to stage 2 or lower with cholesterol as the mimic drug, compared to around 
No change in amount of mimic drug reaching 
lower stages of NGI with increasing SEI 
More cholesterol reaching lower stages of NGI 
than vitamin C – suggesting stronger adhesion 
with lactose carrier particles 
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15% using the generic device (Table 7.1 and Table 7.2). This also applied to vitamin C, 
with around 18% of the available drug being deposited beyond stage 2 using the 
Cyclohaler device, whereas around 9% was delivered using the generic device. The 
remainder of the formulation either stayed in the capsule, device, preseparator or 
stage 1. This can be explained by the dispersion mechanism found within the 
Cyclohaler device that is not featured on the generic sample holder. This device creates 
a tortuous path for the particles suspended in the airstream, and enhances de-
agglomeration of particles, thus increasing the number of fine particles that can be 
deposited in the latter stages of the NGI.  
7.3.3. Effect of Storage on Formulation Characteristics 
7.3.3.1. Particle Size 
Fig. 7.5, Fig. 7.6, and Fig. 7.7 show the d5, d10 and d50 particle size of cholesterol 
formulations stored at 40% and 60% RH for 12 weeks respectively. It can be shown 
that 40% RH stabilises the particle size of the formulations, with d5, d10 and d50 
remaining constant throughout the storage period. However, 60% RH storage 
conditions cause the powder to agglomerate, an effect seen previously, and probably 
due to the formation of liquid bridges (Finot et al., 1996; Bérard et al., 2002; Young et 
al., 2003). PSD increases occur through fines adhering to the surfaces of larger 
particles, and through formation of agglomerates or multiplets of a series of smaller 
particles. This effect has been previously observed by Bridson et al., (2007) and in 
chapters 4 and 5 of this thesis. 
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Fig. 7.5. Effect of storage time and humidity on cholesterol formulation d5 particle size. Results shown are 
averaged from three independent experiments on three separate formulations at each energy input  SEM.  
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Fig. 7.6. Effect of storage time and humidity on cholesterol formulation d10 particle size. Results shown are 
averaged from three independent experiments on three separate formulations at each energy input  SEM. 
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Fig. 7.7. Effect of storage time and humidity on cholesterol formulation d50 particle size. Results shown are 
averaged from three independent experiments on three separate formulations at each energy input  SEM. 
 
It can also be seen that storage effects dominate over blending effects (Fig. 7.9). 
Immediate post-blending (time = 0) data shows that there are significant differences in 
particle size between formulations exposed to different SEI (especially in the d5 and d10 
values). However, after just one week of storage at high humidity, these effects become 
less apparent, and the difference between these formulations is greatly reduced, 
providing further evidence that the capillary forces described by Finot et al., (1996); 
Bérard et al., (2002), and Young et al., (2003) are present.  
Trends for vitamin C containing formulations match those found in cholesterol 
containing formulations, which is to be expected since the mimic drug makes up less 
than 2% of the formulation by weight. Fig. 7.8 shows vitamin C d5 particle size as a 
function of storage time, to highlight the similarity with the cholesterol formulation 
(Fig. 7.5), and emphasising the effects of storage dominating the effects of blending. 
Increase in 
d50 at 60% 
humidity 
Constant d50 at 
40% humidity 
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Fig. 7.8. Effect of storage time and humidity on vitamin C formulations d5 particle size. Results shown are 
averaged from three independent experiments on three separate formulations at each energy input  SEM. 
 
7.3.3.2. Homogeneity 
The chemical homogeneity of formulations was found to remain below 6% CV as 
specified in previous literature (Crooks and Ho, 1976; Flament et al., 2004) over the 
time of the study, thus the formulations were suitable for FBE, AJS and NGI analyses. 
This was the case for all formulations stored at 40% and 60% RH. 
7.3.4. Effects of Storage on Fine Mimic API Particles 
Tests were performed using the FBE, AJS, and NGI methods to assess the effects of 
different storage conditions on the behaviour of formulations. 
7.3.4.1. Fluidised Bed Elutriation 
Fig. 7.9 shows the effect of storage time and RH on the total amount of cholesterol 
elutriated from a 20 g  0.1 g sample of formulation, using a SGV of 6.27 cm s-1.  
The results show that storage at 60% humidity causes less cholesterol to be elutriated 
from the bed than storage at 40%. This was apparent after just one week of storage 
and was consistent across the timescale of the experiment. However, unlike the 
particle size data shown above, the amount of material elutriated did not decrease with 
prolonged storage; instead, it remained consistent across the 12-week timescale. This 
suggests that the fluidisation process may alter the behaviour of the blend, since 
Blending effects 
observed at t=0 
Blending effects removed 
with prolonged storage 
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material stored for 12 weeks at 60% RH behaved in the same way as material stored 
for just one week at 60% RH. Effectively, the fluidisation process may be “normalising” 
any storage effects such that they cannot be observed. However, the fluidisation 
process appears to be insufficient to reverse the effects of storage completely, hence 
the different amounts of total material that can be elutriated from formulations stored 
at 40% and 60% RH. 
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Fig. 7.9. Effect of storage time and RH on total amount of cholesterol elutriated from 20 g  0.1 g 
formulation fluidised with 6.27 cm s
-1
 SGV. Results shown are averaged from three independent 
experiments on three separate formulations at each energy input  SEM. 
 
Fig. 7.10 shows the amount of cholesterol elutriated following 10 min of fluidisation as 
a function of storage time and storage RH. Whilst the amount of cholesterol elutriated 
remains constant when stored at 40% RH, prolonged storage appears to decrease the 
amount elutriated. Unlike Fig. 7.9 which appears to show the ~120 min fluidisation 
process normalising storage effects, just 10 min of fluidisation time does not appear to 
have this effect, hence the reduced amount of cholesterol elutriated from formulations 
stored for longer periods of time at 60% RH. Statistically significant differences 
between cholesterol formulations stored at 40% and 60% RH were first observed 
(found by application of the Kruskal-Wallis test - page 119) following three weeks of 
storage, and the difference increased with further storage. 
High humidity storage effects normalised 
by extended fluidisation. 
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Fig. 7.10. Effect of storage time and RH on amount of cholesterol elutriated from 20 g  0.1 g formulation 
after 10 min fluidisation at 6.27 cm s
-1 
SGV. Results shown are averaged from three independent 
experiments on three separate formulations at each energy input  SEM. 
 
This reduction in amount of cholesterol elutriated appears to correlate with the 
particle size data that showed a coarsening of particle size with prolonged high-
humidity storage, suggesting that the same process affects both particle size and 
elutriation of drug. Previous literature supports this theory with Zeng et al., (2001), 
Price et al., (2002), Young et al., (2004), and Zhu et al., (2008) reporting a decrease in 
salbutamol sulphate FPF due to high humidity storage, whilst Das et al., (2009) shows 
this with salmeterol xinafoate, each due to an increase in interparticulate (capillary) 
forces associated with high humidity storage. Harjunen et al., (2003) also show this 
effect occurs at low budesonide doses; however, at high doses, they report the opposite 
effect, with moisture sorption causing electrostatic forces to decrease, thus allowing 
easier detachment from the carrier surface. Since the formulations in this study use 
relatively low doses (1.46% w/w), it is likely that the increase in capillary interaction 
theory applies, causing the reduction in elutriated fraction with increased storage. 
Vitamin C experiments (Fig. 7.11) showed the same trends as cholesterol (Fig. 7.10), 
however slightly less drug was elutriated than from the cholesterol formulations, 
suggesting the adhesion between vitamin C and lactose is greater than between 
cholesterol and lactose. 
Amount of cholesterol elutriated reduced 
with prolonged 60% RH storage 
Amount of cholesterol elutriated constant with 40% RH storage 
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Fig. 7.11. Effect of storage time and RH on amount of vitamin C elutriated from 20 g  0.1 g formulation 
after 10 min fluidisation at 6.27 cm s
-1 
SGV. Results shown are averaged from three independent 
experiments on three separate formulations at each energy input  SEM. 
 
7.3.4.2. Air Jet Sieve 
Removal of drug by AJS pressure was not seen to alter with storage time at either 40% 
or 60% RH. Results from cholesterol formulations showed that the amount of drug 
removed after 10 s from formulations stored at both 40% and 60% RH remained at 
~85 mg (Fig. 7.12) over the course of the experiment, whereas the amount removed 
after 30 min was ~145 mg (Fig. 7.13).  
Again, the effects of storage appear to have been cancelled by the AJS, similar to the 
effects seen in the fluidised bed. This removes the possibility to distinguish between 
samples stored over different periods of time under high humidity conditions, thus the 
amount of mimic drug removed were similar for formulations stored at both 40% and 
60% and also for formulations stored for just one week and those stored for 12 weeks.  
As seen with the FBE method, the amount of vitamin C removed was less than the 
amount of cholesterol removed (Fig. 7.14, Fig. 7.15), suggesting that the adhesion 
between vitamin C particles and lactose was greater than between cholesterol and 
lactose. This agrees with previous literature that suggest more hydrophilic drug 
substances show a stronger affinity to lactose than hydrophobic substances, hence 
removal of these particles from carrier surfaces is more difficult, this is explained in 
Amount of vitamin C elutriated reduced 
with prolonged 60% RH storage 
Amount of vitamin C elutriated constant with 40% RH storage 
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the CAB literature, which assesses the adhesive/cohesive balance in various drug-
excipient systems (Begat et al., 2004; Young and Price, 2004). 
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Fig. 7.12. Effect of storage time and RH on the amount of cholesterol removed from 10 g  0.1 g initial 
sample using AJS following 10 s sieving time, with 25 m sieve and 600 Pa backpressure. 
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Fig. 7.13. Effect of storage time and RH on the amount of cholesterol removed from 10 g  0.1 g initial 
sample using AJS following 30 min sieving time, with 25 m sieve and 600 Pa backpressure. 
 
Effects of storage cancelled by air jet 
sieve – even at short sieving times and 
low backpressure 
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Fig. 7.14. Effect of storage time and storage RH on the amount of vitamin C removed from 10 g  0.1 g 
initial sample using AJS following 10 s sieving time, with 25 m sieve and 600 Pa backpressure. 
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Fig. 7.15. Effect of storage time and storage RH on the amount of vitamin C removed from 10 g  0.1 g 
initial sample using AJS following 30 min sieving time, with 25 m sieve and 600 Pa backpressure. 
 
 
 
 
 
Amount of vitamin C removed by AJS less 
than amount of cholesterol removed - 
compare with Fig. 7.12 
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7.3.4.3. Next Generation Impactor 
Cascade impactor data shows cholesterol-containing formulations unaffected by 
storage conditions; in both cases, the amount of drug deposited at stage 2 or further in 
the NGI is around 90 g, irrespective of the storage conditions or time. Fig. 7.16 shows 
data from three formulations blended with SEI ~400 kJ kg-1 (formulations blended 
with ~200 kJ kg-1 and ~600 kJ kg-1 showed similar trends and magnitude of fine 
particle mass).  
The greater delivery of cholesterol compared to vitamin C is does not concur with the 
particle size data that suggests vitamin C is finer, however previous work suggests that 
more hydrophobic compounds can produce a greater FPF during aerosolisation testing 
than more hydrophilic compounds (Price et al., 2002; Young et al., 2004; Zeng et al., 
2007). In addition, as described in section 7.3.2.3, formulations that are more cohesive 
have been shown to have better FPF performance, which concurs with the results 
found here as the cholesterol used in this study was found to be more cohesive than 
the vitamin C (Table 3.3). 
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Fig. 7.16. Effect of storage time and storage RH on cholesterol and vitamin C fine particle mass determined 
by NGI using Cyclohaler® device operating at 60 l min
-1
 flow rate with 250 mg formulation loaded into size 
three capsules. Results are averaged from three independent samples from three independent 
formulations with SEI ~400 kJ kg
-1
 stored at each humidity. 
 
Price et al., (2002) show that the separation energy for salbutamol sulphate 
(hydrophilic) particles is much greater than budesonide (hydrophobic) at high 
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humidity. Young et al., (2004) found a decrease in FPF due to high-humidity storage of 
salbutamol sulphate, caused by increased capillary forces and possible liquid bridge 
formation, supporting previous work by Zeng et al., (2001), Price et al., (2002), and 
Harjunen et al., (2003). In addition, Borgstrom et al., (2005) and Zeng et al., (2007) 
have reported significant reductions in FPF due to increased RH storage conditions, 
whilst Traini et al., (2006) used AFM to find that the separation energy required to 
detach salbutamol sulphate, budesonide, and formoterol fumarate dihydrate drug 
particles from carrier increased in high-humidity environments. 
Results from NGI impaction experiments show a decrease in the fine particle delivery 
of vitamin C with prolonged storage at high humidity. Statistically significant 
differences were observed from 8 weeks storage; however, the trend appeared to 
begin at just 3 weeks (Kruskal-Wallis test - page 119). Despite this, corresponding FBE 
and AJS experiments do not show similar reductions. A likely explanation is such that 
the fine particle definition of the NGI is <4.64 m, whereas with the FBE and AJS tests 
developed, the fine particles removed are <25 m, thus the NGI offered greater 
discrimination between formulations. It is able to de-agglomerate any groups of drug 
that may have formed and thus is more representative of an inhalation event than the 
other two methods. Whereas the fluidised bed and AJS methods will remove every 
object (single particle or agglomerate) less than 25 m, the NGI will only assess those 
less than 4.64 m, hence seeing differences that occur in this population of particles.  
In addition, the increased PSD of the formulations with prolonged storage at high 
humidity (Fig. 7.5 - Fig. 7.8), explains the reduced elutriation and NGI FPF, as the 
coarser formulations possess fewer free fines. This is backed up by shear cell analysis 
that showed that formulations stored at 60% RH for a prolonged period had a smaller 
FF, and were hence more cohesive (Table 7.3). This can again be explained by the 
increased liquid bridge formation and enhanced capillary forces that occur in high 
humidity formulations and has been shown previously in Fig. 5.5 where the amount of 
mass elutriated from the fluidised bed reduced for lactose only samples stored at high 
humidity. Although no statistically significant differences could be observed between 
cholesterol and vitamin C formulations, this was expected as the shear cell analysis is a 
bulk characterisation technique and the effects of the mimic drug on the mechanical 
properties of the powders is minimal. Results for the FFs immediately post blending 
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concur with previous results for blended formulations (Table 4.4), and storage at 40% 
RH was not seen to affect the cohesivity, as with PSD and fine particle separation data. 
 
Table 7.3. Flow functions (fc) of cholesterol and vitamin C formulations used in this study. Results show 
average values from three formulations at each energy input with three independent experiments 
performed on each batch. Errors represent  SEM and are rounded to two decimal places. 
 40% storage 60% storage 
Material Week 0 Week 12 Week 0 Week 12 
Vitamin C (~200 kJ kg
-1
) 4.02  0.58 4.32  0.44 4.02  0.67 2.32  0.56 
Vitamin C (~400 kJ kg
-1
) 4.18  0.54 4.06  0.83 3.93  0.61 2.56  0.63 
Vitamin C (~600 kJ kg
-1
) 4.45  0.64 4.30  0.42 4.28  0.97 2.22  0.76 
Cholesterol (~200 kJ kg
-1
) 4.21  0.54 4.46  0.61 4.15  0.86 2.20  0.59 
Cholesterol (~400 kJ kg
-1
) 4.47  0.78 4.05  0.58 4.36  0.66 2.47  0.50 
Cholesterol (~600 kJ kg
-1
) 4.11  0.54 3.99  0.73 4.03  0.71 2.31  0.72 
 
Humidity conditions have affected vitamin C more strongly than cholesterol due to 
their relative hydrophobicities and the greater solubility of vitamin C with respect to 
cholesterol is likely to be a factor in its decreased performance following prolonged 
high RH storage. It has previously been shown that more hydrophobic compounds 
(cholesterol) are less strongly affected by high humidity conditions than more 
hydrophilic compounds (vitamin C). Price et al., (2002) found that the separation 
energy and adhesive force was much greater for salbutamol sulphate (hydrophilic) - 
lactose interactions than budesonide (hydrophobic) - lactose interactions, whilst 
Harjunen et al., (2003) reported an increase in FPF of budesonide associated with 
prolonged high humidity storage. Zeng et al., (2001), Young et al., (2004), and Zhu et 
al., (2008) report a decrease in FPF of salbutamol sulphate due to storage at high RH, 
whilst Das et al., (2009) show a decrease in FPF with the hydrophilic salmeterol 
xinafoate. 
7.4. Conclusion 
This chapter has shown that HSB regimes do not appear to affect the ability of 
micronised cholesterol and vitamin C to separate from inhalation-grade -lactose 
monohydrate, based on FBE, AJS, and NGI studies. These tests showed no significant 
differences in the amount of fine (<25 m) particles elutriated, removed by sieving, or 
comprising the FPF based on NGI experiments (which focussed on fines <4.64 m). 
Tests were performed on chemically homogeneous formulations and showed that 
extended SEI past the point of homogeneity did not affect the separation of drug 
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particles, despite a continual increase in the particle size distribution of the 
formulations. 
On the other hand, storage regimes were shown to affect the performance of DPI 
formulations. Storage of formulations at 60% RH has been shown to reduce the ability 
of fine vitamin C particles to separate from lactose carriers compared to formulations 
stored at 40% using both the FBE and NGI methods. Elutriation of cholesterol from the 
fluidised bed was also seen to decrease with 60% RH storage, whereas NGI data 
showed no difference in the FPF of cholesterol from formulations stored at 40% or 
60%.  
However, the AJS method was seen to cancel storage effects, with no differences 
observed between the formulations stored at 40% and those stored at 60% with 
respect to fine particles removed for both vitamin C and cholesterol containing 
formulations.  
The FBE and AJS methods showed no difference in the amount of drug 
elutriated/removed between cholesterol and vitamin C with respect to SEI. However, 
this is most likely due to these methods not being quite as sensitive to fine particles as 
the NGI, and thus removing the mimic drug particles in small agglomerates with 
lactose particles, and not just single particles being removed. Overall, the FBE has 
shown that it can be used as a tool to assess mimic DPI formulations, however unlike 
the NGI method; it does not have the sensitivity to very fine particles in the respirable 
size range of 1-5 m. Instead, it measures performance based on the elutriation of 
particles with aerodynamic diameter <25 m. It is useful to compare the velocities 
experienced in each analysis technique used. As previously mentioned, the FB method 
uses a SGV of 6.27 cm s-1, which is by far the lowest velocity used. By application of 
Bernoulli’s equation P = ½ v2, where P is the dynamic pressure applied to the system, 
 is the density of air (1.2 kg m-3), and v is the gas velocity, the velocity of air through 
the AJS can be estimated to be ~ 32 ms-1 (at 600 Pa). Finally, velocities in the NGI can 
be estimated by using the cross sectional areas of the nozzle at the collection plate, and 
at the capsule, along with the flow rate used to mimic an inhalation event (60 l min-1). 
At the capsule, with diameter through which the powder flows estimated to be 0.5 mm, 
the velocity is approximately 2 ms-1, whereas this increases to approximately 200 ms-1 
at the collection plate nozzle (diameter ~ 5 m).  
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8.0. Conclusion 
8.1. Importance of Work and Review of Findings 
The main aims and conclusions of this work have been discussed below, with reference 
to the aims outlined in chapter 1. 
The effects of the scale of HSB regimes on the properties of mimic DPI formulations, 
including PSD, SSA, and chemical homogeneity were investigated to compare 
against previous literature. 
HSB was shown to affect the particle size of inhalation-grade lactose such that an 
increased SEI was shown to coarsen the powder by agglomeration of fine particles 
with each other to form multiplets of fine particles, and by attachment to larger carrier 
particles. This agglomeration followed an initial decrease in particle size at low SEIs, an 
event that was previously unseen during the HSB of inhalation-grade lactose and was 
attributed to the redistribution of particles, and the break-up of agglomerates found in 
the unprocessed lactose, before reagglomeration occurred with further energy input. 
Changes to the particle size of lactose were characterised by laser diffraction and SSA 
studies, which were used as tools to confirm the mechanism by which particle changes 
occurred.  
The initial decrease and subsequent increase in PSD was observed across a series of 
laboratory-scale, geometrically similar HSB equipment. However, their magnitude and 
rate at which they occurred differed over the scales tested in this study, with the larger 
bowls appearing to increase both the rate and magnitude at which these changes 
occurred. A novel feature of this work was the use of equipment with distinct high 
shear blending process, previous studies exploring blending effects on DPI 
formulations have often used blenders which do not utilise a high shear process, 
instead using tumbling methods or even equipment with a milling action. 
Regime maps were produced to highlight preferential blending conditions for each 
high shear blender bowls and impellers. Such knowledge was required in order to 
achieve optimal blending conditions for the production of mimic formulations that 
were produced for work later in the thesis. 
Despite the lactose used in this study being the same inhalation-grade powder used by 
the manufacturer, closer investigation proved that the initial PSD was slightly finer 
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than that used in a previous study. This highlighted the importance of characterisation 
of materials used in DPI formulations prior to manufacture of the final product. It 
showed that even slight changes in the initial properties of materials have profound 
effects on the behaviour of such powders, and could have implications for the 
performance of these formulations.  
In addition, the chemical homogeneity of mimic DPI formulations was tested using 
vitamin C and cholesterol as mimic APIs, the rationale of their choice being their 
notably different cohesivities. It was found that a suitably homogenous formulation 
was produced with relatively low SEI, roughly corresponding to the point at which the 
PSD of the formulations began to re-agglomerate. However, unlike the PSD, the 
homogeneity was not seen to alter with additional SEI, and remained below the 
prescribed limit of <6% CV as stated in previous literature. This has implication for the 
pharmaceutical industry as it indicates that extended blending regimes may not be 
beneficial to the quality of formulation in terms of chemical homogeneity.  
It was found that the point at which homogeneity is achieved varies depending on the 
cohesivity of the mimic drugs and hence their particles’ relative affinity to lactose. It 
was shown that the more cohesive cholesterol required a greater energy input to 
achieve chemical homogeneity than vitamin C, which due to its weaker cohesivity, the 
agglomerates present in its micronised state, were more readily distributed 
throughout the bulk lactose powder.  
 
A classical FB was designed, built, and used to test DPI formulations, with the 
principles of elutriation employed to separate fine particles from the bulk powder 
within the bed.  
A classical fluidised bed was designed and built to explore the effects of passing an air 
stream through formulations to explore the effects of blending and storage on the 
separation of fine particles from coarse particles using the principles of elutriation. 
Elutriation of particles is often an undesired effect of fluidisation in chemical 
engineering processes; however, in this project it has been used to classify particles 
according to aerodynamic particle size. Separation of drug particles from carrier 
particles is a key process involved in the delivery of API to the lungs, and although not 
attempting to mimic an inhalation event, the use of classical fluidised bed equipment 
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enabled separation mechanisms similar to those in a DPI to be employed, without 
requiring the use of a real device. 
Tests on lactose-only formulations immediately post-blending showed that 
measurements of pressure drop across the bed vs SGV was not sufficient to distinguish 
between samples exposed to different SEIs, although the bed could differentiate 
batches that had been deliberately coarsened by sieving (section 3.4.5.1) to produce 
samples with significantly different cohesivities. In addition, the amount (mass) of 
material elutriated was not sufficient to differentiate between samples exposed to 
different SEIs. However, closer analysis of the elutriated fraction showed a change in 
the size distribution of particles elutriated, suggesting that the blending process 
affected the particles in the ~25 m size range, along with the fine particles that were 
seen to be affected previously.  
Therefore, the FBE method described in this thesis has shown to be a potential tool for 
assessing formulation behaviour at various stages during the secondary manufacturing 
process. This is a particularly useful technique as it deals with formulations in their 
actual state (does not require suspension of particles in fluids etc.) immediately post-
blending and eliminates the need to fill devices or other equipment to perform such 
adhesion tests. In addition, statistically significant numbers of particles were 
examined; therefore, the bulk properties are being assessed, rather than individual 
particles or pairs of particles, without wasting an excessive amount of valuable 
formulation.  
 
The effects of HSB regimes on the in vitro performance of mimic DPI formulations 
using the novel FBE technique were investigated, and compared to conventional 
AJS and NGI separation techniques used to assess the properties of DPI 
formulations.  
Tests were performed on mimic DPI formulations using cholesterol and vitamin C as 
mimic APIs. Tests were performed using the newly developed FBE technique for 
separating fine particles, and compared to AJS and cascade impactor methods. It was 
found that the effects of blending could not be determined using any of the separation 
techniques, with the amount of drug removed by each method being consistent over a 
range formulation SEIs. This suggested that extended blending regimes might not be 
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beneficial to the formulation performance. Earlier work in this study showed that 
additional SEI beyond the point at which suitable chemical homogeneity was achieved 
increased the PSD of the formulation.  
Differences were observed between the amount of cholesterol removed and the 
amount of vitamin C removed, with the NGI method showing a greater delivery of fine 
cholesterol particles to the latter stages of the impactor than vitamin C. This concurred 
with previous literature that found more cohesive APIs offered greater in vitro 
performance due to the reduced affinity to the larger lactose particles. The FBE and AJS 
methods showed no difference in the amount of drug elutriated/removed between 
cholesterol and vitamin C; however, this is most likely due to these methods not being 
quite as sensitive to fine particles as the NGI, and thus removing the mimic drug 
particles in small agglomerates with lactose particles, and not just single particles 
being removed. 
 
The effects of storage regimes on the in vitro performance of mimic DPI 
formulations using the novel FBE technique were investigated, and compared to 
conventional AJS and NGI, separation techniques used to assess the properties of 
DPI formulations.  
The effects of storage were seen to predominate over the effects of blending, with 
particle size distributions of all formulations seen to increase with prolonged storage 
at 60% RH. This was due the formation of liquid bridges and enhanced capillary forces 
causing particles to agglomerate; this effect was seen in both cholesterol and vitamin C 
formulations to the same degree.  
Fine particle studies using the AJS were inconclusive, with the amount of vitamin C and 
cholesterol removed being similar over all storage periods. However, both the NGI and 
FBE methods showed differences in the amount of vitamin C removed with respect to 
storage conditions. Both methods showed a decrease in fine particle delivery with 
continued storage at 60% RH, an effect explained by the increased capillary forces 
between mimic drug and carrier. Cholesterol fine particle delivery was seen to 
decrease with extended 60% RH storage using the FBE method, although no 
differences were observed using the NGI method. This again was due to the FBE 
method being a method analysing agglomerates of particles, rather than the NGI 
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method that analysed individual particle separation. Cholesterol, due to its 
hydrophobicity was less sensitive to high-humidity storage conditions than the more 
hydrophilic vitamin C, hence the lack of change in fine particle delivery over time.  
With current pharmaceutical emphasis being placed on Quality by Design and Process 
Analytical Technologies, monitoring the performance and behaviour of products at 
each stage of manufacture is vitally important to minimise waste and associated costs. 
Overall, this thesis has shown that the FBE technique can be used to analyse mimic DPI 
formulations, and detect blending and storage induced changes in these powders. It 
can be used in conjunction with existing cascade impactor studies to evaluate the 
performance of formulations throughout the secondary manufacturing process. The 
major limitation is the lack of ability to elutriate the very fine particles since the SGV 
required to elutriate particles solely in the 1-5 m size range required for pulmonary 
deposition is insufficient to fluidise the powder bed, thus collection of these powders is 
difficult.  
Each of the FBE, AJS, and NGI tests used in this study has used bulk separation 
methods. Many previous AFM studies have separated individual drug particles from 
larger carrier particles, and are able to assign values to the adhesive force required to 
separate the particles. A quantitative evaluation of the forces involved in separation of 
drug particles from carriers on a bulk scale would be useful, in order to compare to the 
values attributed to single pairs of particles found through AFM, and provide a value 
for the force required to liberate a given amount of drug. However, due to the range of 
separation mechanisms involved (shear forces, gravitational forces, particle-particle, 
and particle-wall collisions) and the range of particle properties (size, shape, surface 
rugosity, density etc.) featured in DPI formulations, measuring values in bulk is 
extremely difficult.  
Despite the wide range of literature regarding interactive forces in DPI formulations, 
prediction of powder behaviour will continue to be difficult due to the three-
dimensional particle shapes with unknown number and strength of contact points 
between drug and carrier. It should also be considered that minimising the 
interparticulate forces might not always be desirable if the clinical physiological 
response or reliability of treatment is not improved in turn.  
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8.2. Opportunities for Further Work 
The importance of this work was to develop and understand ways to reduce batch 
variability, and increase process understanding in order to eliminate batch failure. In 
addition, increasing the depth of understanding of formulation processing and the 
development of new analysis techniques that allows formulations at different energy 
states to be identified. 
There are several options that could be explored to further the work described in this 
thesis. Firstly, the use of active drugs could be used rather than the mimics used in this 
study, thus enhancing the knowledge of their formulation performance. Secondly, 
alternative blending methods could be explored. As increased HSB was observed to not 
significantly improve the chemical homogeneity of formulations beyond given SEIs, it 
may be useful to determine the effects of other blending regimes on the performance of 
formulations. 
Discrete Element Modelling (DEM) of the interactions present within DPI formulations 
during both the manufacturing process and delivery to the lungs could be explored 
further, although this is often difficult to achieve satisfactorily given the wide range of 
variables that are a feature of these powders. The size, shape surface features, 
variations of forces, non-linear airflow patterns (amongst other variables) make 
modelling difficult for an ensemble of particles making up an interactive mixture with 
multimodal distribution. However, idealised particles can readily be used and each one 
of the factors listed above can be studied independently to enhance knowledge and 
understanding of how they affect DPI performance.  
Finally, a study into the importance of HSB, and the extent to which it is used in DPI 
manufacture could also be undertaken. As shown in the results, extended HSB may be 
preventable if it is seen to not improve performance of the final product. A comparison 
involving low-shear or tumbling blending regimes may be useful in this study.  
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Appendix 
Example density and cumulative distribution curves from dry laser 
diffraction measurements: 
 
Example Raw PSD data of unblended lactose 
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Example Raw PSD data of blended lactose (197 kJ kg-1) 
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Example Raw PSD data of blended lactose (399 kJ kg-1) 
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Example Raw PSD data of blended lactose (618 kJ kg-1) 
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Example Raw PSD data of 71 m lactose 
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Example shear cell measurements of unconfined yield stress ( ), against 
consolidation stress ( ) 
 
Example Mohr’s Circles for Unblended Lactose 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Example Mohr’s Circles for “Deagglomerated” Lactose (Blended for 88 kJ kg-1) 
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Example Mohr’s Circles for “Agglomerated” Lactose (Blended for 602 kJ kg-1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Example Mohr’s Circles for “25 m” Lactose 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Example Mohr’s Circles for “71 m” Lactose 
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